# ::snt Combining global genome and transcriptome approaches to identify the candidate genes of small-effect quantitative trait loci in collagen-induced arthritis .
# ::tok Combining global genome and transcriptome approaches to identify the candidate genes of small-effect quantitative trait loci in collagen-induced arthritis .
# ::alignments 18-19|0.0.0.0.0.0 17-18|0.0.0.0.0 15-16|0.1.1.0 14-15|0.1.1.0.0 13-14|0.1.1.0.1 10-11|0.1.1 9-10|0.1.1.1 7-8|0.1 5-6|0 4-5|0.1.0 3-4|0.0 2-3|0.0.0 1-2|0.0.0.1 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:45:40.513
(a2 / approach-02 
      :ARG0 (a3 / and 
            :op1 (g2 / genome 
                  :ARG1-of (c3 / combine-01 
                        :ARG0 (c / collagen-induc 
                              :mod-of (a / arthritis))) 
                  :mod (g3 / globe))) 
      :ARG1 (i / identify-01 
            :ARG0 (t2 / transcriptome) 
            :ARG1 (g / gene 
                  :mod (l / locus 
                        :mod (t / trait) 
                        :mod (q / quantitative)) 
                  :mod (c2 / candidate))))

# ::snt Quantitative traits such as complex diseases are controlled by many small-effect genes that are difficult to identify .
# ::tok Quantitative traits such as complex diseases are controlled by many small-effect genes that are difficult to identify .
# ::alignments 16-17|0.0.0 14-15|0.0.0.1 11-12|0.0 9-10|0.0.2 7-8|0 5-6|0.0.0.0 4-5|0.0.0.0.0 2-3|0.0.1 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:45:40.798
(c / control-01 
      :ARG0 (g / gene 
            :ARG0-of (i / identify-01 
                  :ARG1 (d2 / disease 
                        :mod (c2 / complex)) 
                  :domain-of (d / difficult)) 
            :domain-of (s / such) 
            :quant (m / many)) 
      :ARG1 (t / trait 
            :mod (q / quantitative)))

# ::snt Here we present a novel strategy to identify the candidate genes for small-effect quantitative trait loci ( QTL ) in collagen induced arthritis ( CIA ) using global genome and transcriptome approaches .
# ::tok Here we present a novel strategy to identify the candidate genes for small-effect quantitative trait loci ( QTL ) in collagen induced arthritis ( CIA ) using global genome and transcriptome approaches .
# ::alignments 31-32|0.2 30-31|0.2.1 29-30|0 28-29|0.1 27-28|0.1.0 26-27|0.0 24-25|0.2.0.1+0.2.0.0.0+0.2.0.0+0.2.0 22-23|0.0.0 21-22|0.0.0.0 20-21|0.0.0.1 15-16|0.0.1.1.0 14-15|0.0.1.1.0.0 13-14|0.0.1.1.0.1 10-11|0.0.1.1 9-10|0.0.1.1.1 7-8|0.0.1 5-6|0.0.1.0 4-5|0.0.1.0.0 2-3|0.0.1.2 1-2|0.0.1.0.1 0-1|0.0.1.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:45:43.615
(a2 / and 
      :ARG1-of (u / use-01 
            :ARG0 (a3 / arthritis 
                  :ARG1-of (i / induce-01) 
                  :mod (c / collagen)) 
            :manner-of (i2 / identify-01 
                  :ARG0 (s / strategy 
                        :mod (n2 / novel) 
                        :poss (w / we)) 
                  :ARG1 (g4 / gene 
                        :mod (l / locus 
                              :mod (t2 / trait) 
                              :mod (q / quantitative)) 
                        :mod (c2 / candidate)) 
                  :purpose-of (p / present 
                        :location (h / here)))) 
      :op1 (g / genome 
            :mod (g2 / globe)) 
      :op2 (a / approach-02 
            :ARG0 (g3 / government-organization 
                  :name (n / name 
                        :op1 "CIA") 
                  :wiki "Central_Intelligence_Agency") 
            :ARG1 (t / transcriptome)))

# ::snt First , we performed genome linkage analysis in F2 progeny of the CIA susceptible and resistant strains to search for small-effect QTL .
# ::tok First , we performed genome linkage analysis in F2 progeny of the CIA susceptible and resistant strains to search for small-effect QTL .
# ::alignments 18-19|0.0.0 16-17|0.0 15-16|0 14-15|0.0.1 13-14|0.0.1.1 12-13|0.0.2.1+0.0.2.0.0+0.0.2.0+0.0.2 9-10|0.0.1.0.1.0 8-9|0.0.1.0.1.0.0 6-7|0.0.1.0.1 5-6|0.0.1.0.1.1 4-5|0.0.1.0.1.2 3-4|0.0.1.0 2-3|0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:45:43.882
(r / resist-01 
      :ARG1 (s2 / strain 
            :ARG1-of (s / search-01) 
            :op3-of (a / and 
                  :op1 (p2 / perform-02 
                        :ARG0 (w / we) 
                        :ARG1 (a2 / analyze-01 
                              :ARG1 (p / progeny 
                                    :mod (f / F2)) 
                              :manner (l / linkage) 
                              :mod (g2 / genome))) 
                  :op2 (s3 / susceptible)) 
            :poss (g / government-organization 
                  :name (n / name 
                        :op1 "CIA") 
                  :wiki "Central_Intelligence_Agency")))

# ::snt Second , we detected gene expression patterns of both strains during CIA .
# ::tok Second , we detected gene expression patterns of both strains during CIA .
# ::alignments 11-12|0.3.1+0.3.0.0+0.3.0+0.3 9-10|0.1.0 8-9|0.1.0.0 6-7|0.1 5-6|0.1.2 4-5|0.1.1 3-4|0 2-3|0.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:45:44.474
(d / detect-01 
      :ARG0 (w / we) 
      :ARG1 (p / pattern-01 
            :ARG1 (s / strain 
                  :mod (b / both)) 
            :mod (g2 / gene) 
            :mod (e / express-01)) 
      :ARG1-of (s2 / second-01) 
      :ARG3 (g / government-organization 
            :name (n / name 
                  :op1 "CIA") 
            :wiki "Central_Intelligence_Agency"))

# ::snt The candidate genes were identified using three criteria : they are located in a genomic region linked to CIA ; they are disease-specific differentially expressed during CIA ; and they are strain-specific differentially expressed regarding the two parental strains .
# ::tok The candidate genes were identified using three criteria : they are located in a genomic region linked to CIA ; they are disease-specific differentially expressed during CIA ; and they are strain-specific differentially expressed regarding the two parental strains .
# ::alignments 38-39|0.0.0.0 37-38|0.0.0.0.0 36-37|0.0.0.0.1 34-35|0.0.0 33-34|0 32-33|0.0 28-29|0.0.1 26-27|0.0.1.3.0.0.1+0.0.1.3.0.0.0.0+0.0.1.3.0.0.0+0.0.1.3.0.0 24-25|0.0.1.3.0 23-24|0.0.1.3 19-20|0.0.1.2 18-19|0.0.1.1.1.0.1+0.0.1.1.1.0.0.0+0.0.1.1.1.0.0+0.0.1.1.1.0 16-17|0.0.1.1.1 15-16|0.0.1.1.2 11-12|0.0.1.1 9-10|0.0.1.1.0 7-8|0.0.1.0.1 6-7|0.0.1.0.1.0 5-6|0.0.1.0 4-5|0.0.1.0.2 2-3|0.0.1.0.0 1-2|0.0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:45:45.781
(e / express-01 
      :ARG1 (d / differentially 
            :ARG2-of (r / regard-01 
                  :ARG1 (s / strain 
                        :mod (p / parental) 
                        :quant 2)) 
            :op3-of (a / and 
                  :ARG2-of (u / use-01 
                        :ARG0 (g3 / gene 
                              :mod (c2 / candidate)) 
                        :ARG1 (c / criteria 
                              :quant 3) 
                        :ARG1-of (i / identify-01)) 
                  :op1 (l2 / locate-01 
                        :ARG1 (t / they) 
                        :ARG1-of (l / link-01 
                              :ARG2 (g2 / government-organization 
                                    :name (n2 / name 
                                          :op1 "CIA") 
                                    :wiki "Central_Intelligence_Agency")) 
                        :location (r2 / region)) 
                  :op1-of (a2 / and) 
                  :op2 (d2 / differentially 
                        :ARG1-of (e2 / express-01 
                              :time (g / government-organization 
                                    :name (n / name 
                                          :op1 "CIA") 
                                    :wiki "Central_Intelligence_Agency"))))))

# ::snt Eight small-effect QTL controlling CIA severity were identified .
# ::tok Eight small-effect QTL controlling CIA severity were identified .
# ::alignments 7-8|0 5-6|0.0 4-5|0.0.1.2+0.0.1.0.0+0.0.1.0+0.0.1 3-4|0.0.0 0-1|0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:45:45.828
(i / identify-01 
      :ARG1 (s / severity 
            :ARG1-of (c / control-01) 
            :mod (g / government-organization 
                  :name (n / name 
                        :op1 "CIA") 
                  :time (e / eight) 
                  :wiki "Central_Intelligence_Agency")))

# ::snt Of 22,000 screened genes , 117 were both strain-specific and disease-specific differentially expressed during CIA .
# ::tok Of 22,000 screened genes , 117 were both strain-specific and disease-specific differentially expressed during CIA .
# ::alignments 14-15|0.2.1+0.2.0.0+0.2.0+0.2 12-13|0 11-12|0.1 9-10|0.1.0 7-8|0.1.0.0 5-6|0.0.0.0 3-4|0.0 2-3|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:45:46.117
(e / express-01 
      :ARG0 (g2 / gene 
            :ARG1-of (s / screen-01 
                  :ARG0 117)) 
      :ARG1 (d / differentially 
            :op1-of (a / and 
                  :mod (b / both))) 
      :time (g / government-organization 
            :name (n / name 
                  :op1 "CIA") 
            :wiki "Central_Intelligence_Agency"))

# ::snt Of these 117 genes , 21 were located inside the support intervals of the 8 small-effect QTL and thus were considered as candidate genes .
# ::tok Of these 117 genes , 21 were located inside the support intervals of the 8 small-effect QTL and thus were considered as candidate genes .
# ::alignments 23-24|0.3.0 22-23|0.3.0.0 20-21|0.3 18-19|0.2 17-18|0 14-15|0.3.1 11-12|0.1.0.0 10-11|0.1.0.0.0 8-9|0.1.0 7-8|0.1 5-6|0.1.0.0.0.1 3-4|0.0 2-3|0.1.0.0.0.0 1-2|0.1.0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:45:46.297
(a / and 
      :example-of (g2 / gene) 
      :op1 (l / locate-01 
            :ARG1 (i2 / inside 
                  :op1 (i / interval 
                        :mod (s / support-01 
                              :ARG0 117 
                              :ARG1 21 
                              :time (t2 / this))))) 
      :op2 (t / thus-far) 
      :op3 (c2 / consider-01 
            :ARG0 (g / gene 
                  :mod (c / candidate)) 
            :ARG1 8))

# ::snt Susceptibility to most complex diseases is controlled by many genes , each having a small effect on the disease .
# ::tok Susceptibility to most complex diseases is controlled by many genes , each having a small effect on the disease .
# ::alignments 18-19|0.0 15-16|0 14-15|0.2 11-12|0.1 9-10|0.3.0.0.1 8-9|0.3.0.0.1.0 6-7|0.3.0.0 4-5|0.3.0 3-4|0.3 2-3|0.3.0.1 0-1|0.3.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:45:46.970
(e / effect-03 
      :ARG0 (d / disease) 
      :ARG1 (e2 / each) 
      :mod (s / small) 
      :mod (c2 / complex 
            :mod-of (d2 / disease 
                  :ARG1-of (c / control-01 
                        :ARG0 (s2 / susceptibility) 
                        :ARG2 (g / gene 
                              :quant (m / many))) 
                  :quant (m2 / most))))

# ::snt One example is rheumatoid arthritis ( RA ) , a common complex multifactorial autoimmune disease .
# ::tok One example is rheumatoid arthritis ( RA ) , a common complex multifactorial autoimmune disease .
# ::alignments 14-15|0.0.0 13-14|0.0.0.1 12-13|0.0.0.2 11-12|0.0.0.3 10-11|0.0.0.0 6-7|0.0.1.0.0+0.0.1.0+0.0.1 4-5|0 3-4|0.1 1-2|0.0 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:45:47.044
(a2 / arthritis 
      :domain (e / example 
            :domain-of (d / disease 
                  :mod (c2 / common) 
                  :mod (a / autoimmune) 
                  :mod (m / multifactorial) 
                  :mod (c / complex)) 
            :domain-of (o / organization 
                  :name (n / name 
                        :op1 "RA")) 
            :quant 1) 
      :mod (r / rheumatoid))

# ::snt Several studies have been carried out to detect the genetic basis of RA , and more than 30 genomic regions have shown evidence of linkage to the disease .
# ::tok Several studies have been carried out to detect the genetic basis of RA , and more than 30 genomic regions have shown evidence of linkage to the disease .
# ::alignments 27-28|0.1.2 24-25|0.1.1.1 22-23|0.1.1 21-22|0.1 19-20|0.1.0 17-18|0.1.0.0 15-16|0.0.0.0 14-15|0 12-13|0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 9-10|0.1.1.0 7-8|0.0.1 4-5|0.0 1-2|0.0.0 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:45:47.550
(a / and 
      :op1 (c / carry-out-03 
            :ARG1 (s2 / study-01 
                  :ARG1 (m / more) 
                  :quant (s3 / several)) 
            :purpose (d2 / detect-01 
                  :ARG1 (o / organization 
                        :name (n / name 
                              :op1 "RA")))) 
      :op2 (s / show-01 
            :ARG0 (r / region 
                  :quant 30) 
            :ARG1 (e / evidence-01 
                  :ARG0 (g / gene) 
                  :ARG1 (l / linkage)) 
            :ARG2 (d / disease)))

# ::snt Most of these genomic regions did not reach a genome-wide significant threshold value of linkage , with P values between 0.05 and 0.001 [ 1-5 ] .
# ::tok Most of these genomic regions did not reach a genome-wide significant threshold value of linkage , with P values between 0.05 and 0.001 [ 1-5 ] .
# ::alignments 21-22|0 18-19|0.1.0 17-18|0.1 14-15|0.0.1.0 12-13|0.0.1 11-12|0.0.1.2 10-11|0.0.1.1 7-8|0.0 6-7|0.0.2 4-5|0.0.1.3.0 2-3|0.0.1.3 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:45:48.125
(a / and 
      :op1 (r / reach-01 
            :ARG0 (m / most) 
            :ARG1 (v2 / value-01 
                  :ARG1 (l / linkage) 
                  :ARG1-of (s / significant-02) 
                  :mod (t / threshold) 
                  :mod (t2 / this 
                        :mod-of (r2 / region))) 
            :polarity -) 
      :op2 (p / P60 
            :mod-of (v / value)))

# ::snt Thus , these loci only have a small effect on RA .
# ::tok Thus , these loci only have a small effect on RA .
# ::alignments 10-11|0.0.0.0.0+0.0.0.0+0.0.0 8-9|0.0 7-8|0.0.1 4-5|0.0.2 3-4|0 2-3|0.1 0-1|0.0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:45:48.180
(l / locus 
      :ARG0-of (e / effect-03 
            :ARG1 (o / organization 
                  :name (n / name 
                        :op1 "RA")) 
            :mod (s / small) 
            :mod (o2 / only) 
            :op1-of (t2 / thu)) 
      :mod (t / this))

# ::snt Small genetic contributions could also be seen from the susceptibility genes of RA identified so far , including HLA-DR4 , PADI4 , PTPN22 and FCRL3 [ 6-9 ] .
# ::tok Small genetic contributions could also be seen from the susceptibility genes of RA identified so far , including HLA-DR4 , PADI4 , PTPN22 and FCRL3 [ 6-9 ] .
# ::alignments 23-24|0 18-19|0.1.0.0+0.1.0+0.1 15-16|0.0.0.1.0.1 13-14|0.0.0.1.0 12-13|0.0.0.1.0.0.1.0+0.0.0.1.0.0.1+0.0.0.1.0.0 10-11|0.0.0.1 9-10|0.0.0.1.1 6-7|0.0.0 4-5|0.0.0.2 3-4|0.0.0.0 2-3|0.0 1-2|0.0.0.1.0.0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:45:48.840
(a / and 
      :op1 (c / contribute-01 
            :ARG1-of (s2 / see-01 
                  :ARG1-of (p / possible-01) 
                  :ARG2 (g / gene 
                        :ARG1-of (i / identify-01 
                              :ARG0 (o / organization 
                                    :mod (g2 / gene) 
                                    :name (n2 / name 
                                          :op1 "RA")) 
                              :ARG2 (f / far)) 
                        :part-of (s / susceptibility)) 
                  :mod (a2 / also)) 
            :mod (s3 / small)) 
      :op2 (t / thing 
            :name (n / name 
                  :op1 "HLA-DR4")))

# ::snt Except for HLA-DR4 , which is strongly associated with RA , all the other susceptibility genes have only a small effect on the disease .
# ::tok Except for HLA-DR4 , which is strongly associated with RA , all the other susceptibility genes have only a small effect on the disease .
# ::alignments 23-24|0.0.0.0.1 20-21|0.0.0.0 19-20|0.0.0.0.2 17-18|0.0.0.0.3 15-16|0.0.0.0.0 14-15|0.0.0.0.0.0 13-14|0.0.0.0.0.1.0 11-12|0.0.0.0.0.1 9-10|0.0.0.2.0.0+0.0.0.2.0+0.0.0.2 7-8|0.0.0 6-7|0.0.0.1 2-3|0.0.1.0+0.0.1+0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:45:49.825
(e2 / except 
      :op1 (t / thing 
            :ARG1-of (a2 / associate-01 
                  :ARG0 (e / effect-03 
                        :ARG0 (g / gene 
                              :mod (s2 / susceptibility) 
                              :quant (a / all 
                                    :quant-of (o2 / other))) 
                        :ARG1 (d / disease) 
                        :mod (s / small) 
                        :mod (o / only)) 
                  :ARG1-of (s3 / strong-02) 
                  :ARG2 (o3 / organization 
                        :name (n / name 
                              :op1 "RA"))) 
            :name (n2 / name 
                  :op1 "HLA-DR4")))

# ::snt In the mouse model of RA , small genetic contributions are also often observed .
# ::tok In the mouse model of RA , small genetic contributions are also often observed .
# ::alignments 13-14|0 12-13|0.2 11-12|0.3 9-10|0.0 8-9|0.0.1 7-8|0.0.0 5-6|0.1.1.0.0+0.1.1.0+0.1.1 3-4|0.1 2-3|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:45:49.887
(o / observe-01 
      :ARG1 (c / contribute-01 
            :mod (s / small) 
            :mod (g / gene)) 
      :ARG2 (m / model 
            :mod (m2 / mouse) 
            :poss (o3 / organization 
                  :name (n / name 
                        :op1 "RA"))) 
      :frequency (o2 / often) 
      :mod (a / also))

# ::snt For example , in a previous study , we carried out a genome screen to identify the quantitative trait loci ( QTL ) in collagen-induced arthritis ( CIA ) , which is a widely used animal model of RA .
# ::tok For example , in a previous study , we carried out a genome screen to identify the quantitative trait loci ( QTL ) in collagen-induced arthritis ( CIA ) , which is a widely used animal model of RA .
# ::alignments 38-39|0.2.1.1.0.0+0.2.1.1.0+0.2.1.1 36-37|0.2.1 35-36|0.2.1.0 34-35|0.2 33-34|0.2.2 27-28|0.2.0.1+0.2.0.0.0+0.2.0.0+0.2.0 25-26|0.0.0.1 24-25|0.0.0.1.0 19-20|0.0.0.0 18-19|0.0.0.0.0 17-18|0.0.0.0.1 15-16|0.0.0 13-14|0.1 12-13|0.1.0 9-10|0 8-9|0.0 6-7|0.0.1 5-6|0.0.1.0 1-2|0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:45:50.704
(c2 / carry-01 
      :ARG0 (w2 / we 
            :ARG0-of (i / identify-01 
                  :ARG1 (l / locus 
                        :mod (t / trait) 
                        :mod (q / quantitative)) 
                  :time (a2 / arthritis 
                        :mod (c / collagen-induc))) 
            :ARG0-of (s2 / study-01 
                  :time (p / previous))) 
      :ARG1 (s / screen 
            :consist-of (g2 / genome)) 
      :ARG2-of (u / use-01 
            :ARG0 (g / government-organization 
                  :name (n2 / name 
                        :op1 "CIA") 
                  :wiki "Central_Intelligence_Agency") 
            :ARG1 (m / model 
                  :mod (a / animal) 
                  :poss (o / organization 
                        :name (n / name 
                              :op1 "RA"))) 
            :manner (w / wide)) 
      :purpose (e / example))

# ::snt Only one QTL , Cia2 , was identified for the phenotype of CIA severity , but this QTL contributes to only 16 % of the phenotype variations for CIA susceptibility in F2 progeny [ 10 ] .
# ::tok Only one QTL , Cia2 , was identified for the phenotype of CIA severity , but this QTL contributes to only 16 % of the phenotype variations for CIA susceptibility in F2 progeny [ 10 ] .
# ::alignments 34-35|0.1.0 32-33|0.1.2.0.0.1.0.0 31-32|0.1.2.0.0.1.0.0.0 29-30|0.1.2.0.0.1.0 28-29|0.1.2.0.0.1.2+0.1.2.0.0.1.1.0+0.1.2.0.0.1.1+0.1.2.0.0.1 26-27|0.0 25-26|0.0.0 22-23|0.1.1 21-22|0.1.1.0 20-21|0.2.2 18-19|0.2 16-17|0.1.0.0 15-16|0 13-14|0.1.2.0 12-13|0.1.2.0.0.2+0.1.2.0.0.0.0+0.1.2.0.0.0+0.1.2.0.0 10-11|0.1.2 7-8|0.1 4-5|0.2.0 2-3|0.2.1 0-1|0.2.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:45:51.428
(c2 / contrast-01 
      :ARG0 (v / variation 
            :mod (p2 / phenotype)) 
      :ARG1 (i / identify-01 
            :ARG0 (1 / 10 
                  :poss-of (t / this)) 
            :ARG1 (p3 / percentage-entity 
                  :value 16) 
            :ARG2 (p4 / phenotype 
                  :mod (s2 / severity 
                        :mod (g2 / government-organization 
                              :name (n2 / name 
                                    :op1 "CIA") 
                              :part (g / government-organization 
                                    :mod-of (s / susceptibility 
                                          :poss (p / progeny 
                                                :mod (f / F2))) 
                                    :name (n / name 
                                          :op1 "CIA") 
                                    :wiki "Central_Intelligence_Agency") 
                              :wiki "Central_Intelligence_Agency")))) 
      :ARG2 (c / contribute-01 
            :ARG0 (c3 / Cia2) 
            :ARG1 (q / QTL 
                  :mod (o2 / only)) 
            :ARG2 (o / only)))

# ::snt This suggests that there must be other susceptibility genes whose contributions were not big enough to reach the stringent significance threshold value of linkage analysis .
# ::tok This suggests that there must be other susceptibility genes whose contributions were not big enough to reach the stringent significance threshold value of linkage analysis .
# ::alignments 24-25|0.1.0.0.0.0 23-24|0.1.0.0.0.0.1 21-22|0.1.0.0.0 20-21|0.1.0.0.0.1 19-20|0.1.0.1.0.0.0 18-19|0.1.0.1.0.0.0.0 16-17|0.1.0.0 14-15|0.1.0.1.0.0 13-14|0.1.0.1 12-13|0.1.0.1.0 10-11|0.1.0 8-9|0.1 7-8|0.1.1 6-7|0.1.0.0.0.0.0 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:45:52.006
(s4 / suggest-01 
      :ARG0 (t2 / this) 
      :ARG1 (g / gene 
            :ARG1-of (c / contribute-01 
                  :ARG0-of (r / reach-01 
                        :ARG1 (v / value-01 
                              :ARG1 (a / analyze-01 
                                    :ARG1 (o / other) 
                                    :manner (l / linkage)) 
                              :mod (t / threshold))) 
                  :domain-of (b / big 
                        :polarity (- / - 
                              :polarity-of (e / enough 
                                    :ARG1-of (s / significant-02 
                                          :ARG0 (s2 / stringent)))))) 
            :part-of (s3 / susceptibility)))

# ::snt One aim of using animal models for complex diseases is to detect the genetic basis of these diseases .
# ::tok One aim of using animal models for complex diseases is to detect the genetic basis of these diseases .
# ::alignments 17-18|0.0.0 16-17|0.0.0.0 13-14|0.0.1.0.1.0.0 11-12|0.0 8-9|0.0.1.0.1 7-8|0.0.1.0.1.0 5-6|0.0.1.0.0 4-5|0 3-4|0.0.1.0 1-2|0.0.1 0-1|0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:45:52.563
(a / animal 
      :ARG0-of (d2 / detect-01 
            :ARG1 (d / disease 
                  :mod (t / this)) 
            :ARG1-of (a2 / aim-01 
                  :ARG0 (u / use-01 
                        :ARG1 (m / model) 
                        :ARG2 (d3 / disease 
                              :mod (c / complex 
                                    :op1 (g / gene)))) 
                  :quant 1)))

# ::snt With controllable environmental factors as well as the known genetic background , animal models are powerful tools to search for susceptibility genes for complex diseases , and have been intensively employed for that purpose .
# ::tok With controllable environmental factors as well as the known genetic background , animal models are powerful tools to search for susceptibility genes for complex diseases , and have been intensively employed for that purpose .
# ::alignments 33-34|0.3.1 32-33|0.3.1.0 30-31|0.3 29-30|0.3.2 26-27|0 24-25|0.2 23-24|0.2.0 21-22|0.0.1 20-21|0.0.0.1.1 18-19|0.0 16-17|0.0.0 15-16|0.0.0.0 13-14|0.0.0.1 12-13|0.0.0.1.0 10-11|0.1.0 9-10|0.1.0.0 8-9|0.1 3-4|0.3.0 2-3|0.3.0.0 1-2|0.3.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:45:52.981
(a / and 
      :ARG1-of (s2 / search-01 
            :ARG0 (t2 / tool 
                  :ARG1-of (p2 / powerful-02) 
                  :domain (m / model 
                        :mod (a2 / animal) 
                        :mod (s / susceptibility))) 
            :ARG2 (g / gene)) 
      :ARG3-of (k / know-02 
            :ARG1 (b / background 
                  :mod (g2 / gene))) 
      :op1 (d / disease 
            :mod (c / complex)) 
      :op2 (e / employ-01 
            :ARG1 (f / factor 
                  :mod (e2 / environment) 
                  :mod (c2 / controllable)) 
            :ARG2 (p / purpose 
                  :mod (t / that)) 
            :manner (i / intensive)))

# ::snt More than 27,000 QTL have been identified in the mouse genome since the first QTL was identified at the beginning of the 1990s [ 11 ] .
# ::tok More than 27,000 QTL have been identified in the mouse genome since the first QTL was identified at the beginning of the 1990s [ 11 ] .
# ::alignments 24-25|0.1 22-23|0.2.0.2.0 19-20|0.2.0.2 16-17|0.2.0 11-12|0.2 10-11|0.0 9-10|0.2.0.1 6-7|0 0-1|0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:45:53.093
(i2 / identify-01 
      :ARG1 (g / genome) 
      :op1-of 11 
      :time (s / since 
            :op1 (i / identify-01 
                  :ARG0 (m2 / more-than) 
                  :ARG1 (m / mouse) 
                  :time (b / begin-01 
                        :ARG1 1990))))

# ::snt By 2005 , approximately 20 quantitative trait genes ( QTGs ) in the mouse genome had been identified [ 12,13 ] .
# ::tok By 2005 , approximately 20 quantitative trait genes ( QTGs ) in the mouse genome had been identified [ 12,13 ] .
# ::alignments 17-18|0.0.0.0 14-15|0.0 13-14|0 9-10|0.0.0.2.1.0.0+0.0.0.2.1.0+0.0.0.2.1 7-8|0.0.0 6-7|0.0.0.1 5-6|0.0.0.1.0 4-5|0.0.0.2.0 3-4|0.0.0.2 1-2|0.0.1.0+0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:45:53.347
(m / mouse 
      :mod-of (g / genome 
            :location-of (g2 / gene 
                  :ARG1-of (i / identify-01) 
                  :mod (t2 / trait 
                        :mod (q / quantitative)) 
                  :quant (a / approximately 
                        :op1 20 
                        :op2 (t / thing 
                              :name (n / name 
                                    :op1 "QTGs")))) 
            :poss-of (d / date-entity 
                  :year 2005)))

# ::snt Interestingly , most QTGs identified in animal models have the causal polymorphisms in the protein-coding region [ 14 ] , which provoke protein structure changes or protein deficiency .
# ::tok Interestingly , most QTGs identified in animal models have the causal polymorphisms in the protein-coding region [ 14 ] , which provoke protein structure changes or protein deficiency .
# ::alignments 27-28|0.0.2.1 26-27|0.0.2.1.0 25-26|0.0.2 24-25|0.0 23-24|0.0.0 22-23|0 21-22|0.0.1 17-18|0.0.2.0.0.2 15-16|0.0.2.0.0.0 14-15|0.0.2.0.0.0.0 11-12|0.0.1.0 10-11|0.0.1.0.0 7-8|0.0.2.0.0.1 6-7|0.0.2.0.0.1.0 4-5|0.0.2.0.0 3-4|0.0.2.0.1.0+0.0.2.0.1+0.0.2.0 2-3|0.0.2.0.2 0-1|0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:45:54.262
(p2 / protein 
      :ARG0-of (c / change-01 
            :ARG1 (s / structure) 
            :ARG1-of (p3 / provoke-01 
                  :ARG0 (p5 / polymorphism 
                        :mod (c2 / causal)) 
                  :ARG2 (i2 / interesting)) 
            :op2-of (o / or 
                  :op1 (t / thing 
                        :ARG1-of (i / identify-01 
                              :ARG0 (r / region 
                                    :mod (p4 / protein-cod)) 
                              :ARG2 (m / model 
                                    :mod (a / animal)) 
                              :op1-of 14) 
                        :name (n / name 
                              :op1 "QTGs") 
                        :quant (m2 / most)) 
                  :op3 (d / deficiency 
                        :mod (p / protein)))))

# ::snt This suggests , on the one hand , that small-effect QTL are difficult to identify with traditional strategies and , on the other hand , that the polymorphisms regulating gene expression might only slightly affect the quantitative traits , and thus are more difficult to identify .
# ::tok This suggests , on the one hand , that small-effect QTL are difficult to identify with traditional strategies and , on the other hand , that the polymorphisms regulating gene expression might only slightly affect the quantitative traits , and thus are more difficult to identify .
# ::alignments 45-46|0.0.2.1.1 43-44|0.0.2.1 42-43|0.0.2.1.0 40-41|0.1 39-40|0.0.2 37-38|0.0.0 36-37|0.0.0.0 34-35|0.0 33-34|0.0.1 32-33|0.0.1.0 31-32|0.0.2.0 30-31|0 29-30|0.3 28-29|0.2 27-28|0.0.2.1.1.0 23-24|0.0.2.1.1.1 22-23|0.0.2.1.1.1.0 18-19|0.0.2.0.0.1.0 17-18|0.0.2.0.0.0 16-17|0.0.2.0.0.0.0 14-15|0.0.2.0.0 12-13|0.0.2.0.0.1 6-7|0.0.2.0.0.1.0.0.1 1-2|0.0.2.0.0.1.0.0 0-1|0.0.2.0.0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:45:55.919
(e / express-01 
      :ARG0-of (a2 / affect-01 
            :ARG1 (t2 / trait 
                  :mod (q / quantitative)) 
            :degree (s / slight 
                  :mod (o / only)) 
            :op2-of (a / and 
                  :op1 (p / possible-01 
                        :ARG1 (i2 / identify-01 
                              :ARG2 (s2 / strategy 
                                    :mod (t3 / tradition)) 
                              :domain-of (d2 / difficult 
                                    :op1-of (a3 / and 
                                          :ARG1-of (s3 / suggest-01 
                                                :ARG0 (t4 / this) 
                                                :ARG2 (h2 / hand)))))) 
                  :op3 (d / difficult 
                        :degree (m / more) 
                        :domain (i / identify-01 
                              :ARG0 (p2 / polymorphism) 
                              :ARG1 (h / hand 
                                    :mod (o2 / other)))))) 
      :ARG1 (t / thus-far) 
      :ARG1-of (r / regulate-01) 
      :mod (g / gene))

# ::snt Microarray-based global gene expression is a powerful technique for investigating complex diseases .
# ::tok Microarray-based global gene expression is a powerful technique for investigating complex diseases .
# ::alignments 11-12|0.0.0.0 10-11|0.0.0.0.0 9-10|0.0.0 7-8|0.0 6-7|0.0.1 3-4|0 2-3|0.1 1-2|0.3 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:45:55.970
(e / express-01 
      :domain-of (t / technique 
            :ARG0-of (i / investigate-01 
                  :ARG1 (d / disease 
                        :mod (c / complex))) 
            :ARG1-of (p / powerful-02)) 
      :mod (g / gene) 
      :mod (m / microarray-bas) 
      :mod (g2 / globe))

# ::snt During disease development , genes involved in the disease are likely to be differentially regulated .
# ::tok During disease development , genes involved in the disease are likely to be differentially regulated .
# ::alignments 14-15|0.0 13-14|0 10-11|0.0.0 8-9|0.0.0.0.0.0.1 5-6|0.0.0.0.0.0 4-5|0.0.0.0.0.0.0 2-3|0.0.0.0 1-2|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:45:56.114
(d / differentially 
      :degree-of (r / regulate-01 
            :condition-of (l / likely-01 
                  :ARG1 (d3 / develop-02 
                        :ARG1 (d4 / disease 
                              :purpose-of (i / involve-01 
                                    :ARG1 (g / gene) 
                                    :ARG2 (d2 / disease)))))))

# ::snt Therefore , signature genes of the diseases could be identified by detecting the expression patterns of the disease-related cells/tissues and their ideal controls .
# ::tok Therefore , signature genes of the diseases could be identified by detecting the expression patterns of the disease-related cells/tissues and their ideal controls .
# ::alignments 22-23|0.0.1.0.1.0 21-22|0.0.1.0.1.0.0 19-20|0.0.1.0.1 18-19|0.0.1.0.0 17-18|0.0.0.0.0 14-15|0.0.1.0 13-14|0.0.1.0.2 11-12|0.0.1 9-10|0.0 7-8|0 6-7|0.0.0.1 3-4|0.0.0 2-3|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:45:56.863
(p2 / possible-01 
      :ARG1 (i2 / identify-01 
            :ARG1 (g / gene 
                  :ARG1-of (s / sign-01 
                        :ARG0 (d / disease-relat)) 
                  :quant-of (d3 / disease)) 
            :ARG2 (d2 / detect-01 
                  :ARG1 (p / pattern-01 
                        :ARG0 (c2 / cells/tissu) 
                        :ARG1 (a / and 
                              :op1 (c / control-01 
                                    :mod (i / ideal))) 
                        :mod (e / express-01)))))

# ::snt In the past decade , many studies applied this technique to study both RA and its animal models [ 15-22 ] .
# ::tok In the past decade , many studies applied this technique to study both RA and its animal models [ 15-22 ] .
# ::alignments 17-18|0.1 16-17|0.0.0.0.0.2 14-15|0 13-14|0.0.0.0.0.1.0+0.0.0.0.0.1+0.0.0.0.0 12-13|0.0.0.0.0.0 11-12|0.0.0.0 9-10|0.0.1 8-9|0.0.1.0 7-8|0.0 6-7|0.0.0 5-6|0.0.0.1 3-4|0.0.2+0.0.2.0 2-3|0.0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:45:57.305
(a2 / and 
      :op1 (a3 / apply-01 
            :ARG0 (s2 / study-01 
                  :ARG0-of (s / study-01 
                        :ARG1 (o / organization 
                              :mod (b / both) 
                              :name (n / name 
                                    :op1 "RA") 
                              :poss-of (a / animal))) 
                  :quant (m2 / many)) 
            :ARG1 (t / technique 
                  :mod (t2 / this)) 
            :time (d / decade 
                  :unit-of (t3 / temporal-quantity 
                        :op1-of (p / past)))) 
      :op2 (m / model))

# ::snt Indeed , genes involved in arthritis show distinct expression patterns in certain tissues and pathological stages of the disease .
# ::tok Indeed , genes involved in arthritis show distinct expression patterns in certain tissues and pathological stages of the disease .
# ::alignments 18-19|0.1.3.0.1 15-16|0.1.3.0 14-15|0.1.3.0.0 13-14|0.1.3 12-13|0.1.0 11-12|0.1.0.0 9-10|0.1 8-9|0.1.1 7-8|0.1.2 6-7|0 5-6|0.0.0.0 3-4|0.0.0 2-3|0.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:45:57.518
(s2 / show-01 
      :ARG0 (g / gene 
            :ARG1-of (i / involve-01 
                  :ARG2 (a2 / arthritis))) 
      :ARG1 (p2 / pattern-01 
            :ARG1 (t / tissue 
                  :mod (c / certain)) 
            :mod (e / express-01) 
            :mod (d2 / distinct) 
            :op1-of (a / and 
                  :op2 (s / stage 
                        :mod (p / pathological) 
                        :poss (d / disease)))) 
      :mod (i2 / indeed))

# ::snt Genes involved in immunoinflammatory responses were differentially expressed in the blood cells in RA patients [ 18 ] .
# ::tok Genes involved in immunoinflammatory responses were differentially expressed in the blood cells in RA patients [ 18 ] .
# ::alignments 16-17|0.0.0.0 14-15|0.1.0.1+0.1.0+0.1.0.0 13-14|0.1.0.0.0.0.0+0.1.0.0.0.0+0.1.0.0.0 11-12|0.1 10-11|0.1.1 7-8|0 6-7|0.2 4-5|0.0.0.1.0+0.0.0.1 1-2|0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:45:57.661
(e / express-01 
      :ARG1 (g / gen 
            :ARG1-of (i / involve-01 
                  :ARG0 18 
                  :ARG2 (t / thing 
                        :ARG2-of (r / respond-01)))) 
      :manner (c / cell 
            :ARG1-of (h / have-rel-role-91 
                  :ARG0 (p / person 
                        :mod (o / organization 
                              :name (n / name 
                                    :op1 "RA"))) 
                  :ARG2 (p2 / patient)) 
            :mod (b / blood)) 
      :mod (d / differentially))

# ::snt Chemokines and adhesion molecules were upregulated in the joint at the initiation phase of arthritis in animal models [ 21,22 ] , while genes involved in cartilage destruction and bone erosion were differentially expressed at the late phase of arthritis in animal models of RA [ 15,16 ] .
# ::tok Chemokines and adhesion molecules were upregulated in the joint at the initiation phase of arthritis in animal models [ 21,22 ] , while genes involved in cartilage destruction and bone erosion were differentially expressed at the late phase of arthritis in animal models of RA [ 15,16 ] .
# ::alignments 44-45|0.0.0.2.0.0+0.0.0.2.0+0.0.0.2 42-43|0.0.0.1.4.0 41-42|0.0.0.1.4 39-40|0.0.0.1.2.0 37-38|0.0.0.1.2 36-37|0.0.0.1.2.1 33-34|0.0.0.1 32-33|0.0.0.1.3 30-31|0.0 29-30|0 28-29|0.0.0 27-28|0.0.0.0.2 26-27|0.0.0.0.2.0 24-25|0.0.0.0 23-24|0.0.0.0.1 17-18|0.0.0.1.0.0 16-17|0.0.0.1.0 14-15|0.0.0.1.0.0.0 12-13|0.0.0.1.0.0.0.0 11-12|0.0.0.1.0.0.0.0.1 8-9|0.0.0.1.0.0.0.0.0 3-4|0.0.0.0.0 2-3|0.0.0.0.0.0 1-2|0.0.0.1.1 0-1|0.0.0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:00.700
(b / bone 
      :mod-of (e2 / erosion 
            :op1-of (a3 / and 
                  :ARG2-of (i / involve-01 
                        :ARG0 (m3 / molecule 
                              :mod (a6 / adhesion)) 
                        :ARG1 (g / gene) 
                        :time (d2 / destroy-01 
                              :degree (c / cartilage))) 
                  :op2 (e / express-01 
                        :ARG0 (a4 / animal 
                              :mod-of (m2 / model 
                                    :location-of (a5 / arthritis 
                                          :part (p2 / phase 
                                                :location-of (j / joint) 
                                                :mod (i2 / initiation))))) 
                        :ARG1 (a7 / and 
                              :op1 (c2 / chemokin)) 
                        :ARG2 (p / phase 
                              :part-of (a2 / arthritis) 
                              :time (l / late)) 
                        :mod (d / differentially) 
                        :topic (a / animal 
                              :mod-of (m / model))) 
                  :op3 (o / organization 
                        :name (n / name 
                              :op1 "RA")))))

# ::snt Besides detecting genes involved in complex diseases , microarrays could also be used to detect the genetic polymorphisms regulating gene expression because differential expressions between two strains might be the result of a polymorphism located in regulatory elements .
# ::tok Besides detecting genes involved in complex diseases , microarrays could also be used to detect the genetic polymorphisms regulating gene expression because differential expressions between two strains might be the result of a polymorphism located in regulatory elements .
# ::alignments 37-38|0.0.1.0.1.0 36-37|0.0.1.0.1.0.0 34-35|0.0.1.0.0.0 33-34|0.0.1.0.0 30-31|0.0.1.0 27-28|0.0.1.0.1 26-27|0.0.2.2.0.1 25-26|0.0.2.2.0.1.0 23-24|0.0.2.2.0.0 22-23|0.0.2.2.0.0.0 21-22|0.0.1 20-21|0.0.2.2.0 19-20|0.0.2.2.0.2 18-19|0.0.2.2 17-18|0.0.2.1 16-17|0.0.1.0.1.0.0.0 14-15|0.0.2 12-13|0.0 10-11|0.0.3 9-10|0 8-9|0.0.2.0 6-7|0.0.0.0.0.0 5-6|0.0.0.0.0.0.0 3-4|0.0.0.0.0 2-3|0.0.0.0 1-2|0.0.0 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:02.381
(p4 / possible-01 
      :ARG1 (u / use-01 
            :ARG0 (d4 / detect-01 
                  :ARG1 (g3 / gene 
                        :ARG1-of (i / involve-01 
                              :ARG2 (d3 / disease 
                                    :mod (c2 / complex)))) 
                  :op1-of (b / besides)) 
            :ARG1-of (c / cause-01 
                  :ARG0 (r2 / result-01 
                        :ARG1 (p / polymorphism 
                              :ARG1-of (l / locate-01)) 
                        :ARG1-of (p2 / possible-01 
                              :location (e / element 
                                    :ARG0-of (r / regulate-01 
                                          :ARG1 (g2 / gene)))))) 
            :ARG2 (d2 / detect-01 
                  :ARG0 (m / microarray) 
                  :ARG1 (p3 / polymorphism) 
                  :ARG2 (r3 / regulate-01 
                        :ARG1 (e3 / express-01 
                              :ARG1 (e2 / expression 
                                    :mod (d / differential)) 
                              :ARG2 (s / strain 
                                    :quant 2) 
                              :mod (g / gene)))) 
            :mod (a / also)))

# ::snt To identify the small-effect QTL of CIA as well as the potential candidate genes inside them , we investigated CIA genetically susceptible and resistant strains at both the genome and transcriptome levels .
# ::tok To identify the small-effect QTL of CIA as well as the potential candidate genes inside them , we investigated CIA genetically susceptible and resistant strains at both the genome and transcriptome levels .
# ::alignments 31-32|0.1 30-31|0.1.0 29-30|0 28-29|0.0 26-27|0.2.0.2 24-25|0.2.0.0.0.0 23-24|0.2.0.0.0.0.0 22-23|0.2 21-22|0.2.1 20-21|0.2.1.0 19-20|0.2.0.0.0.0.0.0.1+0.2.0.0.0.0.0.0.0.0+0.2.0.0.0.0.0.0.0+0.2.0.0.0.0.0.0 18-19|0.2.0.0.0 17-18|0.2.0.0 14-15|0.2.0.3 13-14|0.2.0.3.0 12-13|0.2.0.3.0.0 11-12|0.2.0.3.0.0.0 6-7|0.2.0.1.0.1+0.2.0.1.0.0.0+0.2.0.1.0.0+0.2.0.1.0 4-5|0.2.0.1 1-2|0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:03.608
(a / and 
      :op1 (g / genome) 
      :op2 (l / level 
            :mod (t / transcriptome)) 
      :op3-of (a2 / and 
            :op1 (i3 / identify-01 
                  :ARG0 (w / we 
                        :ARG0-of (i / investigate-01 
                              :ARG1 (s / strain 
                                    :ARG1-of (r / resist-01 
                                          :ARG0 (g3 / government-organization 
                                                :name (n / name 
                                                      :op1 "CIA") 
                                                :wiki "Central_Intelligence_Agency"))))) 
                  :ARG1 (q / QTL 
                        :mod (g5 / government-organization 
                              :name (n2 / name 
                                    :op1 "CIA") 
                              :wiki "Central_Intelligence_Agency")) 
                  :op1-of (b / both) 
                  :time (i2 / inside 
                        :location-of (g4 / gene 
                              :mod (c / candidate 
                                    :mod (p / potential))))) 
            :op2 (s2 / susceptible 
                  :mod (g2 / genetics))))

# ::snt At the genome level , F2 progeny of the CIA susceptible ( DBA/1 ) and resistant ( FVB/N ) strains were generated and a genome-wide linkage analysis was performed to identify small-effect QTL .
# ::tok At the genome level , F2 progeny of the CIA susceptible ( DBA/1 ) and resistant ( FVB/N ) strains were generated and a genome-wide linkage analysis was performed to identify small-effect QTL .
# ::alignments 30-31|0.2.0.0.0.1 28-29|0.2.0.0.0 26-27|0.2.0.0.0.1.0 25-26|0.2.0.0.0.1.0.0 22-23|0.2.0.0 21-22|0.2.0 19-20|0.2 17-18|0.1.0.0.0+0.1.0.0+0.1.0 15-16|0.1 14-15|0 10-11|0.0 9-10|0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 6-7|0.2.0.0.0.0 3-4|0.2.0.0.0.1.1 2-3|0.2.0.0.0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:04.167
(a3 / and 
      :op1 (s2 / susceptible 
            :mod (g2 / government-organization 
                  :name (n2 / name 
                        :op1 "CIA") 
                  :wiki "Central_Intelligence_Agency")) 
      :op2 (r / resist-01 
            :ARG1 (t / thing 
                  :name (n / name 
                        :op1 "FVB/N"))) 
      :op3 (s / strain 
            :ARG1-of (g / generate-01 
                  :op1-of (a2 / and 
                        :op2 (p / perform-02 
                              :ARG0 (p2 / progeny) 
                              :ARG1 (i / identify-01 
                                    :ARG0 (a / analyze-01 
                                          :ARG1 (l / linkage)) 
                                    :ARG1 (l2 / level 
                                          :mod (g3 / genome))))))))

# ::snt At the transcriptome level , we detected the gene expression patterns of both the DBA/1 and FVB/N strains at four different phases of CIA .
# ::tok At the transcriptome level , we detected the gene expression patterns of both the DBA/1 and FVB/N strains at four different phases of CIA .
# ::alignments 23-24|0.1.0.1.1+0.1.0.1.0.0+0.1.0.1.0+0.1.0.1 21-22|0.1.0 20-21|0.1.0.0 19-20|0.1.3.0 17-18|0.1.1.2 16-17|0.1.1.1.0.0+0.1.1.1.0+0.1.1.1 15-16|0.1.1 12-13|0.1.1.0 10-11|0.1 9-10|0.1.3 8-9|0.1.2 6-7|0 5-6|0.0 3-4|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:04.497
(d2 / detect-01 
      :ARG0 (w / we) 
      :ARG1 (p2 / pattern-01 
            :ARG0 (p / phase 
                  :ARG1-of (d / differ-02) 
                  :mod (g / government-organization 
                        :name (n / name 
                              :op1 "CIA") 
                        :wiki "Central_Intelligence_Agency")) 
            :ARG1 (a / and 
                  :mod (b / both) 
                  :op1 (t / thing 
                        :name (n2 / name 
                              :op1 "FVB/N")) 
                  :op2 (s / strain)) 
            :mod (g2 / gene) 
            :mod (e / express-01 
                  :ARG0 4)) 
      :time (l / level))

# ::snt The potential candidate genes were identified based on three criteria : they are located within the genomic region linked to CIA ; they are disease-specific differentially expressed during CIA ; and they are strain-specific differentially expressed between the two parental strains during CIA .
# ::tok The potential candidate genes were identified based on three criteria : they are located within the genomic region linked to CIA ; they are disease-specific differentially expressed during CIA ; and they are strain-specific differentially expressed between the two parental strains during CIA .
# ::alignments 42-43|0.0.1.0.1.1.1+0.0.1.0.1.1.0.0+0.0.1.0.1.1.0+0.0.1.0.1.1 40-41|0.0.1.0.0.0 39-40|0.0.1.0.0 38-39|0.0.1.0.0.0.0 35-36|0.3.0 34-35|0.3 30-31|0 28-29|0.2.0.0.1+0.2.0.0.0.0+0.2.0.0.0+0.2.0.0 26-27|0.2.0 25-26|0.2 21-22|0.1 20-21|0.0.1.0.1.2+0.0.1.0.1.0.0+0.0.1.0.1.0+0.0.1.0.1 18-19|0.0.1.0 17-18|0.0.1 13-14|0.0 11-12|0.0.0 9-10|0.1.0.0 8-9|0.1.0.0.0 6-7|0.1.0 5-6|0.1.0.1 3-4|0.1.0.1.0 2-3|0.1.0.1.0.0 1-2|0.1.0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:06.162
(a / and 
      :op1 (l2 / locate-01 
            :ARG1 (t / they) 
            :location (r / region 
                  :ARG1-of (l / link-01 
                        :ARG0 (p / parental 
                              :mod-of (s / strain 
                                    :quant 2)) 
                        :ARG2 (g3 / government-organization 
                              :name (n3 / name 
                                    :op1 "CIA") 
                              :part (g / government-organization 
                                    :name (n / name 
                                          :op1 "CIA") 
                                    :wiki "Central_Intelligence_Agency") 
                              :wiki "Central_Intelligence_Agency")))) 
      :op1-of (a2 / and 
            :ARG1-of (b / base-02 
                  :ARG2 (c / criteria 
                        :quant 3) 
                  :manner-of (i / identify-01 
                        :ARG1 (g4 / gene 
                              :mod (c2 / candidate 
                                    :mod (p2 / potential)))))) 
      :op2 (d2 / differentially 
            :ARG1-of (e2 / express-01 
                  :time (g2 / government-organization 
                        :name (n2 / name 
                              :op1 "CIA") 
                        :wiki "Central_Intelligence_Agency"))) 
      :op3 (d / differentially 
            :ARG1-of (e / express-01)))

# ::snt Animals , immunisation and assessment of arthritis .
# ::tok Animals , immunisation and assessment of arthritis .
# ::alignments 6-7|0.0.1.0 4-5|0.0.1 3-4|0.0 2-3|0.0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:06.187
(a4 / animal 
      :op1-of (a3 / and 
            :op2 (i / immunisation) 
            :op3 (a2 / assess-01 
                  :ARG1 (a / arthritis))))

# ::snt Both DBA/1 and FVB/N mice used in this study were obtained from the Jackson Laboratory and kept in a climate-controlled environment with 12 hour light/dark cycles in the animal facility at the University of Rostock .
# ::tok Both DBA/1 and FVB/N mice used in this study were obtained from the Jackson Laboratory and kept in a climate-controlled environment with 12 hour light/dark cycles in the animal facility at the University of Rostock .
# ::alignments 34-35|0.0.0.0.0+0.0.0.0+0.0.0 29-30|0.1.1.0 28-29|0.1.1.0.0 25-26|0.1.1 23-24|0.1.1.1.1+0.1.1.1 22-23|0.1.1.1.0 20-21|0.1.2 19-20|0.1.2.0 16-17|0.1 15-16|0 13-15|0.0.1.0.1+0.0.1.0.0+0.0.1.0+0.0.1 10-11|0.0 8-9|0.1.0.0.0 7-8|0.1.0.0.0.0 5-6|0.1.0.0 4-5|0.1.0 3-4|0.1.3.1.0.0+0.1.3.1.0+0.1.3.1 2-3|0.1.3 0-1|0.1.3.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:06.701
(a2 / and 
      :op1 (o2 / obtain-01 
            :ARG0 (c / country 
                  :name (n / name 
                        :op1 "Rostock")) 
            :ARG1 (o / organization 
                  :name (n2 / name 
                        :op1 "Jackson" 
                        :op2 "Laboratory"))) 
      :op2 (k / keep-01 
            :ARG0 (m / mouse 
                  :ARG1-of (u / use-01 
                        :ARG2 (s / study-01 
                              :mod (t2 / this)))) 
            :manner (c2 / cycle-02 
                  :ARG1 (f / facility 
                        :mod (a / animal)) 
                  :duration (t / temporal-quantity 
                        :quant 12 
                        :unit (h / hour))) 
            :manner (e / environment 
                  :mod (c3 / climate-controll)) 
            :op2-of (a3 / and 
                  :mod (b / both) 
                  :op1 (t3 / thing 
                        :name (n3 / name 
                              :op1 "FVB/N")))))

# ::snt All animal experiments were pre-approved by the State Animal Care Committee .
# ::tok All animal experiments were pre-approved by the State Animal Care Committee .
# ::alignments 7-11|0.1.0.3+0.1.0.2+0.1.0.1+0.1.0.0+0.1.0+0.1 2-3|0 1-2|0.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:06.726
(e / experiment-01 
      :ARG1 (a / animal) 
      :location (o / organization 
            :name (n / name 
                  :op1 "State" 
                  :op2 "Animal" 
                  :op3 "Care" 
                  :op4 "Committee")) 
      :quant (a2 / all))

# ::snt CIA was induced in control and experimental animals according to established protocols described previously [ 10 ] .
# ::tok CIA was induced in control and experimental animals according to established protocols described previously [ 10 ] .
# ::alignments 15-16|0.0.0.0.0.0 13-14|0.1.0 12-13|0.0.1 11-12|0.0 10-11|0.0.0 8-9|0 7-8|0.0.0.0 6-7|0.0.0.0.0 5-6|0.1.2 4-5|0.1.2.0 2-3|0.1 0-1|0.1.1.1+0.1.1.0.0+0.1.1.0+0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:06.866
(s / say-01 
      :ARG0 (p2 / protocol 
            :ARG1-of (e / establish-01 
                  :ARG0 (a / animal 
                        :mod (e2 / experiment-01 
                              :ARG1 10))) 
            :ARG1-of (d / describe-01)) 
      :ARG1 (i / induce-01 
            :ARG0 (p / previous) 
            :ARG1 (g / government-organization 
                  :name (n / name 
                        :op1 "CIA") 
                  :wiki "Central_Intelligence_Agency") 
            :location (a2 / and 
                  :op1 (c / control-01))))

# ::snt In brief , DBA/1J , FVB/N and ( DBA/1J  FVB/N ) F2 progeny were immunised at 8 to 12 weeks at the base of the tail with 125 g of bovine Collagen II ( Chondrex , Redmond , WA , USA ) emulsified in CFA ( DIFCO , Detroit , MI , USA ) .
# ::tok In brief , DBA/1J , FVB/N and ( DBA/1J  FVB/N ) F2 progeny were immunised at 8 to 12 weeks at the base of the tail with 125 g of bovine Collagen II ( Chondrex , Redmond , WA , USA ) emulsified in CFA ( DIFCO , Detroit , MI , USA ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:06.871
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt The clinical scoring of arthritis commenced 18 days after immunisation , and animals were monitored three times weekly for signs of CIA .
# ::tok The clinical scoring of arthritis commenced 18 days after immunisation , and animals were monitored three times weekly for signs of CIA .
# ::alignments 21-22|0.1.1.0.1+0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 19-20|0.1.1 17-18|0.0.0.0.0+0.0.0.0 15-16|0.0.1 14-15|0.1 12-13|0.1.0 11-12|0 9-10|0.0.2.0 8-9|0.0.2 7-8|0.0.2.1.1+0.0.2.1 6-7|0.0.2.1.0 5-6|0.0 4-5|0.0.0.1 2-3|0.0.0 1-2|0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:07.576
(a2 / and 
      :op1 (c / commence-01 
            :ARG0 (s2 / score-01 
                  :ARG0 (t / temporal-quantity 
                        :unit (w / week)) 
                  :ARG1 (a4 / arthritis) 
                  :mod (c2 / clinical)) 
            :ARG1 3 
            :time (a3 / after 
                  :op1 (i / immunisation) 
                  :quant (t2 / temporal-quantity 
                        :quant 18 
                        :unit (d / day)))) 
      :op2 (m / monitor-01 
            :ARG1 (a / animal) 
            :purpose (s / sign 
                  :poss (g / government-organization 
                        :name (n / name 
                              :op1 "CIA") 
                        :wiki "Central_Intelligence_Agency"))))

# ::snt Arthritis development was monitored in all four limbs using a three-score system per limb as described previously [ 10 ] .
# ::tok Arthritis development was monitored in all four limbs using a three-score system per limb as described previously [ 10 ] .
# ::alignments 18-19|0.0 16-17|0.2.2.1 15-16|0.2.2 13-14|0.1.0 11-12|0.2.1 8-9|0.2 7-8|0.2.0 6-7|0.1.1 5-6|0.2.0.0 3-4|0 1-2|0.1 0-1|0.2.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:07.757
(m / monitor-01 
      :ARG0 10 
      :ARG1 (d2 / develop-02 
            :ARG0 (l / limb) 
            :ARG2 4) 
      :manner (u / use-01 
            :ARG0 (l2 / limb 
                  :quant (a / all)) 
            :ARG1 (s / system) 
            :purpose (d / describe-01 
                  :ARG1 (a2 / arthriti) 
                  :time (p / previous))))

# ::snt Eight-week old FVB/N and DBA/1J mice were used for the detection of gene expression .
# ::tok Eight-week old FVB/N and DBA/1J mice were used for the detection of gene expression .
# ::alignments 13-14|0.1.0 12-13|0.1.0.0 10-11|0.1 7-8|0 5-6|0.0.1.0 4-5|0.0.1.1.0+0.0.1.1+0.0.1 3-4|0.0 2-3|0.0.0.1.0+0.0.0.1+0.0.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:07.838
(u / use-01 
      :ARG1 (a / and 
            :op1 (t2 / thing 
                  :mod (o / old) 
                  :name (n2 / name 
                        :op1 "FVB/N")) 
            :op2 (t / thing 
                  :mod-of (m / mouse) 
                  :name (n / name 
                        :op1 "DBA/1J"))) 
      :ARG2 (d / detect-01 
            :ARG1 (e / express-01 
                  :mod (g / gene))))

# ::snt They were divided into four experimental groups according to the different phases of CIA , namely naive control ( NC ) , post-immunisation ( PI ) , onset of arthritis ( OA ) and chronic arthritis ( CA ) ( Table 1 ) .
# ::tok They were divided into four experimental groups according to the different phases of CIA , namely naive control ( NC ) , post-immunisation ( PI ) , onset of arthritis ( OA ) and chronic arthritis ( CA ) ( Table 1 ) .
# ::alignments 41-42|0.0.0.0.0 40-41|0.0.0.0 37-38|0.0.0.1.1+0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 35-36|0.0.2.3 34-35|0.0.2.3.0 33-34|0.0.2 31-32|0.0.2.0.0.0.0+0.0.2.0.0.0+0.0.2.0.0 29-30|0.0.2.2.0 27-28|0.0.2.2 24-25|0.1.0 19-20|0.0.2.1.1+0.0.2.1.0.0+0.0.2.1.0+0.0.2.1 17-18|0.0.2.0 16-17|0.0.2.0.2 15-16|0.0.2.0.2.0.1+0.0.2.0.2.0.0+0.0.2.0.2.0 13-14|0.0.1.1+0.0.1.0.0+0.0.1.0+0.0.1 11-12|0.0 10-11|0.0.0 7-8|0 6-7|0.1.2 5-6|0.1.2.0 4-5|0.0.2.0.1 2-3|0.1 0-1|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:08.953
(s3 / say-01 
      :ARG0 (p2 / phase 
            :ARG1-of (d / differ-02 
                  :op1-of (t / table 
                        :mod 1) 
                  :op1-of (s / state 
                        :name (n / name 
                              :op1 "CA") 
                        :wiki "California")) 
            :mod (g / government-organization 
                  :name (n6 / name 
                        :op1 "CIA") 
                  :wiki "Central_Intelligence_Agency") 
            :op1-of (a2 / and 
                  :op2 (c2 / control-01 
                        :ARG0 (o / organization 
                              :name (n2 / name 
                                    :op1 "OA")) 
                        :ARG1 4 
                        :mod (n4 / naive 
                              :mod (c3 / country 
                                    :name (n5 / name) 
                                    :wiki "United_Kingdom"))) 
                  :op3 (s2 / state 
                        :name (n3 / name 
                              :op1 "NC") 
                        :wiki "North_Carolina") 
                  :op4 (o2 / onset 
                        :mod (a3 / arthritis)) 
                  :op5 (a / arthritis 
                        :mod (c / chronic)))) 
      :ARG1 (d2 / divide-02 
            :ARG0 (p / pi) 
            :ARG1 (t2 / they) 
            :ARG2 (g2 / group 
                  :mod (e / experiment-01))))

# ::snt The NC group contained non-immunised mice that were sacrificed at the age of 8 weeks .
# ::tok The NC group contained non-immunised mice that were sacrificed at the age of 8 weeks .
# ::alignments 14-15|0.1.0.0.0.1+0.1.0.0.0 13-14|0.1.0.0.0.0 11-12|0.1.0.0 8-9|0.1.0 5-6|0.1 4-5|0.1.1 3-4|0 2-3|0.0 1-2|0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:09.014
(c / contain-01 
      :ARG0 (g / group 
            :mod (s2 / state 
                  :name (n2 / name 
                        :op1 "NC") 
                  :wiki "North_Carolina")) 
      :ARG1 (m / mouse 
            :ARG1-of (s / sacrifice-01 
                  :time (a / age-01 
                        :ARG1 (t / temporal-quantity 
                              :quant 8 
                              :unit (w / week)))) 
            :mod (n / non-immunis)))

# ::snt The mice in the PI group were sacrificed on day 10 after immunisation .
# ::tok The mice in the PI group were sacrificed on day 10 after immunisation .
# ::alignments 12-13|0.0.0.0.0.0 11-12|0.0.0.0.0 10-11|0.0.0.0.2 9-10|0.0.0.0.1 7-8|0.0.0.0 5-6|0.0 4-5|0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:09.052
(p / pi 
      :mod-of (g / group 
            :location-of (m / mouse 
                  :ARG1-of (s / sacrifice-01 
                        :time (a / after 
                              :op1 (i / immunisation)) 
                        :time (d / day) 
                        :time 10))))

# ::snt The mice in the OA group were sacrificed on day 35 after immunisation .
# ::tok The mice in the OA group were sacrificed on day 35 after immunisation .
# ::alignments 12-13|0.1.0 11-12|0.1 10-11|0.3 9-10|0.2 7-8|0 5-6|0.0.0 4-5|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:09.095
(s / sacrifice-01 
      :ARG1 (m / mouse 
            :location (g / group 
                  :mod (o / organization 
                        :name (n / name 
                              :op1 "OA")))) 
      :time (a / after 
            :op1 (i / immunisation)) 
      :time (d / day) 
      :time 35)

# ::snt Three FVB/N non-arthritic mice and three DBA/1 mice that showed signs of arthritis on day 33 or 34 after immunisation were sacrificed on day 35 after immunisation .
# ::tok Three FVB/N non-arthritic mice and three DBA/1 mice that showed signs of arthritis on day 33 or 34 after immunisation were sacrificed on day 35 after immunisation .
# ::alignments 26-27|0.3.0.2.0 25-26|0.3.0.2 24-25|0.2 23-24|0.3.0.3 21-22|0.3.0 19-20|0.4.0 18-19|0.4 17-18|0.3.0.2.0.0 16-17|0.1.0.0 15-16|0.3.0.0 14-15|0.3.0.1 12-13|0.1.0 10-11|0.1 9-10|0 7-8|0.0 5-6|0.0.0 4-5|0.3 3-4|0.3.1 1-2|0.3.1.0.0.0+0.3.1.0.0+0.3.1.0 0-1|0.3.0.3.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:09.568
(s3 / show-01 
      :ARG0 (m / mouse 
            :quant 3) 
      :ARG1 (s2 / sign 
            :topic (a3 / arthritis 
                  :op1-of (o / or))) 
      :op1-of 35 
      :op2-of (a4 / and 
            :ARG1-of (s / sacrifice-01 
                  :ARG0 33 
                  :ARG2 (d2 / day) 
                  :time (a / after 
                        :op1 (i / immunisation 
                              :quant 34)) 
                  :time (d / day 
                        :mod-of 3)) 
            :op1 (m2 / mouse 
                  :mod (t / thing 
                        :name (n / name 
                              :op1 "FVB/N")))) 
      :time (a2 / after 
            :op1 (i2 / immunisation)))

# ::snt The mice in the CA group were sacrificed on day 95 after immunisation .
# ::tok The mice in the CA group were sacrificed on day 95 after immunisation .
# ::alignments 12-13|0.1.0 11-12|0.1 10-11|0.3 9-10|0.2 7-8|0 5-6|0.0.0 4-5|0.0.0.0.1+0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:09.632
(s / sacrifice-01 
      :ARG1 (m / mouse 
            :location (g / group 
                  :mod (s2 / state 
                        :name (n / name 
                              :op1 "CA") 
                        :wiki "California"))) 
      :time (a / after 
            :op1 (i / immunisation)) 
      :time (d / day) 
      :time 95)

# ::snt Three non-arthritic FVB/N mice and three DBA/1 mice that had developed arthritis for at least two months were sacrificed on day 95 after immunisation .
# ::tok Three non-arthritic FVB/N mice and three DBA/1 mice that had developed arthritis for at least two months were sacrificed on day 95 after immunisation .
# ::alignments 23-24|0.0.2.0.1.0 22-23|0.0.2.0.1 21-22|0.0.1 20-21|0.0.2.0.2 18-19|0.0.2.0 16-17|0.0.2.0.0.1+0.0.2.0.0 15-16|0.0.2.0.0.0 11-12|0 10-11|0.0 7-8|0.0.0 5-6|0.0.0.0 4-5|0.0.2 3-4|0.0.2.1 2-3|0.0.2.1.0.0.0+0.0.2.1.0.0+0.0.2.1.0 0-1|0.0.2.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:10.425
(a2 / arthritis 
      :ARG1-of (d2 / develop-02 
            :ARG0 (m2 / mouse 
                  :quant 3) 
            :ARG2 95 
            :op2-of (a3 / and 
                  :ARG1-of (s / sacrifice-01 
                        :ARG0 (t / temporal-quantity 
                              :quant 2 
                              :unit (m / month)) 
                        :time (a / after 
                              :op1 (i / immunisation)) 
                        :time (d / day 
                              :mod-of 3)) 
                  :op1 (m3 / mouse 
                        :mod (t2 / thing 
                              :name (n / name 
                                    :op1 "FVB/N"))))))

# ::snt Detailed information on genotyping of the genome screen has been described previously [ 10 ] .
# ::tok Detailed information on genotyping of the genome screen has been described previously [ 10 ] .
# ::alignments 13-14|0.1.0.0.0 11-12|0.1.1 10-11|0.1 7-8|0.0 6-7|0 1-2|0.1.0 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:10.493
(g / genome 
      :consist (s / screen) 
      :mod-of (d / describe-01 
            :ARG1 (i / information 
                  :ARG1-of (d2 / detail-01 
                        :ARG0 10)) 
            :time (p / previous)))

# ::snt In short , we genotyped 290 F2 mice using 126 informative microsatellite markers covering the genome with an average inter-marker distance of 11.5 cM for 290 F2 progeny .
# ::tok In short , we genotyped 290 F2 mice using 126 informative microsatellite markers covering the genome with an average inter-marker distance of 11.5 cM for 290 F2 progeny .
# ::alignments 27-28|0.0.2.1.1.0.0 23-24|0.0.0 22-23|0.0.2.2 20-21|0.0 19-20|0 18-19|0.0.1 15-16|0.0.2.0 13-14|0.0.2 12-13|0.0.2.1.1 11-12|0.0.2.1.1.1 10-11|0.0.2.1.1.0 8-9|0.0.2.1 7-8|0.0.2.1.2 3-4|0.0.2.1.0 1-2|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:11.565
(i / inter-mark 
      :degree-of (d / distance-01 
            :ARG1 (c / cm) 
            :ARG1-of (a / average-01 
                  :ARG0 (s / short)) 
            :prep-with-of (c2 / cover-01 
                  :ARG1 (g / genome) 
                  :ARG2-of (u / use-01 
                        :ARG0 (w / we) 
                        :ARG1 (m / marker 
                              :ARG1-of (i2 / inform-01 
                                    :ARG0 (p / progeny)) 
                              :mod (m2 / microsatellite)) 
                        :polarity (m3 / mouse)) 
                  :time 11.5)))

# ::snt All linkage analyses were performed with QTX Map manager software [ 23 ] .
# ::tok All linkage analyses were performed with QTX Map manager software [ 23 ] .
# ::alignments 11-12|0.0.2.0 9-10|0.0.0.0 8-9|0.0.0 6-8|0.0.0.0.0.0.1+0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 4-5|0.0.1 2-3|0.0 1-2|0 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:11.608
(l / linkage 
      :mod-of (a / analysis 
            :ARG0-of (m / manage-01 
                  :mod-of (s / software 
                        :mod (t / thing 
                              :name (n / name 
                                    :op1 "QTX" 
                                    :op2 "Map")))) 
            :ARG1-of (p / perform-02) 
            :quant (a2 / all 
                  :poss 23)))

# ::snt The main clinical phenotype of CIA , arthritis severity , was taken as phenotype .
# ::tok The main clinical phenotype of CIA , arthritis severity , was taken as phenotype .
# ::alignments 13-14|0.1 11-12|0.1.0 8-9|0 7-8|0.0 5-6|0.1.0.0.0.1+0.1.0.0.0.0.0+0.1.0.0.0.0+0.1.0.0.0 3-4|0.1.0.0 2-3|0.1.0.0.2 1-2|0.1.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:11.695
(s / severity 
      :mod (a / arthritis) 
      :op1 (p / phenotype 
            :ARG2-of (t / take-01 
                  :ARG1 (p2 / phenotype 
                        :mod (g / government-organization 
                              :name (n / name 
                                    :op1 "CIA") 
                              :wiki "Central_Intelligence_Agency") 
                        :mod (m / main) 
                        :mod (c / clinical)))))

# ::snt To detect the small-effect QTL , the threshold value of linkage was set as P = 0.05 ( Chi-square test ) .
# ::tok To detect the small-effect QTL , the threshold value of linkage was set as P = 0.05 ( Chi-square test ) .
# ::alignments 19-20|0.1 14-15|0 10-11|0.0.0 8-9|0.0 7-8|0.0.2 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:11.799
(p / P60 
      :ARG0-of (v / value-01 
            :ARG1 (l / linkage) 
            :ARG1-of (d / detect-01) 
            :mod (t2 / threshold)) 
      :ARG1-of (t / test-01))

# ::snt Sample preparation and microarray hybridisation .
# ::tok Sample preparation and microarray hybridisation .
# ::alignments 3-4|0.1 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:11.812
(a / and 
      :op1 (p / prepare-02 
            :ARG1-of (s / sample-01)) 
      :op2 (m / microarray))

# ::snt Lymph nodes ( LNs ) draining the immunisation site were used for total RNA preparation .
# ::tok Lymph nodes ( LNs ) draining the immunisation site were used for total RNA preparation .
# ::alignments 14-15|0.0.0 13-14|0.0.0.0 12-13|0.0 10-11|0.0.0.1 8-9|0.0.0.1.0.0.0 7-8|0.0.0.1.0.0.0.0 5-6|0.0.0.1.0.0 3-4|0 1-2|0.0.0.1.0 0-1|0.0.0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:11.937
(l / ln 
      :ARG0-of (t / total-01 
            :ARG2 (p / prepare-02 
                  :ARG1 (r / rna) 
                  :ARG2-of (u / use-01 
                        :ARG1 (n / nod-01 
                              :ARG1 (d / drain-01 
                                    :ARG1 (s / site 
                                          :mod (i / immunisation))) 
                              :mod (l2 / lymph))))))

# ::snt The total RNA was extracted from the tissue homogenates using a commercial kit in accordance with the provided protocol ( QIGEN , Hilden , Germany ) .
# ::tok The total RNA was extracted from the tissue homogenates using a commercial kit in accordance with the provided protocol ( QIGEN , Hilden , Germany ) .
# ::alignments 24-25|0.2.2.0.0.0.1+0.2.2.0.0.0.0.0+0.2.2.0.0.0.0+0.2.2.0.0.0 22-23|0.2.0.0.0+0.2.0.0+0.2.0 20-21|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 18-19|0.2.2.0 17-18|0.2.2.0.0 14-15|0.2.2 12-13|0.2.1 11-12|0.2.1.0 9-10|0.2 8-9|0.1 7-8|0.1.0 4-5|0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:12.333
(e / extract-01 
      :ARG1 (r / rna 
            :ARG2-of (t2 / total-01 
                  :ARG1 (o / organization 
                        :name (n3 / name 
                              :op1 "QIGEN")))) 
      :ARG2 (h / homogenat 
            :mod (t / tissue)) 
      :ARG2-of (u / use-01 
            :ARG0 (c2 / country 
                  :name (n2 / name 
                        :op1 "Hilden")) 
            :ARG1 (k / kit 
                  :mod (c3 / commerce)) 
            :ARG3-of (a / accord-02 
                  :ARG2 (p / protocol 
                        :ARG1-of (p2 / provide-01 
                              :ARG0 (c / country 
                                    :name (n / name 
                                          :op1 "Germany") 
                                    :wiki "Germany"))))))

# ::snt Analysis of gene expression was conducted using a U430A array ( Affymetrix , Santa Clara , CA , USA ) interrogating more than 22,000 genes .
# ::tok Analysis of gene expression was conducted using a U430A array ( Affymetrix , Santa Clara , CA , USA ) interrogating more than 22,000 genes .
# ::alignments 24-25|0.1.2.0 21-22|0.2 20-21|0.1.2 18-19|0.1.0.0.3.1+0.1.0.0.3.0.0+0.1.0.0.3.0+0.1.0.0.3 16-17|0.1.0.0.0.1+0.1.0.0.0.0.0+0.1.0.0.0.0+0.1.0.0.0 13-15|0.0.0.1+0.0.0.0+0.0.0+0.0 11-12|0.1.0.0.1.0.0+0.1.0.0.1.0+0.1.0.0.1 9-10|0.1.1 8-9|0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 6-7|0.1 5-6|0 3-4|0.1.0.0 2-3|0.1.0.0.2 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:13.214
(c3 / conduct-01 
      :ARG0 (o / organization 
            :name (n3 / name 
                  :op1 "Santa" 
                  :op2 "Clara")) 
      :ARG1 (u / use-01 
            :ARG0 (a2 / analysi 
                  :mod (e / express-01 
                        :ARG0 (s / state 
                              :name (n2 / name 
                                    :op1 "CA") 
                              :wiki "California") 
                        :ARG2 (o2 / organization 
                              :name (n4 / name 
                                    :op1 "Affymetrix")) 
                        :mod (g2 / gene) 
                        :op1-of (c / country 
                              :name (n / name 
                                    :op1 "USA") 
                              :wiki "United_States"))) 
            :ARG1 (a / array 
                  :mod (c2 / country 
                        :name (n5 / name 
                              :op1 "U430A"))) 
            :ARG2 (i / interrogate-01 
                  :ARG1 (g / gene))) 
      :op1-of (m / more))

# ::snt RNA probes were labelled in accordance with the manufacturer 's instructions .
# ::tok RNA probes were labelled in accordance with the manufacturer 's instructions .
# ::alignments 10-11|0.1.0 8-9|0.1.0.0 5-6|0.1 3-4|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:13.241
(l / label-01 
      :ARG1 (p / probe 
            :mod (r / rna)) 
      :ARG1-of (a / accord-02 
            :ARG2 (i / instruction 
                  :poss (m / manufacture-01))))

# ::snt Samples from individual mice were hybridised onto individual arrays .
# ::tok Samples from individual mice were hybridised onto individual arrays .
# ::alignments 8-9|0.0.0.0 7-8|0.0.0.0.0 6-7|0.0.0.0.1 5-6|0 3-4|0.0.0 2-3|0.0.0.1 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:13.271
(h / hybridise 
      :domain (s / sample-01 
            :ARG2 (m / mouse 
                  :ARG1-of (a / array-01 
                        :mod (i / individual) 
                        :op1-of (o / onto)) 
                  :mod (i2 / individual))))

# ::snt Hybridisation and washing of gene chips were done as previously described [ 16 ] .
# ::tok Hybridisation and washing of gene chips were done as previously described [ 16 ] .
# ::alignments 12-13|0.0.1.0 10-11|0.0.0 9-10|0.0.0.0 7-8|0 5-6|0.0.1.1 4-5|0.0.1.1.0 2-3|0.0.1 1-2|0.0 0-1|0.0.1.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:13.459
(d2 / do-02 
      :ARG1 (a / and 
            :ARG1-of (d / describe-01 
                  :time (p / previous)) 
            :op1 (w / wash-01 
                  :ARG0 16 
                  :ARG1 (c / chip 
                        :mod (g / gene) 
                        :mod-of (h / hybridisation)))))

# ::snt Fluorescent signals were collected by laser scan ( Hewlett-Packard Gene Scanner ) .
# ::tok Fluorescent signals were collected by laser scan ( Hewlett-Packard Gene Scanner ) .
# ::alignments 9-11|0.1.1.1.0.1+0.1.1.1.0.0+0.1.1.1.0+0.1.1.1 8-9|0.1.1.0.0+0.1.1.0+0.1.1 6-7|0.0 5-6|0.0.0 3-4|0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:13.598
(c / collect-01 
      :ARG0 (s / scan-01 
            :ARG1 (l / laser)) 
      :ARG1 (s2 / signal 
            :mod (f / fluorescent) 
            :mod-of (o / organization 
                  :name (n2 / name 
                        :op1 "Hewlett-Packard") 
                  :poss-of (p / person 
                        :name (n / name 
                              :op1 "Gene" 
                              :op2 "Scanner")))))

# ::snt Normalisation of the expression level was done using Affymetrix software MAS 5 , which is based on global scaling of total gene expression level per microarray .
# ::tok Normalisation of the expression level was done using Affymetrix software MAS 5 , which is based on global scaling of total gene expression level per microarray .
# ::alignments 25-26|0.1.0.0 23-24|0.1 22-23|0 21-22|0.1.1 20-21|0.1.0.1.1 18-19|0.1.0 17-18|0.1.0.2 15-16|0.1.0.1 11-12|0.0 10-11|0.1.0.1.0.1.0+0.1.0.1.0.1+0.1.0.1.0 9-10|0.1.0.1.0.0.0.0 8-9|0.1.0.1.0.0.0.0.0.0.0+0.1.0.1.0.0.0.0.0.0+0.1.0.1.0.0.0.0.0 7-8|0.1.0.1.0.0.0 6-7|0.1.0.1.0.0 4-5|0.1.0.1.0.0.0.1.0 3-4|0.1.0.1.0.0.0.1.0.0 0-1|0.1.0.1.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:14.037
(e / express-01 
      :ARG1 5 
      :mod-of (l / level 
            :ARG1-of (s / scale-01 
                  :ARG0 (m / microarray) 
                  :ARG2-of (b / base-02 
                        :ARG1 (o / organization 
                              :ARG0-of (d / do-02 
                                    :ARG1 (u / use-01 
                                          :ARG1 (s2 / software 
                                                :mod (o2 / organization 
                                                      :name (n2 / name 
                                                            :op1 "Affymetrix"))) 
                                          :ARG2 (n3 / normalisation 
                                                :poss (l2 / level 
                                                      :mod (e2 / express-01))))) 
                              :name (n / name 
                                    :op1 "MAS")) 
                        :ARG1-of (t / total-01)) 
                  :mod (g2 / globe)) 
            :mod (g / gene)))

# ::snt The normalised expression values were imported to and analysed by dCHIP [ 24 ] .
# ::tok The normalised expression values were imported to and analysed by dCHIP [ 24 ] .
# ::alignments 12-13|0.0.0.1.0 7-8|0 5-6|0.0 3-4|0.0.0 2-3|0.0.0.1 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:14.065
(a / and 
      :op1 (i / import-01 
            :ARG1 (v / value 
                  :mod (n / normalise) 
                  :mod (e / express-01 
                        :ARG1 24))))

# ::snt Differentially expressed genes were identified by defining the appropriate filtering criteria in the dCHIP software as : lower 90 % confidence boundary of fold change between the group means exceeded twofold ; the absolute difference between the two groups exceeded 100 ; the P value threshold of the unpaired t-test was 0.05 .
# ::tok Differentially expressed genes were identified by defining the appropriate filtering criteria in the dCHIP software as : lower 90 % confidence boundary of fold change between the group means exceeded twofold ; the absolute difference between the two groups exceeded 100 ; the P value threshold of the unpaired t-test was 0.05 .
# ::alignments 49-50|0.1.0.0.1.0.1.0.1.0.0 48-49|0.1.0.0.1.0.1.0.1.0.0.0 45-46|0.1.0.0.1.0.1.0.1.0 44-45|0.1.0.0.1.0.1.0.1 43-44|0.1.0.0.1.0.1.0.1.1 40-41|0.1.0.0.1.0.0.0.0 39-40|0.1.0.0 38-39|0.1.0.0.0.0 37-38|0.1.0.0.0.0.0 34-35|0.1.0.0.0 33-34|0.1.0.0.0.1 31-32|0.1.0.0.1 30-31|0.1.0.0.1.0.2.0 29-30|0.1.0.0.1.0.2 28-29|0.1.0.0.1.0 27-28|0.1.0.0.1.0.0 24-25|0.1.0.0.1.0.0.0 23-24|0.1.0.0.1.0.0.0.1 21-22|0.1.0.0.1.0.1 20-21|0.1.0.0.1.0.1.1 19-20|0.1.0.0.1.0.1.0.0.0 18-19|0.1.0.0.1.0.1.0.0 17-18|0.1.0.0.1.0.1.0 14-15|0.1.1.0.1.0 13-14|0.1.1.0.1.0.0 10-11|0.1.1.0 9-10|0.1.1.0.0 8-9|0.1.1.0.1 6-7|0.1.1 4-5|0.1 2-3|0.1.0 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:15.603
(e3 / express-01 
      :ARG0 (d4 / differentially) 
      :ARG1 (i / identify-01 
            :ARG1 (g3 / gene 
                  :ARG1-of (e / exceed-01 
                        :ARG0 (d / differ-02 
                              :ARG1 (g / group 
                                    :quant 2) 
                              :mod (a / absolute)) 
                        :mode (a2 / and 
                              :ARG2-of (m / mean-01 
                                    :ARG0 (g2 / group 
                                          :ARG1-of (c / change-01 
                                                :ARG0 100 
                                                :mod (f / fold))) 
                                    :ARG1 (b / boundary 
                                          :ARG1-of (l / low-04 
                                                :ARG0 (9 / 90 
                                                      :value-of (p2 / percentage-entity)) 
                                                :ARG2-of (v / value-01 
                                                      :ARG0 (t2 / threshold 
                                                            :poss (t / t-t 
                                                                  :mod (u / unpair))) 
                                                      :ARG1 (p / P60))) 
                                          :mod (c2 / confidence)) 
                                    :ARG1-of (e2 / exceed-01 
                                          :ARG2 (t3 / twofold)))))) 
            :ARG2 (d3 / define-01 
                  :ARG1 (c3 / criteria 
                        :ARG1-of (f2 / filter-02) 
                        :ARG1-of (a3 / appropriate-02 
                              :location (s / software 
                                    :mod (d2 / dCHIP)))))))

# ::snt The false discovery rate was established with a permutation test for each pairwise comparison to estimate the proportion of false-positive genes .
# ::tok The false discovery rate was established with a permutation test for each pairwise comparison to estimate the proportion of false-positive genes .
# ::alignments 20-21|0.0.0.0.0 17-18|0.0.0.0 15-16|0.0.0 13-14|0.1 11-12|0.1.0 9-10|0.0.0.1 8-9|0.0.0.1.0 5-6|0 3-4|0.0 2-3|0.0.2 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:15.682
(e3 / establish-01 
      :ARG1 (r / rate 
            :ARG0-of (e / estimate-01 
                  :ARG1 (p / proportion 
                        :mod-of (g / gene)) 
                  :purpose-of (t / test-01 
                        :ARG1 (p2 / permutation))) 
            :mod (f / false) 
            :mod (d / discover-01)) 
      :purpose (c / compare-01 
            :mod (e2 / each)))

# ::snt Hierarchical gene clustering was performed with dCHIP to characterise the gene expression patterns during CIA .
# ::tok Hierarchical gene clustering was performed with dCHIP to characterise the gene expression patterns during CIA .
# ::alignments 14-15|0.1.0.1+0.1.0.0.0+0.1.0.0+0.1.0 12-13|0.1 11-12|0 10-11|0.1.1 6-7|0.0 4-5|0.0.0 2-3|0.0.0.0 1-2|0.0.0.0.1 0-1|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:15.788
(e / express-01 
      :ARG1 (d / dCHIP 
            :ARG2-of (p2 / perform-02 
                  :ARG1 (c / cluster-01 
                        :ARG1 (h / hierarchical) 
                        :mod (g3 / gene)))) 
      :mod-of (p / pattern-01 
            :ARG1 (g / government-organization 
                  :name (n / name 
                        :op1 "CIA") 
                  :wiki "Central_Intelligence_Agency") 
            :mod (g2 / gene)))

# ::snt The default clustering algorithm of genes was as follows : the distance between two genes is defined as 1 -- r , where r is the Pearson correlation coefficient between the standardised expression values of the two genes across the samples used .
# ::tok The default clustering algorithm of genes was as follows : the distance between two genes is defined as 1 -- r , where r is the Pearson correlation coefficient between the standardised expression values of the two genes across the samples used .
# ::alignments 41-42|0.0.0 40-41|0+0.0 38-39|0.0.1 37-38|0.0.1.1 36-37|0.0.1.1.0 33-34|0.0.1.0 32-33|0.0.1.0.1 31-32|0.0.1.0.0 28-29|0.0.1.0.1.1.1.0.1.0.0 27-28|0.0.1.0.1.1.1.0.1.0.0.0 26-27|0.0.1.0.1.1.1.0.1.0.1.0+0.0.1.0.1.1.1.0.1.0.1+0.0.1.0.1.1.1.0.1.0 20-21|0.0.0.0 18-19|0.0.1.0.1.0 16-17|0.0.1.0.1.1.1 14-15|0.0.1.0.1.1.0 13-14|0.0.1.0.1.1.0.0 11-12|0.0.1.0.1.1 8-9|0.0.1.0.1.1.1.0.0 5-6|0.0.1.0.1.1.1.0.0.0 3-4|0.0.1.0.1.1.1.0 2-3|0.0.1.0.1.1.1.0.1 1-2|0.0.1.0.1.1.1.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:16.905
(s / sample-01 
      :ARG1 (t / thing 
            :ARG1-of (u / use-01 
                  :ARG0 (r / r)) 
            :op1-of (a / across 
                  :extent-of (v / value 
                        :mod (s2 / standardise) 
                        :mod (e / express-01 
                              :ARG0 1 
                              :ARG1 (d2 / distance-01 
                                    :ARG1 (g2 / gene 
                                          :quant 2) 
                                    :ARG1-of (d / define-01 
                                          :ARG0 (a2 / algorithm 
                                                :ARG1-of (f / follow-01 
                                                      :ARG0 (g3 / gene)) 
                                                :ARG1-of (c3 / cluster-01 
                                                      :ARG0 (t2 / thing 
                                                            :mod-of (c / coefficient 
                                                                  :mod (c2 / correlation)) 
                                                            :name (n / name 
                                                                  :op1 "Pearson"))) 
                                                :ARG1-of (d3 / default-01)))))) 
                  :location-of (g / gene 
                        :quant 2))))

# ::snt To characterise the functional relationship between differentially expressed genes , Gene Ontology ( GO ) term classification incorporated in DNA-Chip Analyzer was performed .
# ::tok To characterise the functional relationship between differentially expressed genes , Gene Ontology ( GO ) term classification incorporated in DNA-Chip Analyzer was performed .
# ::alignments 22-23|0.1.1 19-21|0.1.1.1.0.0.1.1+0.1.1.1.0.0.1.0+0.1.1.1.0.0.1+0.1.1.1.0.0 17-18|0.1.1.1.0 16-17|0.1.1.1 15-16|0.1.0 13-14|0.1.1.1.0.0.0 10-12|0.1.1.0.0.1+0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 8-9|0.0 7-8|0 6-7|0.2 4-5|0.1 3-4|0.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:17.204
(e / express-01 
      :ARG1 (g2 / gene) 
      :ARG1-of (r / relation-03 
            :ARG0 (t2 / term) 
            :condition-of (p / perform-02 
                  :ARG1 (p2 / person 
                        :name (n2 / name 
                              :op1 "Gene" 
                              :op2 "Ontology")) 
                  :ARG1-of (c / classify-01 
                        :ARG1-of (i / incorporate-01 
                              :ARG2 (t / thing 
                                    :ARG1-of (g / go-01) 
                                    :name (n / name 
                                          :op1 "DNA-Chip" 
                                          :op2 "Analyzer"))))) 
            :mod (f / functional)) 
      :mod (d / differentially))

# ::snt The significant level for a function cluster was set at P < 0.005 , and the minimum size of a cluster was three genes .
# ::tok The significant level for a function cluster was set at P < 0.005 , and the minimum size of a cluster was three genes .
# ::alignments 23-24|0.2 22-23|0.2.1 20-21|0.2.0.1 17-18|0.2.0 16-17|0.2.0.0 14-15|0 10-11|0.1.1 6-7|0.1.0 5-6|0.1 2-3|0.0.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:17.323
(a / and 
      :ARG0-of (s2 / significant-02 
            :ARG1 (l / level)) 
      :op1 (f / function-01 
            :ARG0 (c2 / cluster) 
            :ARG1 (p / P60)) 
      :op2 (g / gene 
            :domain (s / size 
                  :mod (m / minimum) 
                  :poss (c / cluster)) 
            :quant 3))

# ::snt Small-effect QTL of CIA in ( DBA/1  FVB/N ) F2 progeny .
# ::tok Small-effect QTL of CIA in ( DBA/1  FVB/N ) F2 progeny .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:17.325
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt In a previous study , we carried out a genome screen to identify QTL controlling CIA susceptibility in ( DBA/1  FVB/N ) F2 progeny .
# ::tok In a previous study , we carried out a genome screen to identify QTL controlling CIA susceptibility in ( DBA/1  FVB/N ) F2 progeny .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:17.328
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt For the phenotype of arthritis severity , only one QTL , Cia2 , was identified , with a highly significant logarithm of the odds ( LOD ) score of 12 [ 10 ] .
# ::tok For the phenotype of arthritis severity , only one QTL , Cia2 , was identified , with a highly significant logarithm of the odds ( LOD ) score of 12 [ 10 ] .
# ::alignments 31-32|0.0.0.0 29-30|0.0.1 27-28|0.0 25-26|0.0.2.0.0+0.0.2.0+0.0.2 23-24|0.0.3 20-21|0.0.0.1 19-20|0.0.0.1.0 18-19|0.0.0.1.0.1 14-15|0.0.0 11-12|0 7-8|0.0.0.1.0.0 5-6|0.0.0.2.0 4-5|0.0.0.2.0.0 2-3|0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:17.553
(c2 / Cia2 
      :ARG1-of (s / score-01 
            :ARG1-of (i / identify-01 
                  :ARG0 10 
                  :ARG2 (l / logarithm 
                        :ARG1-of (s2 / significant-02 
                              :ARG0 (o2 / only) 
                              :degree (h / high))) 
                  :purpose (p / phenotype 
                        :mod (s3 / severity 
                              :mod (a / arthritis)))) 
            :ARG2 12 
            :location (c / country 
                  :name (n / name 
                        :op1 "LOD")) 
            :mod (o / odds)))

# ::snt However , Cia2 contributed to only 16 % of the phenotype variations , indicating that there should be some small-effect QTL whose contributions to CIA were not big enough to reach the significant threshold value of linkage .
# ::tok However , Cia2 contributed to only 16 % of the phenotype variations , indicating that there should be some small-effect QTL whose contributions to CIA were not big enough to reach the significant threshold value of linkage .
# ::alignments 36-37|0.0 34-35|0 33-34|0.3 32-33|0.1 30-31|0.2 28-29|0.2.0.2.0.0 27-28|0.2.0.2 26-27|0.2.0.2.0 24-25|0.2.0.1.1+0.2.0.1.0.0+0.2.0.1.0+0.2.0.1 22-23|0.2.0 18-19|0.1.0 16-17|0.2.1.1 13-14|0.2.1 11-12|0.2.0.0 10-11|0.2.0.0.0 7-8|0.2.1.0.0.1 6-7|0.2.1.0.0.1.0 5-6|0.2.1.0.0.0 3-4|0.2.1.0.0 2-3|0.2.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:18.532
(v / value-01 
      :ARG1 (l / linkage) 
      :ARG1-of (s / significant-02 
            :ARG0 (s2 / some)) 
      :ARG1-of (r / reach-01 
            :ARG0 (c / contribute-01 
                  :ARG1 (v2 / variation 
                        :mod (p / phenotype)) 
                  :ARG2 (g / government-organization 
                        :name (n / name 
                              :op1 "CIA") 
                        :wiki "Central_Intelligence_Agency") 
                  :domain-of (b / big 
                        :polarity (- / - 
                              :polarity-of (e / enough)))) 
            :ARG1-of (i / indicate-01 
                  :ARG0 (c3 / Cia2 
                        :ARG0-of (c2 / contribute-01 
                              :ARG1 (o / only) 
                              :ARG2 (p2 / percentage-entity 
                                    :value 16))) 
                  :ARG2 (r2 / recommend-01))) 
      :mod (t / threshold))

# ::snt To identify these potential small-effect QTL , we reanalyzed the data using a lower threshold value of linkage ( P = 0.05 ) .
# ::tok To identify these potential small-effect QTL , we reanalyzed the data using a lower threshold value of linkage ( P = 0.05 ) .
# ::alignments 19-20|0.1.0.0.0.0.1 17-18|0.1.1 15-16|0.1 14-15|0.0 13-14|0 11-12|0.1.0.0 10-11|0.1.0 7-8|0.1.0.0.0 5-6|0.1.0.0.0.0.0 3-4|0.1.0.0.0.0.0.0 2-3|0.1.0.0.0.0.0.1 1-2|0.1.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:18.974
(l2 / low-04 
      :ARG1 (t / threshold) 
      :ARG2-of (v / value-01 
            :ARG0 (d / data 
                  :ARG1-of (u / use-01 
                        :ARG0 (w / we 
                              :ARG0-of (i / identify-01 
                                    :ARG1 (q / QTL 
                                          :mod (p2 / potential) 
                                          :mod (t2 / this)) 
                                    :ARG2 (p / P60))))) 
            :ARG1 (l / linkage)))

# ::snt We reasoned that since the main candidate gene of Cia2 , complement component C5 ( Hc ) , was proven to be essential for CIA development and because the FVB/N strain is C5 deficient [ 10,25 ] , some small-effect QTL might be masked by Cia2 .
# ::tok We reasoned that since the main candidate gene of Cia2 , complement component C5 ( Hc ) , was proven to be essential for CIA development and because the FVB/N strain is C5 deficient [ 10,25 ] , some small-effect QTL might be masked by Cia2 .
# ::alignments 43-44|0.0 41-42|0.0.1 40-41|0.0.0 38-39|0.0.0.0 33-34|0.0.1.1.0.0.1 30-31|0.1.1+0.1 29-30|0.1.0.0.0+0.1.0.0+0.1.0 27-28|0 26-27|0.0.1.2 25-26|0.0.1.1.0.0 24-25|0.0.1.1.0.0.0.1+0.0.1.1.0.0.0.0.0+0.0.1.1.0.0.0.0+0.0.1.1.0.0.0 22-23|0.0.1.1.0 19-20|0.0.1.1 13-14|0.0.1.2.0.1 12-13|0.0.1.2.0.1.0 11-12|0.0.1.2.0 9-10|0.0.1.2.0.0 7-8|0.0.1.1.1.0.0.0 6-7|0.0.1.1.1.0 5-6|0.0.1.1.1.0.0 3-4|0.0.1.1.1 1-2|0.0.1.0 0-1|0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:20.135
(c / cause-01 
      :ARG0 (m / mask-01 
            :ARG1 (q / QTL 
                  :quant (s / some)) 
            :ARG1-of (p / possible-01 
                  :ARG1-of (r / reason-01 
                        :ARG0 (w / we)) 
                  :condition (p2 / prove-01 
                        :ARG1 (e / essential 
                              :purpose (d2 / develop-02 
                                    :ARG0 (g / government-organization 
                                          :name (n2 / name 
                                                :op1 "CIA") 
                                          :wiki "Central_Intelligence_Agency") 
                                    :ARG1 (d / deficient))) 
                        :op2-of (s3 / since 
                              :op1 (c6 / candidate 
                                    :mod (m2 / main 
                                          :mod-of (g2 / gene))))) 
                  :op2-of (a / and 
                        :op1 (c4 / complement-01 
                              :ARG0 (c5 / Cia2) 
                              :ARG1 (c2 / C5 
                                    :mod (c3 / component)))))) 
      :ARG1 (s2 / strain 
            :mod (t / thing 
                  :name (n / name 
                        :op1 "FVB/N")) 
            :wiki "Influenza_A_virus_subtype_H5N1"))

# ::snt To exclude the masking effect of C5 , we performed linkage analysis with 3 datasets , the first containing all 290 F2 progeny , the second 77 C5 + / + F2 progeny and the third 133 C5 + / - F2 progeny .
# ::tok To exclude the masking effect of C5 , we performed linkage analysis with 3 datasets , the first containing all 290 F2 progeny , the second 77 C5 + / + F2 progeny and the third 133 C5 + / - F2 progeny .
# ::alignments 42-43|0.0.2.0.0.0.0 39-40|0.3 33-34|0 32-33|0.2 29-30|0.1 26-27|0.0.2.0.0.0.1 22-23|0.0.2.0.1.0 19-20|0.0.0 18-19|0.0.2.0.1 14-15|0.0.2.0.0.1 13-14|0.0.2.0.0.1.0 11-12|0.0.2.0.0.0 10-11|0.0.2.0.0.0.2 9-10|0.0.2.0.0 8-9|0.0.2.0 4-5|0.0 3-4|0.0.1 1-2|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:20.802
(a / and 
      :ARG0-of (e / effect-03 
            :ARG1 (a2 / all) 
            :ARG1-of (m / mask-01) 
            :ARG1-of (e2 / exclude-01 
                  :ARG0 (w / we 
                        :ARG0-of (p4 / perform-02 
                              :ARG1 (a3 / analyze-01 
                                    :ARG0 (p / progeny) 
                                    :ARG1 77 
                                    :manner (l / linkage)) 
                              :ARG2 (d / dataset 
                                    :quant 3)) 
                        :ARG0-of (c / contain-01 
                              :ARG1 (p3 / progeny))))) 
      :op1 (s2 / slash) 
      :op2 (p2 / progeny) 
      :op3 (s / slash))

# ::snt Eight genomic regions were linked to the phenotype of CIA severity ( loci 1 to 8 , Table 2 ) , with P values varying between 0.043 and 0.003 .
# ::tok Eight genomic regions were linked to the phenotype of CIA severity ( loci 1 to 8 , Table 2 ) , with P values varying between 0.043 and 0.003 .
# ::alignments 27-28|0 24-25|0.0 23-24|0.0.0 22-23|0.0.0.0 18-19|0.0.2.2 17-18|0.0.2.2.0 15-16|0.0.3 13-14|0.0.4 12-13|0.0.1 10-11|0.0.2.0.0.0 9-10|0.0.2.0.0.2+0.0.2.0.0.1.0+0.0.2.0.0.1+0.0.2.0.0 7-8|0.0.2.1 4-5|0.0.2 2-3|0.0.2.0 0-1|0.0.2.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:21.135
(a / and 
      :op1 (v / vary-01 
            :ARG1 (v2 / value 
                  :mod (p / P60)) 
            :ARG2 (l / locus) 
            :manner-of (l2 / link-01 
                  :ARG1 (r / region 
                        :mod-of (g / government-organization 
                              :mod-of (s / severity) 
                              :name (n / name 
                                    :op1 "CIA") 
                              :wiki "Central_Intelligence_Agency") 
                        :quant (e / eight)) 
                  :ARG2 (p2 / phenotype) 
                  :op1-of (2 / 2 
                        :mod-of (t / table))) 
            :op1-of 8 
            :op1-of 1))

# ::snt These eight small-effect QTL were located on chromosomes 5 , 6 , 7 , 10 , 11 , 16 , and 17 .
# ::tok These eight small-effect QTL were located on chromosomes 5 , 6 , 7 , 10 , 11 , 16 , and 17 .
# ::alignments 21-22|0.0 20-21|0.3 18-19|0.2.0.0.0 16-17|0.2.1 14-15|0.2.0.1 12-13|0.2.0.3 10-11|0.2.0.2 8-9|0.1.0 7-8|0.1 5-6|0 3-4|0.2 1-2|0.2.0.0 0-1|0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:21.472
(l / locate-01 
      :ARG0 17 
      :ARG1 (c / chromosom 
            :mod 5) 
      :ARG2 (q / QTL 
            :mod (t / this 
                  :op1 (8 / 8 
                        :poss 16) 
                  :op1-of 10 
                  :op2 6 
                  :poss 7) 
            :poss-of 11) 
      :purpose (a / and))

# ::snt Five loci were identified in at least two datasets .
# ::tok Five loci were identified in at least two datasets .
# ::alignments 8-9|0.1 7-8|0.1.0 3-4|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:21.490
(i / identify-01 
      :ARG1 (l / locus 
            :mod 5) 
      :time (d / dataset 
            :quant 2))

# ::snt Of the eight loci , five had DBA/1 as the susceptibility allele , and three had FVB/N as the susceptibility allele .
# ::tok Of the eight loci , five had DBA/1 as the susceptibility allele , and three had FVB/N as the susceptibility allele .
# ::alignments 20-21|0.0.0 19-20|0.0.0.0 16-17|0.2.0.0+0.2.0+0.2 14-15|0.0.0.0.1.0 13-14|0 11-12|0.1 10-11|0.1.0 5-6|0.0.0.0.0 3-4|0.0 2-3|0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:21.557
(a2 / and 
      :example-of (l / locus 
            :poss-of (a / allele 
                  :mod (s / susceptibility 
                        :mod-of 5 
                        :poss (8 / 8 
                              :poss 3)))) 
      :op1 (a3 / allele 
            :mod (s2 / susceptibility)) 
      :op2 (t / thing 
            :name (n / name 
                  :op1 "FVB/N")))

# ::snt Lander and Botstein [ 26 ] suggested a LOD score of between 2 and 3 to ensure an overall false positive rate of 5 % , which means that using a lower threshold value will prevent false negative QTL at the expense of increasing false positive QTL .
# ::tok Lander and Botstein [ 26 ] suggested a LOD score of between 2 and 3 to ensure an overall false positive rate of 5 % , which means that using a lower threshold value will prevent false negative QTL at the expense of increasing false positive QTL .
# ::alignments 45-46|0.0.1.0.0.3.1 44-45|0.0.1.0.0.3.2 43-44|0.0.1.0.0.3 41-42|0.0.1.0.0.3.0 37-38|0.2.0 36-37|0.0.1.0.0.2 35-36|0.0.1.0.0 33-34|0.0.1.0.1 32-33|0.0.1.0.1.1 31-32|0.0.1.0.1.2 29-30|0.0.1.0 27-28|0.0.1.0.0.1 24-25|0.0.1.0.0.1.1 23-24|0.0.1.0.0.1.1.0 21-22|0.2.1 20-21|0.2.1.2 19-20|0.2.1.1 18-19|0.2.1.0 16-17|0.2 14-15|0.1.1 13-14|0.0.1.0.0.0 12-13|0.0.1.0.1.0 9-10|0.1 8-9|0.1.0.0.0+0.1.0.0+0.1.0 6-7|0 4-5|0.0.1.0.0.1.0 2-3|0.0.1.1.0+0.0.1.1+0.0.1 1-2|0.0 0-1|0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:22.288
(s2 / suggest-01 
      :ARG0 (a2 / and 
            :op1 (p6 / person 
                  :name (n4 / name 
                        :op1 "Lander")) 
            :op2 (p5 / person 
                  :ARG0-of (u / use-01 
                        :ARG0-of (p2 / prevent-01 
                              :ARG1 (a / and) 
                              :ARG2-of (m / mean-01 
                                    :ARG0 26 
                                    :ARG1 (p3 / percentage-entity 
                                          :value 5)) 
                              :ARG3 (f2 / false) 
                              :purpose (i / increase-01 
                                    :ARG1-of (e / expend-01) 
                                    :manner (p / positive) 
                                    :manner (f / false))) 
                        :ARG1 (v / value-01 
                              :ARG0 2 
                              :ARG1 (t / threshold) 
                              :ARG1-of (l / low-04))) 
                  :name (n3 / name 
                        :op1 "Botstein"))) 
      :ARG1 (s / score-01 
            :ARG0 (c / country 
                  :name (n2 / name 
                        :op1 "LOD")) 
            :ARG1 3) 
      :purpose (e2 / ensure-01 
            :ARG0 (n / negative) 
            :ARG1 (r / rate 
                  :mod (o / overall) 
                  :mod (f3 / false) 
                  :mod (p4 / positive))))

# ::snt Being aware of this , we examined these genomic regions to search whether they , or their syntenic genomic regions on the human genome , have been previously linked to arthritis .
# ::tok Being aware of this , we examined these genomic regions to search whether they , or their syntenic genomic regions on the human genome , have been previously linked to arthritis .
# ::alignments 30-31|0.0.0.2 28-29|0.0.0 27-28|0.0.0.3 23-24|0.0.0.1.1.1.0.0 22-23|0.0.0.1.1.1.0 19-20|0.1 15-16|0 13-14|0.0 11-12|0.0.0.1 9-10|0.0.0.1.1.0 7-8|0.0.0.1.1.0.0 6-7|0.0.0.1.1 5-6|0.0.0.1.0 3-4|0.0.0.0 0-1|0.0.0.1.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:22.517
(o / or 
      :domain (t / they 
            :ARG1-of (l / link-01 
                  :ARG0 (t3 / this) 
                  :ARG1-of (s / search-01 
                        :ARG0 (w / we) 
                        :purpose-of (e / examine-01 
                              :ARG1 (r2 / region 
                                    :mod (t2 / this)) 
                              :ARG1-of (b / be-01 
                                    :ARG0 (h / human 
                                          :mod-of (g / genome))) 
                              :ARG0 w)) 
                  :ARG2 (a / arthritis) 
                  :time (p / previous))) 
      :op1 (r / region))

# ::snt Four small-effect QTL overlapped with arthritis QTL on the mouse genome identified previously .
# ::tok Four small-effect QTL overlapped with arthritis QTL on the mouse genome identified previously .
# ::alignments 12-13|0.0.0.2 11-12|0.0.0 10-11|0.0 9-10|0.0.1 5-6|0.0.0.1 3-4|0 2-3|0.1 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:22.573
(o / overlap-01 
      :ARG0 (g / genome 
            :ARG1-of (i / identify-01 
                  :ARG0 4 
                  :op1-of (a / arthritis) 
                  :time (p / previous)) 
            :mod (m / mouse)) 
      :ARG1 (q / QTL))

# ::snt Locus 1 and 2 overlap with Cia13 and Cia14 , which control severity of CIA in ( DBA/1  BALB/C ) F2 progeny [ 27 ] .
# ::tok Locus 1 and 2 overlap with Cia13 and Cia14 , which control severity of CIA in ( DBA/1  BALB/C ) F2 progeny [ 27 ] .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:22.575
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Locus 5 located on chromosome 10 overlaps with Cia8 , which was identified in ( DBA/1  B10.Q ) F2 progeny [ 28 ] .
# ::tok Locus 5 located on chromosome 10 overlaps with Cia8 , which was identified in ( DBA/1  B10.Q ) F2 progeny [ 28 ] .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:22.578
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Locus 6 overlaps with Pgia7 , which controls susceptibility to proteoglycan-induced arthritis ( PGIA ) and was identified in ( BALB/C  DBA/2 ) F2 progeny [ 29 ] .
# ::tok Locus 6 overlaps with Pgia7 , which controls susceptibility to proteoglycan-induced arthritis ( PGIA ) and was identified in ( BALB/C  DBA/2 ) F2 progeny [ 29 ] .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:22.582
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt The syntenic genomic regions of five small-effect QTL on the human genome have been reported to be linked to RA .
# ::tok The syntenic genomic regions of five small-effect QTL on the human genome have been reported to be linked to RA .
# ::alignments 19-20|0.0.2.0.0+0.0.2.0+0.0.2 17-18|0.0 14-15|0 11-12|0.0.1 10-11|0.0.1.0 5-6|0.0.3 3-4|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:22.707
(r / report-01 
      :ARG1 (l / link-01 
            :ARG0 (r2 / region) 
            :ARG1 (g / genome 
                  :mod (h / human)) 
            :ARG2 (o / organization 
                  :name (n / name 
                        :op1 "RA")) 
            :op1-of 5))

# ::snt These are genomic regions 22q11 and 12p13-q24 on chromosome 22 and 12 ( the counterparts of locus 2 ) , 12p13-pter on chromosome 12 ( the counterpart of locus 3 ) , 21q22-qter and 10q22-23 on chromosome 21 and 10 ( the counterparts of locus 5 ) , 17q21-25 on chromosome 17 ( the counterpart of locus 6 ) and 3q29-qter on chromosome 3 ( the counterpart of locus 7 ) [ 2,4 ] .
# ::tok These are genomic regions 22q11 and 12p13-q24 on chromosome 22 and 12 ( the counterparts of locus 2 ) , 12p13-pter on chromosome 12 ( the counterpart of locus 3 ) , 21q22-qter and 10q22-23 on chromosome 21 and 10 ( the counterparts of locus 5 ) , 17q21-25 on chromosome 17 ( the counterpart of locus 6 ) and 3q29-qter on chromosome 3 ( the counterpart of locus 7 ) [ 2,4 ] .
# ::alignments 69-70|0.2.0.3.1.0.0.2 68-69|0.2.0.3.1.0.0.0.0 66-67|0.2.0.3.1.0.0.0.1+0.2.0.3.1.0.0.0 63-64|0.2.1.0 62-63|0.2.2.0 60-61|0.2.2 59-60|0.2 57-58|0.2.3.0 56-57|0.2.0.0.0 54-55|0.2.0.0.2+0.2.0.0 51-52|0.2.0.0.1.2 50-51|0.2.0.0.1.0 45-46|0.2.0.3.1.0.0 42-43|0.2.1 39-40|0.2.2.1 38-39|0 37-38|0.1.0 36-37|0.2.3 33-34|0.2.0 32-33|0.2.0.1 29-30|0.2.0.0.1 26-27|0.2.0.0.1.2.0.0+0.2.0.0.1.2.0 23-24|0.2.0.3.1.0.0.1 22-23|0.2.0.3.1.0 20-21|0.2.0.3.1 17-18|0.0 16-17|0.1 14-15|0.2.0.3.0 11-12|0.2.0.1.0 10-11|0.2.0.2 9-10|0.2.0.1.1 8-9|0.2.0.0.1.1 5-6|0.2.0.3 3-4|0.3 0-1|0.2.0.3.1.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:23.484
(a2 / and 
      :mod-of 2 
      :mod-of (l3 / locu 
            :mod 21) 
      :op2-of (a / and 
            :op1 (a3 / and 
                  :mod-of (c3 / counterpart 
                        :mod (l2 / locu) 
                        :mod (33 / 3 
                              :mod-of (c4 / chromosome) 
                              :mod-of (c10 / chromosome) 
                              :mod-of (1 / 17 
                                    :mod-of (c7 / counterpart 
                                          :wiki "Abdel_Rahman_Shalgham"))) 
                        :wiki "Abdel_Rahman_Shalgham") 
                  :op1 (22 / 21q22-qt 
                        :mod-of 12 
                        :mod-of 22) 
                  :op1-of (a4 / and) 
                  :op3-of (a5 / and 
                        :op1 (c9 / counterpart) 
                        :op2 (14 / 12p13-pt 
                              :location (c8 / chromosome 
                                    :mod (5 / 5 
                                          :mod (c / counterpart 
                                                :mod (l / locu) 
                                                :wiki "Abdel_Rahman_Shalgham") 
                                          :mod-of (13 / 12 
                                                :mod (t / this)) 
                                          :poss 7))))) 
            :op3 (c5 / counterpart 
                  :mod-of 3) 
            :op4 (32 / 3q29-qt 
                  :location (c2 / chromosome) 
                  :mod 10) 
            :poss-of (c6 / chromosome 
                  :mod 6)) 
      :poss (r / region))

# ::snt Strain-specific differentially expressed genes .
# ::tok Strain-specific differentially expressed genes .
# ::alignments 3-4|0.1 2-3|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:23.494
(e / express-01 
      :ARG0 (d / differentially) 
      :ARG1 (g / gene))

# ::snt We detected the gene expression profiles using three mice per group , which is a small number .
# ::tok We detected the gene expression profiles using three mice per group , which is a small number .
# ::alignments 16-17|0.1.0 15-16|0.1.0.0 10-11|0.1.0.1 8-9|0.1.1.0 7-8|0.1.1.0.0 6-7|0.1.1 5-6|0.1 4-5|0.1.2 3-4|0.1.3 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:23.658
(d / detect-01 
      :ARG0 (w / we) 
      :ARG1 (p / profile-01 
            :ARG0 (n / number 
                  :mod (s / small) 
                  :mod-of (g / group)) 
            :ARG0-of (u / use-01 
                  :ARG1 (m / mouse 
                        :quant 3)) 
            :ARG1 (e / express-01) 
            :mod (g2 / gene)))

# ::snt Being aware of the importance of data reproducibility , we determined the coefficient of variation ( CV ) to measure data variability .
# ::tok Being aware of the importance of data reproducibility , we determined the coefficient of variation ( CV ) to measure data variability .
# ::alignments 21-22|0.0.0.0 20-21|0.0.0.0.0 19-20|0.0.0 16-17|0.0.0.0.0.0.0.1+0.0.0.0.0.0.0.0.0+0.0.0.0.0.0.0.0+0.0.0.0.0.0.0 14-15|0.1.0 12-13|0.1 10-11|0 9-10|0.0 7-8|0.1.1.0 6-7|0.1.1 4-5|0.1.1.0.0 0-1|0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:23.928
(d2 / determine-01 
      :ARG0 (w / we 
            :ARG0-of (m / measure-01 
                  :ARG1 (v / variability 
                        :mod (d / data 
                              :op1 (b / be-01 
                                    :ARG0 (s / ship 
                                          :name (n / name 
                                                :op1 "CV") 
                                          :wiki -)))))) 
      :ARG1 (c / coefficient 
            :mod (v2 / variation) 
            :op1 (d3 / data 
                  :mod-of (r / reproducibility 
                        :mod-of (i / important)))))

# ::snt The CV for each gene on the chip and the mean CV for the entire probe set were calculated .
# ::tok The CV for each gene on the chip and the mean CV for the entire probe set were calculated .
# ::alignments 18-19|0 15-16|0.0.1.0 14-15|0.0.1.0.1 11-12|0.0.1.1.2+0.0.1.1.1.0+0.0.1.1.1+0.0.1.1 10-11|0.0.1.1.0 8-9|0.0.1 7-8|0.0.1.0.0.1 4-5|0.0.1.0.0 3-4|0.0.1.0.0.0 1-2|0.0.2+0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:24.313
(c / calculate-01 
      :ARG1 (s2 / ship 
            :name (n2 / name 
                  :op1 "CV") 
            :op1-of (a / and 
                  :ARG0-of (p / probe-01 
                        :ARG1 (g / gene 
                              :mod (e2 / each) 
                              :topic (c2 / chip)) 
                        :mod (e / entire)) 
                  :op2 (s / ship 
                        :ARG1-of (m / mean-01) 
                        :name (n / name 
                              :op1 "CV") 
                        :wiki -)) 
            :wiki -))

# ::snt The mean CV ranged between 18.4 % and 25.8 % for all experimental groups , and this relatively low CV indicated that these data could be used for further analysis ( Table 1 ) .
# ::tok The mean CV ranged between 18.4 % and 25.8 % for all experimental groups , and this relatively low CV indicated that these data could be used for further analysis ( Table 1 ) .
# ::alignments 32-33|0.2.1.0.0.0.0 31-32|0.2.1.0.0.0.0.0 29-30|0.2.1.0.2 28-29|0.2.1.0.2.1 26-27|0.2.1.0 24-25|0.2.1 23-24|0.2.1.0.1 22-23|0.2.1.0.1.0 20-21|0.2 19-20|0.2.0.3+0.2.0.2.0+0.2.0.2+0.2.0 18-19|0.2.0.0 17-18|0.2.0.0.0 16-17|0.2.0.1 15-16|0 13-14|0.2.1.0.0 12-13|0.2.1.0.0.0 11-12|0.2.1.0.2.0 9-10|0.1 7-8|0.0.1 6-7|0.0.1.0 3-4|0.0 2-3|0.0.0.2+0.0.0.1.0+0.0.0.1+0.0.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:25.342
(a2 / and 
      :op1 (r2 / range-01 
            :ARG0 (s2 / ship 
                  :ARG1-of (m / mean-01) 
                  :name (n2 / name 
                        :op1 "CV") 
                  :wiki -) 
            :ARG1 (a4 / and 
                  :op1 (p3 / percentage-entity))) 
      :op2 (p2 / percentage-entity) 
      :op3 (i / indicate-01 
            :ARG0 (s / ship 
                  :ARG1-of (l / low-04 
                        :mod (r / relative)) 
                  :mod (t3 / this) 
                  :name (n / name 
                        :op1 "CV") 
                  :wiki -) 
            :ARG1 (p / possible-01 
                  :ARG1 (u / use-01 
                        :ARG0 (g / group 
                              :mod (e / experiment-01 
                                    :ARG1 (1 / 1 
                                          :mod-of (t / table)))) 
                        :ARG1 (d / data 
                              :mod (t2 / this)) 
                        :ARG2 (a / analyze-01 
                              :ARG1 (a3 / all) 
                              :mod (f / further))))))

# ::snt To search for strain-specific differentially expressed genes , we performed comparisons of gene expression between the DBA/1 and FVB/N strains at all four phases of CIA , including NC , PI , OA and CA .
# ::tok To search for strain-specific differentially expressed genes , we performed comparisons of gene expression between the DBA/1 and FVB/N strains at all four phases of CIA , including NC , PI , OA and CA .
# ::alignments 34-35|0.0.1.0.0.0.2.4.1+0.0.1.0.0.0.2.4.0.0+0.0.1.0.0.0.2.4.0+0.0.1.0.0.0.2.4 33-34|0.0.1.0.0.0.2 32-33|0.0.1.0.0.0.2.3.0.0+0.0.1.0.0.0.2.3.0+0.0.1.0.0.0.2.3 30-31|0.0.1.0.0.0.2.2.0.0+0.0.1.0.0.0.2.2.0+0.0.1.0.0.0.2.2 28-29|0.0.1.0.0.0.2.1.1+0.0.1.0.0.0.2.1.0.0+0.0.1.0.0.0.2.1.0+0.0.1.0.0.0.2.1 25-26|0.0.1.0.0.0.2.0.2+0.0.1.0.0.0.2.0.1.0+0.0.1.0.0.0.2.0.1+0.0.1.0.0.0.2.0 23-24|0.0.1.0.0.0.2.0.0 22-23|0.0.0 21-22|0.0.2 19-20|0.0.1.0.0.0.1 18-19|0.0.1.0.0.0.0.0.0+0.0.1.0.0.0.0.0+0.0.1.0.0.0.0 17-18|0.0.1.0.0.0 13-14|0.0.1.0.0 12-13|0.0.1.0.0.1 10-11|0.0.1.0 9-10|0.0.1.0.1 8-9|0.0.1.0.1.0 6-7|0.0.1.1 5-6|0.0.1 4-5|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:26.438
(d / differentially 
      :ARG2-of (s4 / search-01 
            :ARG0 4 
            :ARG0-of (e2 / express-01 
                  :ARG0-of (c2 / compare-01 
                        :ARG1 (e / express-01 
                              :ARG1 (a3 / and 
                                    :op1 (t / thing 
                                          :name (n6 / name 
                                                :op1 "FVB/N")) 
                                    :op2 (s3 / strain) 
                                    :op3 (a / and 
                                          :op1 (g / government-organization 
                                                :mod-of (p / phase) 
                                                :name (n5 / name 
                                                      :op1 "CIA") 
                                                :wiki "Central_Intelligence_Agency") 
                                          :op2 (s2 / state 
                                                :name (n4 / name 
                                                      :op1 "NC") 
                                                :wiki "North_Carolina") 
                                          :op3 (c / country 
                                                :name (n3 / name 
                                                      :op1 "PI")) 
                                          :op4 (o / organization 
                                                :name (n2 / name 
                                                      :op1 "OA")) 
                                          :op5 (s / state 
                                                :name (n / name 
                                                      :op1 "CA") 
                                                :wiki "California"))) 
                              :mod (g2 / gene)) 
                        :ARG1-of (p2 / perform-02 
                              :ARG0 (w / we))) 
                  :ARG1 (g3 / gene)) 
            :ARG1 (a2 / all)))

# ::snt For the naive mice without immunisation , 361 genes were differentially expressed between the two strains .
# ::tok For the naive mice without immunisation , 361 genes were differentially expressed between the two strains .
# ::alignments 15-16|0.3 14-15|0.3.0 11-12|0 10-11|0.1 8-9|0.0 5-6|0.2.1 3-4|0.2 2-3|0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:26.480
(e / express-01 
      :ARG1 (g / gene) 
      :mod (d / differentially) 
      :purpose (m / mouse 
            :mod (n / naive) 
            :source (i / immunisation)) 
      :time (s / strain 
            :quant 2))

# ::snt On day 10 after immunisation , when both strains did not show any sign of the disease , 141 genes were differentially expressed .
# ::tok On day 10 after immunisation , when both strains did not show any sign of the disease , 141 genes were differentially expressed .
# ::alignments 22-23|0 21-22|0.1 19-20|0.0 16-17|0.3.1.1 13-14|0.3.1 12-13|0.3.1.2 11-12|0.3 10-11|0.3.2 8-9|0.3.0 7-8|0.3.0.0 4-5|0.2.0 3-4|0.2 2-3|0.3.1.0 1-2|0.4 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:26.609
(e / express-01 
      :ARG1 (g / gene) 
      :mod (d / differentially) 
      :time (a2 / after 
            :op1 (i / immunisation)) 
      :time (s2 / show-01 
            :ARG0 (s3 / strain 
                  :mod (b / both)) 
            :ARG1 (s / sign-02 
                  :ARG0 10 
                  :ARG1 (d2 / disease) 
                  :mod (a / any)) 
            :polarity -) 
      :time (d3 / day))

# ::snt After DBA/1 mice developed CIA , 184 and 85 differentially expressed genes were identified between these two strains at the onset and chronic phases , respectively .
# ::tok After DBA/1 mice developed CIA , 184 and 85 differentially expressed genes were identified between these two strains at the onset and chronic phases , respectively .
# ::alignments 25-26|0.1.1.0.1.0.0 23-24|0.1.1.0 22-23|0.1.1.0.0 21-22|0.1.1.0.1 20-21|0.1.1 17-18|0.1.2 16-17|0.1.2.1 15-16|0.1.2.0 13-14|0.1 11-12|0.1.0 10-11|0 9-10|0.2 8-9|0.0 7-8|0.1.1.0.1.0 4-5|0.3.1.1+0.3.1.0.0+0.3.1.0+0.3.1 3-4|0.3 2-3|0.3.0 0-1|0.3.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:26.939
(e / express-01 
      :ARG0 85 
      :ARG1 (i / identify-01 
            :ARG1 (g / gene) 
            :ARG2 (o / onset 
                  :mod-of (p / phase 
                        :mod (c / chronic) 
                        :op2-of (a / and 
                              :op1 (a2 / and 
                                    :mod (r / respective))))) 
            :time (s / strain 
                  :mod (t / this) 
                  :quant 2)) 
      :mod (d / differentially) 
      :time (d2 / develop-02 
            :ARG0 (m / mouse) 
            :ARG1 (g2 / government-organization 
                  :name (n / name 
                        :op1 "CIA") 
                  :wiki "Central_Intelligence_Agency") 
            :op1-of (a3 / after)))

# ::snt When the lists of the differentially expressed genes at the four phases were merged and overlapping genes were excluded , 509 genes were identified ( Additional file 1 ) .
# ::tok When the lists of the differentially expressed genes at the four phases were merged and overlapping genes were excluded , 509 genes were identified ( Additional file 1 ) .
# ::alignments 27-28|0.0.0.0.2.0 26-27|0.0.0.0.0.1.0 25-26|0.0.0.0.0.1.0.0 23-24|0.0.0.0.0.1 21-22|0.0.0.0.0.1.1 20-21|0.0.0.0.0.1.1.0 18-19|0.0.0 16-17|0.0 15-16|0.0.0.0.2 14-15|0.0.0.0 13-14|0.0.0.0.1 11-12|0 10-11|0.0.0.0.2.1 7-8|0.0.0.0.1.0 6-7|0.0.0.0.0 5-6|0.0.0.0.0.0.0 2-3|0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:27.594
(p / phase 
      :mod (g2 / gene 
            :ARG1-of (e / exclude-01 
                  :op3-of (a2 / and 
                        :ARG1-of (e2 / express-01 
                              :ARG0 (l / list-01 
                                    :ARG1 (d / differentially)) 
                              :purpose-of (i / identify-01 
                                    :ARG0 (f / file 
                                          :time (a / additional)) 
                                    :ARG1 (g / gene 
                                          :part-of 509))) 
                        :op1 (m / merge-01 
                              :ARG1 (g3 / gene)) 
                        :op2 (o / overlap-01 
                              :ARG0 1 
                              :ARG1 4)))))

# ::snt Twenty-one genes consistently showed differential expression between the two strains at all phases .
# ::tok Twenty-one genes consistently showed differential expression between the two strains at all phases .
# ::alignments 12-13|0.0.0.0 11-12|0.0.0.0.0 9-10|0.1.1 8-9|0.1.1.0 5-6|0.1 4-5|0.1.0 3-4|0 2-3|0.2 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:27.702
(s2 / show-01 
      :ARG0 (g / gene 
            :part-of (t / twenty-one 
                  :poss-of (p / phase 
                        :quant (a / all)))) 
      :ARG1 (e / express-01 
            :ARG0 (d / differential) 
            :ARG1 (s / strain 
                  :quant 2)) 
      :manner (c / consistent))

# ::snt Besides these 21 genes , only 3 additional genes were strain-specific differentially expressed during the 3 phases after CIA induction ( PI , OA and CA ; Figure 1 ) .
# ::tok Besides these 21 genes , only 3 additional genes were strain-specific differentially expressed during the 3 phases after CIA induction ( PI , OA and CA ; Figure 1 ) .
# ::alignments 28-29|0.0.0.1.0.1.0.1.0 27-28|0.1.3 26-27|0 25-26|0.1.2.1+0.1.2.0.0+0.1.2.0+0.1.2 24-25|0.1 23-24|0.1.1.0.0+0.1.1.0+0.1.1 21-22|0.1.0.0.0+0.1.0.0+0.1.0 19-20|0.0.0 18-19|0.0.2+0.0.1.0+0.0.1+0.0 17-18|0.0.0.1 16-17|0.0.0.1.0.2 15-16|0.0.0.1.0.2.0 12-13|0.0.0.1.0 11-12|0.0.0.1.0.1 8-9|0.0.0.1.0.1.0 7-8|0.0.0.1.0.1.0.0 6-7|0.0.0.1.0.1.0.2 5-6|0.0.0.1.0.1.0.1 3-4|0.0.0.1.0.0 2-3|0.0.0.0 1-2|0.0.0.1.0.0.0 0-1|0.0.0.1.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:28.288
(a / and 
      :op1 (g / government-organization 
            :ARG1-of (i / induct-02 
                  :ARG0 21 
                  :op1-of (a3 / after 
                        :time-of (e / express-01 
                              :ARG0 (g3 / gene 
                                    :mod (t / this) 
                                    :op1-of (b / besides)) 
                              :ARG1 (d / differentially 
                                    :domain (g2 / gene 
                                          :mod (a4 / additional) 
                                          :quant (o3 / only 
                                                :op1 1) 
                                          :quant 3)) 
                              :time (p / phase 
                                    :quant 3)))) 
            :name (n4 / name 
                  :op1 "CIA") 
            :wiki "Central_Intelligence_Agency") 
      :op4-of (a2 / and 
            :op1 (o2 / organization 
                  :name (n3 / name 
                        :op1 "PI")) 
            :op2 (o / organization 
                  :name (n2 / name 
                        :op1 "OA")) 
            :op3 (s / state 
                  :name (n / name 
                        :op1 "CA") 
                  :wiki "California") 
            :op5 (f / figure)))

# ::snt Disease-specific differentially expressed genes .
# ::tok Disease-specific differentially expressed genes .
# ::alignments 3-4|0.1 2-3|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:28.299
(e / express-01 
      :ARG0 (d / differentially) 
      :ARG1 (g / gene))

# ::snt To identify the disease-specific differentially expressed genes in CIA , we detected the genes that were differentially expressed in LNs during CIA in the susceptible strain .
# ::tok To identify the disease-specific differentially expressed genes in CIA , we detected the genes that were differentially expressed in LNs during CIA in the susceptible strain .
# ::alignments 25-26|0.1.0.0.1+0.1.0.0 24-25|0.1.0.0.0 21-22|0.2.1+0.2.0.0+0.2.0+0.2 19-20|0.1.0.1 17-18|0.1.0 13-14|0.1 11-12|0 10-11|0.0 8-9|0.0.0.0.0.1.1+0.0.0.0.0.1.0.0+0.0.0.0.0.1.0+0.0.0.0.0.1 6-7|0.0.0.0.0.0 5-6|0.0.0.0.0 4-5|0.0.0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:28.990
(d / detect-01 
      :ARG0 (w / we 
            :ARG0-of (i / identify-01 
                  :ARG1 (d2 / differentially 
                        :ARG0-of (e2 / express-01 
                              :ARG1 (g4 / gene) 
                              :manner (g3 / government-organization 
                                    :name (n2 / name 
                                          :op1 "CIA") 
                                    :wiki "Central_Intelligence_Agency"))))) 
      :ARG1 (g2 / gene 
            :ARG1-of (e / express-01 
                  :ARG0 (s / strain 
                        :mod (s2 / susceptible) 
                        :wiki "Influenza_A_virus_subtype_H5N1") 
                  :manner (l / ln))) 
      :time (g / government-organization 
            :name (n / name 
                  :op1 "CIA") 
            :wiki "Central_Intelligence_Agency"))

# ::snt Three experimental conditions , PI , OA and CA , were compared with the NC group .
# ::tok Three experimental conditions , PI , OA and CA , were compared with the NC group .
# ::alignments 15-16|0.0.0.0 14-15|0.0.0.0.0.1+0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 11-12|0.0.0 8-9|0.0.1.2.1+0.0.1.2.0.0+0.0.1.2.0+0.0.1.2 7-8|0.0.1 6-7|0.0.1.1.0.0+0.0.1.1.0+0.0.1.1 4-5|0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 2-3|0.0 1-2|0 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:29.084
(e / experiment-01 
      :mod-of (c2 / condition 
            :ARG1-of (c / compare-01 
                  :ARG2 (g / group 
                        :mod (s / state 
                              :name (n / name 
                                    :op1 "NC") 
                              :wiki "North_Carolina"))) 
            :op1-of (a / and 
                  :op2 (o2 / organization 
                        :name (n4 / name 
                              :op1 "PI")) 
                  :op3 (o / organization 
                        :name (n3 / name 
                              :op1 "OA")) 
                  :op4 (s2 / state 
                        :name (n2 / name 
                              :op1 "CA") 
                        :wiki "California")) 
            :quant 3))

# ::snt On day 10 after immunisation , 102 genes were differentially expressed -- most of them were upregulated ( 78 out of 102 ) -- while at the onset phase of the disease , only 26 genes were differentially expressed .
# ::tok On day 10 after immunisation , 102 genes were differentially expressed -- most of them were upregulated ( 78 out of 102 ) -- while at the onset phase of the disease , only 26 genes were differentially expressed .
# ::alignments 38-39|0.5 35-36|0.5.1 34-35|0.5.1.0.0 33-34|0.5.1.0 31-32|0.5.2.0 28-29|0.5.2 27-28|0.5.2.1 21-22|0.5.0 18-19|0.5.3 12-13|0.0 10-11|0 9-10|0.2 7-8|0.1 6-7|0.1.0 4-5|0.3.0 3-4|0.3 2-3|0.5.2.1.0 1-2|0.4 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:29.509
(e2 / express-01 
      :ARG0 (m / most) 
      :ARG1 (g2 / gene 
            :quant 102) 
      :mod (d2 / differentially) 
      :time (a / after 
            :op1 (i / immunisation)) 
      :time (d3 / day) 
      :time (e / express-01 
            :ARG0 102 
            :ARG1 (g / gene 
                  :mod (o / only 
                        :op1 26)) 
            :ARG2 (p / phase 
                  :mod (d / disease) 
                  :mod (o2 / onset 
                        :mod 10)) 
            :op1-of 78))

# ::snt At the chronic phase of the disease , 184 differentially expressed genes were identified , with 156 downregulated genes .
# ::tok At the chronic phase of the disease , 184 differentially expressed genes were identified , with 156 downregulated genes .
# ::alignments 18-19|0.0.0.0.1 17-18|0.0.0.0.1.0 13-14|0.0.0.0 11-12|0.0.0 10-11|0.0 9-10|0 6-7|0.0.0.0.0.0 3-4|0.0.0.0.0 2-3|0.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:29.607
(d2 / differentially 
      :mod-of (e / express-01 
            :ARG1 (g2 / gene 
                  :ARG1-of (i / identify-01 
                        :ARG2 (p / phase 
                              :mod (d3 / disease) 
                              :mod (c / chronic)) 
                        :manner (g / gene 
                              :part-of (d / downregulat))))))

# ::snt Only one gene was differentially expressed at all three phases of CIA .
# ::tok Only one gene was differentially expressed at all three phases of CIA .
# ::alignments 11-12|0.2.0.1+0.2.0.0.0+0.2.0.0+0.2.0 9-10|0.2 8-9|0.2.1 7-8|0.2.2 5-6|0 4-5|0.1 2-3|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:29.652
(e / express-01 
      :ARG1 (g2 / gene 
            :mod (o / only)) 
      :mod (d / differentially) 
      :time (p / phase 
            :mod (g / government-organization 
                  :name (n / name 
                        :op1 "CIA") 
                  :wiki "Central_Intelligence_Agency") 
            :quant 3 
            :quant (a / all)))

# ::snt Besides this gene , five , one and six differentially expressed genes were shared by PI with OA , PI with CA and OA with CA , respectively ( Figure 2a ) .
# ::tok Besides this gene , five , one and six differentially expressed genes were shared by PI with OA , PI with CA and OA with CA , respectively ( Figure 2a ) .
# ::alignments 30-31|0.1.2.0.1.0 29-30|0.1.2.0.1 27-28|0.1.2.0.0 25-26|0.1.2.2.2+0.1.2.2.0.0+0.1.2.2.0+0.1.2.2 22-23|0.1.2 21-22|0.1.2.1.1+0.1.2.1.0.0+0.1.2.1.0+0.1.2.1 17-18|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 15-16|0.1.0.1.0+0.1.0.1+0.1.0 13-14|0.1 11-12|0.1.1 10-11|0 9-10|0.3 8-9|0.0 7-8|0.1.2.0 4-5|0.1.2.2.1 2-3|0.2 1-2|0.2.0 0-1|0.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:30.156
(e / express-01 
      :ARG0 6 
      :ARG1 (s3 / share-01 
            :ARG0 (o2 / organization 
                  :mod (o / organization 
                        :name (n3 / name 
                              :op1 "OA")) 
                  :name (n4 / name 
                        :op1 "PI")) 
            :ARG1 (g / gene) 
            :op2-of (a / and 
                  :op1 (a2 / and 
                        :mod (r / respective) 
                        :op1 (f / figure 
                              :mod 2a)) 
                  :op3 (s2 / state 
                        :name (n2 / name 
                              :op1 "CA") 
                        :wiki "California") 
                  :op4 (s / state 
                        :name (n / name 
                              :op1 "CA") 
                        :quant 5 
                        :wiki "California"))) 
      :manner (g2 / gene 
            :mod (t / this) 
            :op1-of (b / besides)) 
      :mod (d / differentially))

# ::snt Taken together , 310 disease-specific differentially expressed genes were differentially regulated during CIA in DBA/1 mice ( Additional file 2 ) .
# ::tok Taken together , 310 disease-specific differentially expressed genes were differentially regulated during CIA in DBA/1 mice ( Additional file 2 ) .
# ::alignments 19-20|0.2.1 18-19|0.2.0 17-18|0.2.3 15-16|0.1.2 12-13|0.1.0.1+0.1.0.0.0+0.1.0.0+0.1.0 10-11|0.1 7-8|0.1.1 6-7|0 5-6|0.0 3-4|0.0.0 1-2|0.2.2 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:30.514
(e / express-01 
      :ARG0 (d / differentially 
            :mod 310) 
      :ARG1 (r / regulate-01 
            :ARG0 (g / government-organization 
                  :name (n / name 
                        :op1 "CIA") 
                  :wiki "Central_Intelligence_Agency") 
            :ARG1 (g2 / gene) 
            :location (m / mouse)) 
      :ARG2 (t2 / take-01 
            :ARG1 (f / file) 
            :ARG2 2 
            :mod (t / together) 
            :op1-of (a / additional)))

# ::snt To further characterise the gene expression pattern during CIA , we performed hierarchical cluster analysis for these 310 genes .
# ::tok To further characterise the gene expression pattern during CIA , we performed hierarchical cluster analysis for these 310 genes .
# ::alignments 18-19|0.0.0.1.1 16-17|0.0.0.1.1.0 14-15|0.0.0.1 13-14|0.0.0.1.0 12-13|0.0.0.1.0.0 11-12|0.0.0 10-11|0.0.0.0 8-9|0.2.1+0.2.0.0+0.2.0+0.2 6-7|0.0 5-6|0 4-5|0.1 1-2|0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:30.944
(e / express-01 
      :ARG0 (p2 / pattern 
            :time-of (p / perform-02 
                  :ARG0 (w / we) 
                  :ARG1 (a / analyze-01 
                        :ARG1 (c / cluster 
                              :mod (h / hierarchical)) 
                        :ARG2 (g / gene 
                              :mod (t / this))) 
                  :concession (f / further))) 
      :ARG1 (g3 / gene) 
      :time (g2 / government-organization 
            :name (n / name 
                  :op1 "CIA") 
            :wiki "Central_Intelligence_Agency"))

# ::snt Six gene clusters were identified ( clusters I to VI , Figure 2b ) , each with a distinct gene expression pattern during CIA .
# ::tok Six gene clusters were identified ( clusters I to VI , Figure 2b ) , each with a distinct gene expression pattern during CIA .
# ::alignments 23-24|0.0.3.1+0.0.3.0.0+0.0.3.0+0.0.3 21-22|0.0 20-21|0 19-20|0.1 18-19|0.0.1 15-16|0.0.2 12-13|0.2 11-12|0.2.0 7-8|0.4 6-7|0.0.0.1 4-5|0.0.0 2-3|0.0.0.0 1-2|0.0.0.0.0 0-1|0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:31.262
(e / express-01 
      :ARG0 (p / pattern 
            :ARG2-of (i2 / identify-01 
                  :ARG0 (c2 / cluster 
                        :mod (g3 / gene)) 
                  :ARG1 (c / cluster)) 
            :mod (d / distinct) 
            :mod (e2 / each) 
            :mod (g / government-organization 
                  :name (n / name 
                        :op1 "CIA") 
                  :wiki "Central_Intelligence_Agency")) 
      :ARG1 (g2 / gene) 
      :ARG2 (2 / 2b 
            :mod-of (f / figure)) 
      :op1-of 6 
      :op1-of (i / i))

# ::snt Cluster I contains 16 genes , representing genes that were upregulated after induction of CIA .
# ::tok Cluster I contains 16 genes , representing genes that were upregulated after induction of CIA .
# ::alignments 14-15|0.0.0.0.0.0.1+0.0.0.0.0.0.0.0+0.0.0.0.0.0.0+0.0.0.0.0.0 12-13|0.0.0.0.0 11-12|0.0.0.0.0.1 7-8|0.0.0.0 6-7|0.0.0 4-5|0.1 3-4|0.1.0 2-3|0 1-2|0.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:31.749
(c / contain-01 
      :ARG0 (i2 / i 
            :ARG0-of (r / represent-01 
                  :ARG1 (g2 / gene 
                        :ARG0-of (i / induct-02 
                              :ARG1 (g / government-organization 
                                    :name (n / name 
                                          :op1 "CIA") 
                                    :wiki "Central_Intelligence_Agency") 
                              :op1-of (a / after))))) 
      :ARG1 (g3 / gene 
            :quant 16) 
      :ARG2 (c2 / cluster))

# ::snt The expression of these genes reached a peak at the onset phase of the disease and functional clustering results revealed that they are related to the immune response .
# ::tok The expression of these genes reached a peak at the onset phase of the disease and functional clustering results revealed that they are related to the immune response .
# ::alignments 27-28|0.1.2 26-27|0.1.2.1 23-24|0.1 21-22|0.1.1 19-20|0 18-19|0.1.0.0+0.1.0 17-18|0.1.0.0.0 16-17|0.1.0.0.0.0 15-16|0.1.0.1 14-15|0.1.0.1.0.0.1.1 11-12|0.1.0.1.0.0.1 10-11|0.1.0.1.0.0.1.0 7-8|0.1.0.1.0.0.0 5-6|0.1.0.1.0.0 4-5|0.1.0.1.0 3-4|0.1.2.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:32.574
(r3 / reveal-01 
      :ARG0 (e / express-01) 
      :ARG1 (r2 / relate-01 
            :ARG0 (t2 / thing 
                  :ARG2-of (r4 / result-01 
                        :ARG1 (c / cluster-01 
                              :ARG0 (f / functional))) 
                  :op2-of (a / and 
                        :op1 (g / gene 
                              :ARG0-of (r5 / reach-01 
                                    :ARG1 (p2 / peak-01) 
                                    :location (p / phase 
                                          :mod (o / onset) 
                                          :mod (d / disease)))))) 
            :ARG1 (t / they) 
            :ARG2 (r / respond-01 
                  :ARG1 (t3 / this) 
                  :ARG1-of (i / immune-02))))

# ::snt Cluster II contains 12 genes whose expression was gradually upregulated and reached a peak at the chronic phase of CIA .
# ::tok Cluster II contains 12 genes whose expression was gradually upregulated and reached a peak at the chronic phase of CIA .
# ::alignments 19-20|0.1.1.0.1.0.1+0.1.1.0.1.0.0.0+0.1.1.0.1.0.0+0.1.1.0.1.0 17-18|0.1.1.0.1 16-17|0.1.1.0.1.1 13-14|0.1.1.0 11-12|0.1 10-11|0.1.1 8-9|0.1.1.0.0 6-7|0 4-5|0.1.0 3-4|0.0 2-3|0.1.0.0 0-2|0.1.0.0.0.0.1+0.1.0.0.0.0.0+0.1.0.0.0.0+0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:33.223
(e / express-01 
      :ARG1 12 
      :ARG1-of (r / reach-01 
            :ARG0 (g3 / gene 
                  :ARG1-of (c2 / contain-01 
                        :ARG0 (t / thing 
                              :name (n2 / name 
                                    :op1 (c3 / Cluster) 
                                    :op2 (i / II))))) 
            :op1-of (a / and 
                  :op2 (p2 / peak-01 
                        :ARG0 (g2 / gradual) 
                        :ARG1 (p / phase 
                              :mod (g / government-organization 
                                    :name (n / name 
                                          :op1 "CIA") 
                                    :wiki "Central_Intelligence_Agency") 
                              :mod (c / chronic))))))

# ::snt These genes are mainly related to the immune response , organelle membrane and extracellular region and space .
# ::tok These genes are mainly related to the immune response , organelle membrane and extracellular region and space .
# ::alignments 16-17|0.2 15-16|0 14-15|0.0.3.0 13-14|0.0.3.0.0 12-13|0.0.3 11-12|0.1 10-11|0.1.0 8-9|0.0 7-8|0.0.1 4-5|0.0.2 3-4|0.0.0 1-2|0.0.2.0 0-1|0.0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:33.310
(a / and 
      :op1 (r2 / respond-01 
            :ARG1 (m2 / main) 
            :ARG1-of (i / immune-02) 
            :ARG2-of (r3 / relate-01 
                  :ARG1 (g / gene 
                        :mod (t / this))) 
            :op1-of (a2 / and 
                  :op2 (r / region 
                        :mod (e / extracellular)))) 
      :op2 (m / membrane 
            :mod (o / organelle)) 
      :op3 (s / space))

# ::snt Cluster III contains 78 genes that were only upregulated at the PI phase .
# ::tok Cluster III contains 78 genes that were only upregulated at the PI phase .
# ::alignments 12-13|0.2.0 11-12|0.2.1.0+0.2.1+0.2 8-9|0.1.0 7-8|0.1.0.0 4-5|0.1 3-4|0.1.1 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:33.402
(c / contain-01 
      :ARG0 (i / iii 
            :mod (c2 / cluster)) 
      :ARG1 (g / gene 
            :mod (u / upregulat 
                  :mod (o / only)) 
            :quant 78) 
      :ARG2 (t / thing 
            :mod-of (p / phase) 
            :name (n / name 
                  :op1 "PI")))

# ::snt These genes are related to the intercellular junction .
# ::tok These genes are related to the intercellular junction .
# ::alignments 7-8|0.1 6-7|0.1.0 3-4|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:33.429
(r / relate-01 
      :ARG1 (g / gene 
            :mod (t / this)) 
      :ARG2 (j / junction 
            :mod (i / intercellular)))

# ::snt More than half of the genes ( 156 of 310 ) belong to cluster IV and represent genes specifically downregultaed at the chronic phase .
# ::tok More than half of the genes ( 156 of 310 ) belong to cluster IV and represent genes specifically downregultaed at the chronic phase .
# ::alignments 23-24|0 22-23|0.1 18-19|0.0.1.0 17-18|0.0.1.2.1 16-17|0.0.1.2 15-16|0.0.1 13-14|0.0.1.1 11-12|0.0 5-6|0.0.0 2-3|0.0.1.2.0 0-1|0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:33.607
(p / phase 
      :ARG2-of (b / belong-01 
            :ARG0 (g2 / gene) 
            :ARG1 (a / and 
                  :ARG1-of (s / specific-02 
                        :ARG0 (m / more-than)) 
                  :op1 (c2 / cluster) 
                  :op2 (r / represent-01 
                        :ARG0 (h / half) 
                        :ARG1 (g / gene)))) 
      :mod (c / chronic))

# ::snt These genes are functionally related to lymphocyte proliferation , T cell activation , protein binding as well as the notch signal pathway .
# ::tok These genes are functionally related to lymphocyte proliferation , T cell activation , protein binding as well as the notch signal pathway .
# ::alignments 21-22|0.1 20-21|0.1.0 19-20|0 14-15|0.0.0.0.0 13-14|0.0.0.0.0.0 11-12|0.0.0.0.0.1.0.0 10-11|0.0.0.0.0.1.0 9-10|0.0.0.0.0.1.2+0.0.0.0.0.1.1.0+0.0.0.0.0.1.1+0.0.0.0.0.1 7-8|0.0.1 6-7|0.0.1.0 4-5|0.0 3-4|0.0.2 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:33.831
(n / notch 
      :ARG0-of (r / relate-01 
            :ARG1 (g / gene 
                  :mod (t / this 
                        :ARG0-of (b / binding-07 
                              :ARG1 (p2 / protein) 
                              :purpose (a2 / aircraft-type 
                                    :mod-of (c / cell 
                                          :mod-of (a / activation)) 
                                    :name (n2 / name 
                                          :op1 "T50") 
                                    :wiki "Sukhoi_PAK_FA")))) 
            :ARG2 (p3 / proliferate-01 
                  :mod (l / lymphocyte)) 
            :mod (f / functionally)) 
      :mod-of (p / pathway 
            :mod (s / signal)))

# ::snt Cluster V contains eight genes downregulated at the PI phase .
# ::tok Cluster V contains eight genes downregulated at the PI phase .
# ::alignments 9-10|0.2 8-9|0.2.0.1.0+0.2.0.1+0.2.0 4-5|0.1 3-4|0.2.0.0 2-3|0 0-2|0.0.0.1+0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:33.900
(c / contain-01 
      :ARG0 (t2 / thing 
            :name (n2 / name 
                  :op1 (c2 / Cluster) 
                  :op2 (v / V))) 
      :ARG1 (g / gene) 
      :ARG2 (p / phase 
            :mod (t / thing 
                  :mod-of 8 
                  :name (n / name 
                        :op1 "PI"))))

# ::snt Cluster VI contains 18 genes downregulated at the OA phase .
# ::tok Cluster VI contains 18 genes downregulated at the OA phase .
# ::alignments 9-10|0.2.0 8-9|0.2.1.0+0.2.1+0.2 4-5|0.1 3-4|0.1.0 2-3|0 0-2|0.0.0.1+0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:34.027
(c / contain-01 
      :ARG0 (t / thing 
            :name (n2 / name 
                  :op1 (c2 / Cluster) 
                  :op2 (v / VI))) 
      :ARG1 (g / gene 
            :quant 18) 
      :ARG2 (o / organization 
            :mod-of (p / phase) 
            :name (n / name 
                  :op1 "OA")))

# ::snt The GO term classification showed no functional cluster that was significantly enriched in these two gene clusters .
# ::tok The GO term classification showed no functional cluster that was significantly enriched in these two gene clusters .
# ::alignments 16-17|0.2.1 15-16|0.2.1.0 14-15|0.2.1.2 13-14|0.2.1.1 11-12|0.2 10-11|0.2.0 7-8|0.1 6-7|0.1.0 5-6|0.3 4-5|0 3-4|0.0 2-3|0.0.0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:34.726
(s2 / show-01 
      :ARG0 (c3 / classify-01 
            :ARG1-of (g2 / go-01 
                  :ARG0 (t2 / term))) 
      :ARG1 (c2 / cluster 
            :mod (f / functional)) 
      :ARG1-of (e / enrich-01 
            :ARG1-of (s / significant-02) 
            :topic (c / cluster 
                  :mod (g / gene) 
                  :mod (t / this) 
                  :quant 2)) 
      :polarity -)

# ::snt Candidate genes for the small-effect QTL of CIA .
# ::tok Candidate genes for the small-effect QTL of CIA .
# ::alignments 7-8|0.0.1+0.0.0.0+0.0.0+0.0 1-2|0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:34.745
(g2 / gene 
      :location (g / government-organization 
            :name (n / name 
                  :op1 "CIA") 
            :wiki "Central_Intelligence_Agency") 
      :part-of (c / candidate))

# ::snt To identify candidate susceptibility genes for the CIA small-effect QTL , we compared the list of strain-specific differentially expressed genes with the list of disease-specific differentially expressed genes ; 117 genes were shared by both lists ( Additional file 3 ) .
# ::tok To identify candidate susceptibility genes for the CIA small-effect QTL , we compared the list of strain-specific differentially expressed genes with the list of disease-specific differentially expressed genes ; 117 genes were shared by both lists ( Additional file 3 ) .
# ::alignments 39-40|0.0.0.0.0.0.0 38-39|0.2.0 37-38|0.0.0.1.0 35-36|0.0.0.0.0.0 34-35|0.0.0.0.0.0.1 32-33|0.0.0.0.0 30-31|0.0.0.0.0.1 29-30|0.0.0.1.2.0.0 28-29|0.0.0.0 27-28|0.1.1 26-27|0.1 25-26|0.0.0.1.2.0.1 22-23|0.0.0.1.2.0 19-20|0.1.0 18-19|0 17-18|0.0.0.1.2 14-15|0.0.0.1 12-13|0.0.0 11-12|0.0 9-10|0.2.2 7-8|0.0.0.1.1.1+0.0.0.1.1.0.0+0.0.0.1.1.0+0.0.0.1.1 4-5|0.2.1 3-4|0.2.1.0 2-3|0.2.1.0.0 1-2|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:36.298
(e2 / express-01 
      :ARG0 (w / we 
            :ARG0-of (c / compare-01 
                  :ARG1 (a2 / and 
                        :op1 (s / share-01 
                              :ARG0 (l / list-01 
                                    :ARG1 3 
                                    :mod (b / both)) 
                              :ARG1 (g / gene))) 
                  :ARG2 (l3 / list-01 
                        :ARG0 (a / additional) 
                        :ARG1 (g4 / government-organization 
                              :name (n / name 
                                    :op1 "CIA") 
                              :wiki "Central_Intelligence_Agency") 
                        :ARG2 (d2 / differentially 
                              :ARG0-of (l2 / list-01 
                                    :ARG1 117 
                                    :ARG2 (d / differentially)))))) 
      :ARG1 (e / express-01 
            :ARG0 (g3 / gene) 
            :ARG1 (g2 / gene)) 
      :time (i / identify-01 
            :ARG0 (f / file) 
            :ARG1 (g5 / gene 
                  :mod (s2 / susceptibility 
                        :mod (c2 / candidate))) 
            :ARG2 (q / QTL)))

# ::snt Figure 3 visualises positions of the 117 genes retrieved from Ensembl [ 30 ] in relation to the 8 small-effect QTL .
# ::tok Figure 3 visualises positions of the 117 genes retrieved from Ensembl [ 30 ] in relation to the 8 small-effect QTL .
# ::alignments 18-19|0.1.0.0.0 15-16|0.1.0.0 12-13|0.0 10-11|0.2.0.0+0.2.0+0.2 8-9|0 7-8|0.1 6-7|0.1.1 3-4|0.1.0 2-3|0.1.0.1 1-2|0.1.0.2 0-1|0.1.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:36.479
(r2 / retrieve-01 
      :ARG0 30 
      :ARG1 (g / gene 
            :poss-of (p / position 
                  :ARG0-of (r / relate-01 
                        :ARG1 8 
                        :op1-of (f / figure)) 
                  :mod (v / visualis) 
                  :quant 3) 
            :quant 117) 
      :ARG2 (c / country 
            :name (n / name 
                  :op1 "Ensembl")))

# ::snt The eight loci were located on 7 chromosomes , 5 , 6 , 7 , 10 , 11 , 16 and 17 .
# ::tok The eight loci were located on 7 chromosomes , 5 , 6 , 7 , 10 , 11 , 16 and 17 .
# ::alignments 21-22|0.1.0 20-21|0 19-20|0.1.1 17-18|0.1.2 15-16|0.1.3 13-14|0.1.4 11-12|0.1.6.0.1 9-10|0.0 7-8|0.1.6 6-7|0.1 4-5|0.1.6.0 2-3|0.1.6.0.0 1-2|0.1.5 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:36.640
(a / and 
      :op1 5 
      :op1-of (72 / 7 
            :mod 17 
            :mod 16 
            :mod 11 
            :mod 10 
            :mod 7 
            :op1-of 8 
            :quant-of (c / chromosom 
                  :ARG3-of (l / locate-01 
                        :ARG1 (l2 / locus) 
                        :ARG2 6))))

# ::snt Since the confidence intervals of QTL in F2 progeny are around 20 cM [ 26 ] , we used 40 Mb as the confidence intervals for all loci .
# ::tok Since the confidence intervals of QTL in F2 progeny are around 20 cM [ 26 ] , we used 40 Mb as the confidence intervals for all loci .
# ::alignments 27-28|0.1.3.0.2 26-27|0.1.3.0.2.1 24-25|0.1.2 23-24|0.1.2.0 20-21|0.1.1.0.0+0.1.1.0+0.1.1 19-20|0.1.3.0.1.0 18-19|0.1 17-18|0.1.0 14-15|0.1.3.0.2.0 12-13|0.1.3.0.0.0 11-12|0.1.3.0.0.0.0 10-11|0.1.3.0.0 8-9|0.0 7-8|0 3-4|0.1.3.0 2-3|0.1.3.0.1 0-1|0.1.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:36.930
(f / F2 
      :mod-of (p / progeny) 
      :op1 (u / use-01 
            :ARG0 (w / we) 
            :ARG1 (c2 / country 
                  :name (n / name 
                        :op1 "Mb")) 
            :ARG2 (i / interval 
                  :mod (c / confidence)) 
            :time (s / since 
                  :op1 (i2 / interval 
                        :location (a2 / around 
                              :op1 (c3 / cm 
                                    :quant 20)) 
                        :mod (c4 / confidence 
                              :poss-of 40) 
                        :poss-of (l / locus 
                              :poss-of 26 
                              :quant (a / all))))))

# ::snt Twenty-one genes were located in the confidence intervals of six of the eight QTL .
# ::tok Twenty-one genes were located in the confidence intervals of six of the eight QTL .
# ::alignments 13-14|0.3 12-13|0.0 9-10|0.3.0 7-8|0.2 6-7|0.2.0 3-4|0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:37.023
(l / locate-01 
      :ARG0 8 
      :ARG1 (g / gene 
            :mod (t / twenty-one)) 
      :location (i / interval 
            :mod (c / confidence)) 
      :location (q / QTL 
            :quant 6))

# ::snt We located 5 , 4 , 2 , 1 , 3 and 6 potential candidate genes within the confidence intervals of loci 1 , 2 , 3 , 5 , 6 and 8 , respectively , while no candidate gene was identified for loci 4 and 7 .
# ::tok We located 5 , 4 , 2 , 1 , 3 and 6 potential candidate genes within the confidence intervals of loci 1 , 2 , 3 , 5 , 6 and 8 , respectively , while no candidate gene was identified for loci 4 and 7 .
# ::alignments 46-47|0.1.8.2 45-46|0 44-45|0.1.8.8 43-44|0.1.1 41-42|0.1 39-40|0.1.0 38-39|0.1.0.0 37-38|0.1.7 34-35|0.0.0 32-33|0.1.8.3 31-32|0.0 30-31|0.1.8.5 28-29|0.1.8.7 26-27|0.1.8.1 24-25|0.1.8.4 22-23|0.1.8.6 21-22|0.0.2.1 19-20|0.0.2 18-19|0.0.2.0 15-16|0.0.1.1 14-15|0.0.1.1.0 13-14|0.0.1.1.0.0 12-13|0.0.1.0 11-12|0.0.1 10-11|0.1.4 8-9|0.1.2 6-7|0.1.3 4-5|0.1.5 2-3|0.1.8.0 1-2|0.1.8 0-1|0.1.6 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:37.795
(a / and 
      :op1 (a2 / and 
            :mod (r / respective) 
            :op3-of (a3 / and 
                  :op1 6 
                  :op2 (g2 / gene 
                        :mod (c3 / candidate 
                              :mod (p / potential)))) 
            :time (i2 / interval 
                  :mod (c2 / confidence) 
                  :mod (l2 / locus))) 
      :op2 (i / identify-01 
            :ARG1 (g / gene 
                  :mod (c / candidate)) 
            :ARG2 (l / locus) 
            :op1-of 1 
            :op1-of 2 
            :op1-of 3 
            :op1-of 4 
            :op1-of (w / we) 
            :polarity - 
            :purpose-of (l3 / locate-01 
                  :ARG1 5 
                  :op1-of 3 
                  :op1-of 7 
                  :op1-of 8 
                  :op1-of 2 
                  :op1-of 6 
                  :op1-of 1 
                  :op1-of 5 
                  :op1-of 4)))

# ::snt Table 3 summarises the 21 candidate genes identified in this study .
# ::tok Table 3 summarises the 21 candidate genes identified in this study .
# ::alignments 10-11|0.2 9-10|0.2.1 7-8|0 6-7|0.1 5-6|0.1.0 4-5|0.1.0.0 1-2|0.2.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:37.846
(i / identify-01 
      :ARG0 (t2 / table) 
      :ARG1 (g / gene 
            :mod (c / candidate 
                  :quant 21)) 
      :ARG2 (s / study-01 
            :ARG1 3 
            :mod (t / this)))

# ::snt Two genes , hspa1a and Oas1a , were upregulated at the OA phase of CIA and Oas1a was also upregulated at the PI phase .
# ::tok Two genes , hspa1a and Oas1a , were upregulated at the OA phase of CIA and Oas1a was also upregulated at the PI phase .
# ::alignments 23-24|0.1.1.0 22-23|0.1.1.0.0.0.0+0.1.1.0.0.0+0.1.1.0.0 18-19|0.0 15-16|0.1.0.0 14-15|0.1.0.0.0.2+0.1.0.0.0.1.0+0.1.0.0.0.1+0.1.0.0.0 12-13|0.1.0.0.0.0 11-12|0.1.0.0.0.0.0.0.0+0.1.0.0.0.0.0.0+0.1.0.0.0.0.0 8-9|0.1.0 5-6|0.3.0.0+0.3.0+0.3 4-5|0 3-4|0.2 1-2|0.1 0-1|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:37.973
(a3 / and 
      :mod (a / also) 
      :op1 (g2 / gene 
            :domain-of (u / upregulat 
                  :op1-of (a2 / and 
                        :op2 (g / government-organization 
                              :mod-of (p2 / phase 
                                    :mod (o / organization 
                                          :name (n3 / name 
                                                :op1 "OA"))) 
                              :name (n2 / name 
                                    :op1 "CIA") 
                              :wiki "Central_Intelligence_Agency"))) 
            :quant (2 / 2 
                  :mod-of (p / phase 
                        :mod (t / thing 
                              :name (n / name 
                                    :op1 "PI"))))) 
      :op2 (h / hspa1a) 
      :op3 (o2 / organization 
            :name (n4 / name 
                  :op1 "Oas1a")))

# ::snt Except for these two genes , all other 19 genes were downregulated at the chronic phase of CIA .
# ::tok Except for these two genes , all other 19 genes were downregulated at the chronic phase of CIA .
# ::alignments 17-18|0.0.4+0.0.2.0+0.0.2+0.0 15-16|0.0.1 14-15|0.0.1.0 9-10|0.0.3 8-9|0.0.3.1 7-8|0.0.0 6-7|0.0.3.0 4-5|0.0.1.1.0 3-4|0.0.1.1 2-3|0.0.1.1.0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:38.045
(e / except 
      :poss (g / government-organization 
            :mod (o / other) 
            :mod-of (p / phase 
                  :mod (c / chronic) 
                  :mod (2 / 2 
                        :quant-of (g3 / gene 
                              :mod (t / this)))) 
            :name (n / name 
                  :op1 "CIA") 
            :quant (g2 / gene 
                  :quant (a / all) 
                  :quant 19) 
            :wiki "Central_Intelligence_Agency"))

# ::snt All genes , except hspa1a , showed expression differences between the two strains at the NC phase .
# ::tok All genes , except hspa1a , showed expression differences between the two strains at the NC phase .
# ::alignments 16-17|0.2.0.0 15-16|0.2.0.2+0.2.0.1.0+0.2.0.1+0.2.0 12-13|0.1.1 11-12|0.1.1.0 8-9|0.1 7-8|0.1.0 6-7|0 4-5|0.2.1 3-4|0.2 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:38.282
(s3 / show-01 
      :ARG0 (g / gene 
            :quant (a / all)) 
      :ARG1 (d / differ-01 
            :ARG1 (e / express-01) 
            :ARG2 (s2 / strain 
                  :quant 2)) 
      :ARG2-of (e2 / except-01 
            :ARG0 (s / state 
                  :mod-of (p / phase) 
                  :name (n / name 
                        :op1 "NC") 
                  :wiki "North_Carolina") 
            :ARG1 (h / hspa1a)))

# ::snt Five genes were differentially expressed at all phases of CIA , including H2-Q10 , Mapk14 , Pscd1 , Kpnb1 and Wdr1 .
# ::tok Five genes were differentially expressed at all phases of CIA , including H2-Q10 , Mapk14 , Pscd1 , Kpnb1 and Wdr1 .
# ::alignments 20-21|0.2.0.1.4 19-20|0.2.0.1 18-19|0.2.0.1.3 16-17|0.2.0.1.2 14-15|0.2.0.1.1.0.0+0.2.0.1.1.0+0.2.0.1.1 12-13|0.2.0.1.0.0.0+0.2.0.1.0.0+0.2.0.1.0 9-10|0.2.0.2+0.2.0.0.0+0.2.0.0+0.2.0 7-8|0.2 6-7|0.2.1 4-5|0 3-4|0.1 1-2|0.0 0-1|0.2.0.1.4.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:38.532
(e / express-01 
      :ARG1 (g2 / gene) 
      :mod (d / differentially) 
      :time (p2 / phase 
            :mod (g / government-organization 
                  :name (n3 / name 
                        :op1 "CIA") 
                  :op1-of (a / and 
                        :op2 (t2 / thing 
                              :name (n2 / name 
                                    :op1 "H2-Q10")) 
                        :op3 (t / thing 
                              :name (n / name 
                                    :op1 "Mapk14")) 
                        :op4 (p / Pscd1) 
                        :op5 (k / Kpnb1) 
                        :op6 (w / Wdr1 
                              :poss 5)) 
                  :wiki "Central_Intelligence_Agency") 
            :quant (a2 / all)))

# ::snt Among these five genes , H2-Q10 had a consistently higher expression in the DBA/1 than the FVB/N strain in all CIA phases , while the other four genes had a higher expression in the DBA/1 strain at the early stages , including NC , PI and OA , but a lower expression at the chronic phase .
# ::tok Among these five genes , H2-Q10 had a consistently higher expression in the DBA/1 than the FVB/N strain in all CIA phases , while the other four genes had a higher expression in the DBA/1 strain at the early stages , including NC , PI and OA , but a lower expression at the chronic phase .
# ::alignments 55-56|0.2.2 54-55|0.2.2.0 51-52|0.2 50-51|0.2.1 48-49|0 46-47|0.3.3.0.0+0.3.3.0+0.3.3 45-46|0.3 44-45|0.3.2.0.0+0.3.2.0+0.3.2 42-43|0.3.1.2+0.3.1.1.0+0.3.1.1+0.3.1 39-40|0.3.0 38-39|0.3.0.0 35-36|0.4.0.1.0+0.4.0.1 31-32|0.4.0 30-31|0.4 27-28|0.4.0.0 26-27|0.2.0 25-26|0.1.0.0.0 21-22|0.1.0.2 20-21|0.1.0.2.0.1+0.1.0.2.0.0.0+0.1.0.2.0.0+0.1.0.2.0 19-20|0.3.1.0 17-18|0.1.0.1.1+0.1.0.1 16-17|0.1.0.1.0.0.0+0.1.0.1.0.0+0.1.0.1.0 10-11|0.1.0 9-10|0.1.0.0 8-9|0.4.1 5-6|0.1.1.0+0.1.1+0.1 3-4|0.0 2-3|0.1.0.0.1 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:40.600
(c2 / contrast-01 
      :ARG0 (g3 / gene 
            :mod (t4 / this)) 
      :ARG1 (t3 / thing 
            :ARG1-of (e4 / express-01 
                  :ARG1-of (h2 / high-02 
                        :ARG0 (o2 / other) 
                        :ARG2 5) 
                  :ARG2 (s4 / strain 
                        :mod (t2 / thing 
                              :name (n5 / name 
                                    :op1 "FVB/N")) 
                        :wiki "Influenza_A_virus_subtype_H5N1") 
                  :location (p2 / phase 
                        :mod (g2 / government-organization 
                              :name (n4 / name 
                                    :op1 "CIA") 
                              :wiki "Central_Intelligence_Agency"))) 
            :name (n6 / name 
                  :op1 "H2-Q10")) 
      :ARG2 (e / express-01 
            :ARG1 4 
            :ARG1-of (l / low-04) 
            :ARG2 (p / phase 
                  :mod (c / chronic))) 
      :op5-of (a / and 
            :op1 (s2 / stage 
                  :time (e2 / early)) 
            :op2 (s / state 
                  :mod (a2 / all) 
                  :name (n3 / name 
                        :op1 "NC") 
                  :wiki "North_Carolina") 
            :op3 (t / thing 
                  :name (n2 / name 
                        :op1 "PI")) 
            :op4 (o / organization 
                  :name (n / name 
                        :op1 "OA"))) 
      :purpose (h / high-02 
            :ARG1 (e3 / express-01 
                  :ARG0 (g / gene) 
                  :ARG1 (s3 / strain 
                        :wiki "Influenza_A_virus_subtype_H5N1")) 
            :ARG2 (c3 / consistent)))

# ::snt GO term classification analysis revealed that the functional cluster of protein kinase cascade was significantly enriched in the 21 candidate genes .
# ::tok GO term classification analysis revealed that the functional cluster of protein kinase cascade was significantly enriched in the 21 candidate genes .
# ::alignments 20-21|0.0.0.0.0.2 19-20|0.0.0.0.0.2.0 18-19|0.0.0.0.0.2.0.0 15-16|0.0.0.0.0 14-15|0.0.0.0.0.1 12-13|0.0.0.0.0.0.1 11-12|0.0.0.0.0.0.1.0 10-11|0 8-9|0.0.0.0.0.0 7-8|0.0.0.0.0.0.0 4-5|0.0.0.0 3-4|0.0.0 2-3|0.0 1-2|0.0.0.1.0 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:41.102
(p / protein 
      :ARG1-of (c4 / classify-01 
            :ARG1-of (a / analyze-01 
                  :ARG0-of (r / reveal-01 
                        :ARG1 (e / enrich-01 
                              :ARG1 (c3 / cluster 
                                    :mod (f / functional) 
                                    :topic-of (c2 / cascade-01 
                                          :ARG1 (k / kinase))) 
                              :ARG1-of (s / significant-02) 
                              :topic (g / gene 
                                    :mod (c / candidate 
                                          :quant 21)))) 
                  :manner (g2 / go-01 
                        :ARG1 (t / term)))))

# ::snt This functional cluster contained four genes , including Mapk14 , Mapk8ip3 , Stat5a and Gna12 .
# ::tok This functional cluster contained four genes , including Mapk14 , Mapk8ip3 , Stat5a and Gna12 .
# ::alignments 14-15|0.4.0.0+0.4.0+0.4 13-14|0 12-13|0.3.0.0+0.3.0+0.3 10-11|0.2 8-9|0.1.0.0+0.1.0+0.1 5-6|0.0.1 4-5|0.0.1.0 3-4|0.0 2-3|0.0.0 1-2|0.0.0.1 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:41.188
(a / and 
      :op1 (c / contain-01 
            :ARG0 (c2 / cluster 
                  :mod (t2 / this) 
                  :mod (f / functional)) 
            :ARG1 (g / gene 
                  :quant 4)) 
      :op2 (t / thing 
            :name (n3 / name 
                  :op1 "Mapk14")) 
      :op3 (m / Mapk8ip3) 
      :op4 (p2 / person 
            :name (n2 / name 
                  :op1 "Stat5a")) 
      :op5 (p / person 
            :name (n / name 
                  :op1 "Gna12")))

# ::snt In this study , we attempted for the first time to identify small-effect QTL in an F2 progeny .
# ::tok In this study , we attempted for the first time to identify small-effect QTL in an F2 progeny .
# ::alignments 17-18|0.1.0.0 11-12|0.1.0 9-10|0.1 5-6|0 4-5|0.0 2-3|0.0.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:41.225
(a / attempt-01 
      :ARG0 (w / we 
            :ARG0-of (s / study-01 
                  :mod (t2 / this))) 
      :ARG1 (t / time 
            :purpose (i / identify-01 
                  :ARG2 (p / progeny))))

# ::snt Small-effect QTL are defined as those reaching the threshold value of P = 0.05 but that did not reach the significant threshold value suggested by Lander and Botstein [ 26 ] .
# ::tok Small-effect QTL are defined as those reaching the threshold value of P = 0.05 but that did not reach the significant threshold value suggested by Lander and Botstein [ 26 ] .
# ::alignments 29-30|0.0.0.0.0 27-28|0.0.2.0.0+0.0.2.0+0.0.2 26-27|0.0 25-26|0.0.1.0.0+0.0.1.0+0.0.1 23-24|0.0.0 22-23|0.0.0.0 21-22|0.0.0.0.1 20-21|0.0.0.0.2 18-19|0.0.0.0.3 17-18|0.0.0.0.3.0.0.1.0 14-15|0 11-12|0.0.0.0.3.0.0.0 9-10|0.0.0.0.3.0.0 8-9|0.0.0.0.3.0.0.2 6-7|0.0.0.0.3.0 3-4|0.0.0.0.3.0.0.1 0-2|0.0.0.0.3.0.0.1.1.0.1+0.0.0.0.3.0.0.1.1.0.0+0.0.0.0.3.0.0.1.1.0+0.0.0.0.3.0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:42.234
(c / contrast-01 
      :ARG2 (a / and 
            :ARG0-of (s / suggest-01 
                  :ARG1 (v / value-01 
                        :ARG0 26 
                        :ARG1 (t / threshold) 
                        :ARG1-of (s2 / significant-02) 
                        :ARG1-of (r / reach-01 
                              :ARG1-of (r2 / reach-01 
                                    :ARG0 (v2 / value-01 
                                          :ARG1 (p3 / P60) 
                                          :ARG2-of (d / define-01 
                                                :ARG0 - 
                                                :ARG1 (t3 / thing 
                                                      :name (n3 / name 
                                                            :op1 (s3 / Small-effect) 
                                                            :op2 (q / QTL)))) 
                                          :mod (t2 / threshold)))))) 
            :op1 (p2 / person 
                  :name (n2 / name 
                        :op1 "Lander")) 
            :op2 (p / person 
                  :name (n / name 
                        :op1 "Botstein"))))

# ::snt Although not significant , there is evidence that most of the eight small-effect QTL likely contain susceptibility genes for CIA .
# ::tok Although not significant , there is evidence that most of the eight small-effect QTL likely contain susceptibility genes for CIA .
# ::alignments 19-20|0.1.0.0.1+0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 17-18|0.1.0 16-17|0.1.0.1 15-16|0.1 14-15|0.1.1 11-12|0.2.0 8-9|0.0 6-7|0 2-3|0.2 1-2|0.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:42.361
(e / evidence-01 
      :ARG0 (m / most) 
      :ARG1 (c / contain-01 
            :ARG1 (g2 / gene 
                  :beneficiary (g / government-organization 
                        :name (n / name 
                              :op1 "CIA") 
                        :wiki "Central_Intelligence_Agency") 
                  :part-of (s / susceptibility)) 
            :ARG1-of (l / likely-01)) 
      :ARG1-of (s2 / significant-02 
            :ARG0 8 
            :polarity -))

# ::snt First , we performed the linkage analysis in three datasets , including all 290 F progeny , 76 C5 + / + F2 progeny and 133 C5 + / - F2 progeny .
# ::tok First , we performed the linkage analysis in three datasets , including all 290 F progeny , 76 C5 + / + F2 progeny and 133 C5 + / - F2 progeny .
# ::alignments 31-32|0.0.1.1 28-29|0.3 24-25|0 23-24|0.2 22-23|0.2.0 20-21|0.1 17-18|0.0.1.0.0+0.0.1.0 15-16|0.0.0.0 14-15|0.0.0.0.0.1+0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 12-13|0.0.0.0.1 9-10|0.0.2 8-9|0.0.2.0 6-7|0.0.1 5-6|0.0.1.2 3-4|0.0 2-3|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:42.656
(a / and 
      :op1 (p5 / perform-02 
            :ARG0 (w / we 
                  :poss-of (p4 / progeny 
                        :mod (a2 / aircraft-type 
                              :name (n / name 
                                    :op1 "F22") 
                              :wiki "Lockheed_Martin_F-22_Raptor") 
                        :mod (a3 / all))) 
            :ARG1 (a4 / analyze-01 
                  :ARG0 (p3 / person 
                        :quant 76) 
                  :ARG1 (p / progeny) 
                  :manner (l / linkage)) 
            :location (d / dataset 
                  :quant 3)) 
      :op2 (s2 / slash) 
      :op3 (p2 / progeny 
            :mod (f / F2)) 
      :op4 (s / slash))

# ::snt Five of the eight small-effect QTL were identified in at least two datasets , suggesting that these QTL are reproducible .
# ::tok Five of the eight small-effect QTL were identified in at least two datasets , suggesting that these QTL are reproducible .
# ::alignments 19-20|0.1.1 16-17|0.0 14-15|0.1 12-13|0.2 11-12|0.2.0 7-8|0 3-4|0.1.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:42.714
(i / identify-01 
      :ARG0 (t / this 
            :mod 5) 
      :ARG1 (s / suggest-01 
            :ARG0 8 
            :ARG1 (r / reproducible)) 
      :time (d / dataset 
            :quant 2))

# ::snt Second , many QTL identified in the present study overlap with arthritis QTL previously identified , including loci 1 , 2 , 5 and 6 .
# ::tok Second , many QTL identified in the present study overlap with arthritis QTL previously identified , including loci 1 , 2 , 5 and 6 .
# ::alignments 24-25|0.1.0 23-24|0.0.0.2 22-23|0.1.1 20-21|0.0.0.1.0 18-19|0.0.0.0 17-18|0.0.0.2.0 14-15|0.0.0.1.2 13-14|0.0.0.1.2.0 11-12|0.0.0.1.1 9-10|0 8-9|0.0.0.1 7-8|0.0.0.1.3 4-5|0.0.0 3-4|0.0 2-3|0.0.1 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:43.098
(o / overlap-01 
      :ARG0 (q / QTL 
            :ARG1-of (i2 / identify-01 
                  :ARG0 1 
                  :ARG2 (s / study-01 
                        :ARG0 2 
                        :ARG1 (a2 / arthritis) 
                        :ARG1-of (i / identify-01 
                              :time (p / previous)) 
                        :time (p2 / present)) 
                  :op1-of (a / and 
                        :op2 (l / locus))) 
            :quant (m / many)) 
      :ARG1 (s2 / second-01 
            :op1-of 6 
            :op1-of 5))

# ::snt In addition , syntenic analysis revealed that the counterpart genomic regions on the human genome of many of these eight QTL are linked to RA .
# ::tok In addition , syntenic analysis revealed that the counterpart genomic regions on the human genome of many of these eight QTL are linked to RA .
# ::alignments 24-25|0.1.2.0.0+0.1.2.0+0.1.2 22-23|0.1 20-21|0.1.0 19-20|0.0.1 18-19|0.0.0 16-17|0.1.0.0 14-15|0.2.0 13-14|0.2.0.0 10-11|0.1.1 8-9|0.1.1.0.0+0.1.1.0 5-6|0 4-5|0.0 1-2|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:43.321
(r2 / reveal-01 
      :ARG0 (a / analyze-01 
            :ARG0 (t / this) 
            :ARG1 8) 
      :ARG1 (l / link-01 
            :ARG0 (q / QTL 
                  :quant (m / many)) 
            :ARG1 (r / region 
                  :name-of (c / counterpart 
                        :wiki "Abdel_Rahman_Shalgham")) 
            :ARG2 (o / organization 
                  :name (n / name 
                        :op1 "RA"))) 
      :location (a2 / addition 
            :name-of (g / genome 
                  :mod (h / human))))

# ::snt For five of the eight small-effect QTL the DBA/1 alleles are the arthritis-enhancing alleles , while the FVBN alleles are the arthritis-enhancing alleles in the other three QTL , indicating that some susceptibility genes could come from the resistant strain .
# ::tok For five of the eight small-effect QTL the DBA/1 alleles are the arthritis-enhancing alleles , while the FVBN alleles are the arthritis-enhancing alleles in the other three QTL , indicating that some susceptibility genes could come from the resistant strain .
# ::alignments 39-40|0.1.0.1.1+0.1.0.1 38-39|0.1.0.1.0 35-36|0.1.0 34-35|0.1 33-34|0.1.0.0 32-33|0.1.0.0.0 31-32|0.1.0.0.1 29-30|0 26-27|0.1.0.1.0.0 25-26|0.1.0.1.0.1 22-23|0.0 18-19|0.0.0 13-14|0.0.0.0 12-13|0.0.0.0.1 9-10|0.0.0.0.0 4-5|0.2 1-2|0.1.0.1.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:43.696
(i / indicate-01 
      :ARG0 (a / allel 
            :domain (a2 / allel 
                  :domain-of (a3 / allel 
                        :domain (a5 / allel) 
                        :mod (a4 / arthritis-enhanc)))) 
      :ARG1 (p / possible-01 
            :ARG1 (c / come-01 
                  :ARG1 (g / gene 
                        :part-of (s2 / susceptibility) 
                        :quant (s3 / some)) 
                  :ARG3 (s / strain 
                        :mod (r / resist-01 
                              :ARG0 3 
                              :ARG1 (o / other) 
                              :op1-of 5) 
                        :wiki "Influenza_A_virus_subtype_H5N1"))) 
      :ARG2 8)

# ::snt Interestingly , loci 2 and 7 partially overlap with two arthritis-related QTL identified by us in the same F2 progeny [ 10 ] .
# ::tok Interestingly , loci 2 and 7 partially overlap with two arthritis-related QTL identified by us in the same F2 progeny [ 10 ] .
# ::alignments 21-22|0.4 19-20|0.5 17-18|0.1.0.1 12-13|0.1.0 11-12|0.1.0.0 10-11|0.1.0.0.0 9-10|0.1.0.0.1 7-8|0 6-7|0.1.0.1.0 5-6|0.2 4-5|0.0 3-4|0.1.0.1.1 2-3|0.1 0-1|0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:44.008
(o / overlap-01 
      :ARG0 (a2 / and) 
      :ARG1 (l / locus 
            :ARG0-of (i / identify-01 
                  :ARG1 (q / QTL 
                        :mod (a / arthritis-relat) 
                        :quant 2) 
                  :ARG1-of (s / same-01 
                        :ARG0 (p2 / partial) 
                        :op1-of 2))) 
      :ARG2 7 
      :manner (i2 / interesting) 
      :op1-of 10 
      :op1-of (p / progeny))

# ::snt Locus 2 was located at the same genomic region as Cia27 , a QTL controlling IgG2a antibody levels to collagen II .
# ::tok Locus 2 was located at the same genomic region as Cia27 , a QTL controlling IgG2a antibody levels to collagen II .
# ::alignments 19-21|0.0.1+0+0.0+0.0.0 17-18|0.0.0.1.1 16-17|0.0.0.1.1.0 15-16|0.0.0.1.1.1.0.0+0.0.0.1.1.1.0+0.0.0.1.1.1 14-15|0.0.0.1 13-14|0.0.0.1.0 10-11|0.0.0.0.1.1 8-9|0.0.0.0.1 6-7|0.0.0.0 3-4|0.0.0.0.1.0 1-2|0.0.0.0.0 0-1|0.0.0.0.1.0.0.0.0+0.0.0.0.1.0.0.0+0.0.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:44.643
(c / collagen 
      :op1-of (n / name 
            :name-of (t / thing 
                  :ARG2-of (s / same-01 
                        :ARG0 2 
                        :ARG1 (r / region 
                              :location-of (l2 / locate-01 
                                    :ARG1 (o / organization 
                                          :name (n3 / name 
                                                :op1 "Locus"))) 
                              :mod (c4 / Cia27))) 
                  :ARG2-of (c3 / control-01 
                        :ARG0 (q / QTL) 
                        :ARG1 (l / level 
                              :mod (a / antibody) 
                              :mod (c2 / country 
                                    :name (n2 / name 
                                          :op1 "IgG2a"))))) 
            :op2 (i / II)))

# ::snt Recently , we have refined this QTL into a 4.1 Mb genomic region and showed that a gene within this region regulates CIA severity by controlling the IgG2a antibody levels to collagen II [ 31 ] .
# ::tok Recently , we have refined this QTL into a 4.1 Mb genomic region and showed that a gene within this region regulates CIA severity by controlling the IgG2a antibody levels to collagen II [ 31 ] .
# ::alignments 34-35|0.0.2 31-33|0.1.1.1+0.1.1.0+0.1.1+0.1 29-30|0.0.1.3.0 28-29|0.0.1.2 27-28|0.0.1.1.1.0.0+0.0.1.1.1.0+0.0.1.1.1 25-26|0.0.1.3 23-24|0.0.1.1 22-23|0.0.1.1.0.1+0.0.1.1.0.0.0+0.0.1.1.0.0+0.0.1.1.0 21-22|0.0.1 20-21|0.0.1.0.0 19-20|0.0.1.0.0.0 17-18|0.0.1.0 14-15|0.0 13-14|0 12-13|0.0.0.1 10-11|0.0.0.1.0.0.0+0.0.0.1.0.0+0.0.0.1.0 9-10|0.0.0.1.0.1 5-6|0.1.0 4-5|0.0.0.0 2-3|0.0.0 0-1|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:45.428
(a2 / and 
      :op1 (s2 / show-01 
            :ARG0 (w / we 
                  :ARG0-of (r4 / refine-01 
                        :time (r5 / recent)) 
                  :poss-of (r3 / region 
                        :mod (c4 / country 
                              :name (n4 / name 
                                    :op1 "Mb") 
                              :quant 4.1))) 
            :ARG1 (r / regulate-01 
                  :ARG0 (g2 / gene 
                        :location (r2 / region 
                              :mod (t2 / this))) 
                  :ARG1 (s / severity 
                        :mod (g / government-organization 
                              :name (n3 / name 
                                    :op1 "CIA") 
                              :wiki "Central_Intelligence_Agency") 
                        :mod (c2 / country 
                              :name (n2 / name 
                                    :op1 "IgG2a"))) 
                  :ARG2 (a / antibody) 
                  :manner (c3 / control-01 
                        :ARG1 (l / level))) 
            :op1-of 31) 
      :op2 (t / thing 
            :mod (t3 / this) 
            :name (n / name 
                  :op1 (c / collagen) 
                  :op2 (i / II))))

# ::snt Locus 7 on chromosome 16 overlaps with Lp1 , which controls lymphocyte proliferation .
# ::tok Locus 7 on chromosome 16 overlaps with Lp1 , which controls lymphocyte proliferation .
# ::alignments 12-13|0.1.1 11-12|0.1.1.1 10-11|0.1 5-6|0 4-5|0.1.0 3-4|0.1.2 1-2|0.1.1.0 0-1|0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:45.532
(o / overlap-01 
      :ARG0 (o2 / organization 
            :name (n / name 
                  :op1 "Locus")) 
      :ARG1 (c / control-01 
            :ARG0 16 
            :ARG1 (p / proliferate-01 
                  :ARG1 7 
                  :mod (l / lymphocyte)) 
            :ARG2 (c2 / chromosome)))

# ::snt Furthermore , according to our unpublished data , loci 8 on chromosome 17 controls lymphocyte adherence during development of CIA .
# ::tok Furthermore , according to our unpublished data , loci 8 on chromosome 17 controls lymphocyte adherence during development of CIA .
# ::alignments 19-20|0.1.2.1.1+0.1.2.1.0.0+0.1.2.1.0+0.1.2.1 17-18|0.1.2 15-16|0.1.1 14-15|0.1.1.2 13-14|0.1 12-13|0.1.1.1 11-12|0.1.2.0 9-10|0.1.1.0 8-9|0.1.0 6-7|0.0 5-6|0.0.0 4-5|0.0.1 2-3|0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:45.856
(s / say-01 
      :ARG0 (d2 / data 
            :mod (u / unpublish) 
            :poss (w / we)) 
      :ARG1 (c / control-01 
            :ARG0 (l2 / locus) 
            :ARG1 (a / adhere-02 
                  :ARG0 8 
                  :ARG1 17 
                  :mod (l / lymphocyte)) 
            :time (d / develop-02 
                  :ARG0 (c2 / chromosome) 
                  :ARG1 (g / government-organization 
                        :name (n / name 
                              :op1 "CIA") 
                        :wiki "Central_Intelligence_Agency"))) 
      :mod (f / furthermore))

# ::snt Therefore , the gene within the small-effect QTL could affect CIA severity through controlling arthritis-related phenotypes .
# ::tok Therefore , the gene within the small-effect QTL could affect CIA severity through controlling arthritis-related phenotypes .
# ::alignments 15-16|0.3.0 14-15|0.3.0.0 13-14|0.3 11-12|0.1 10-11|0.1.0.1+0.1.0.0.0+0.1.0.0+0.1.0 9-10|0 8-9|0.2 3-4|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:45.907
(a2 / affect-01 
      :ARG0 (g2 / gene) 
      :ARG1 (s / severity 
            :mod (g / government-organization 
                  :name (n / name 
                        :op1 "CIA") 
                  :wiki "Central_Intelligence_Agency")) 
      :ARG1-of (p2 / possible-01) 
      :ARG2 (c / control-01 
            :ARG1 (p / phenotyp 
                  :mod (a / arthritis-relat))))

# ::snt Several studies have been carried out to detect gene expression during CIA , all of which used joints as the target tissue [ 15,16,21,22 ] .
# ::tok Several studies have been carried out to detect gene expression during CIA , all of which used joints as the target tissue [ 15,16,21,22 ] .
# ::alignments 21-22|0 20-21|0.0.1.0.0.0.0.1 17-18|0.0.0 16-17|0.0 13-14|0.0.1.0.0.0.0.0 11-12|0.0.1.2+0.0.1.1.0+0.0.1.1+0.0.1 9-10|0.0.1.0 8-9|0.0.1.0.1 7-8|0.0.1.0.0 4-5|0.0.1.0.0.0 1-2|0.0.1.0.0.0.0 0-1|0.0.1.0.0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:46.488
(t / tissue 
      :ARG0-of (u / use-01 
            :ARG1 (j / joint) 
            :ARG2 (g / government-organization 
                  :ARG1-of (e / express-01 
                        :ARG1-of (d / detect-01 
                              :purpose-of (c / carry-out-03 
                                    :ARG1 (s / study-01 
                                          :ARG0 (a / all) 
                                          :ARG1 (t2 / target-01) 
                                          :quant (s2 / several)))) 
                        :mod (g2 / gene)) 
                  :name (n / name 
                        :op1 "CIA") 
                  :wiki "Central_Intelligence_Agency")))

# ::snt This study , for the first time , detected gene expression in LNs during CIA .
# ::tok This study , for the first time , detected gene expression in LNs during CIA .
# ::alignments 14-15|0.0.0.0.1+0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 12-13|0.2.0.0+0.2.0+0.2 10-11|0 9-10|0.3 8-9|0.0 6-7|0.1 1-2|0.0.0 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:46.609
(e / express-01 
      :ARG1-of (d / detect-01 
            :ARG0 (s / study-01 
                  :ARG1 (g / government-organization 
                        :name (n / name 
                              :op1 "CIA") 
                        :wiki "Central_Intelligence_Agency") 
                  :mod (t2 / this))) 
      :ARG2 (t / time) 
      :location (c / country 
            :name (n2 / name 
                  :op1 "LNs")) 
      :mod (g2 / gene))

# ::snt We present an extensive study of gene expression patterns in LNs of both genetically susceptible and resistant strains at four different phases of CIA .
# ::tok We present an extensive study of gene expression patterns in LNs of both genetically susceptible and resistant strains at four different phases of CIA .
# ::alignments 23-24|0.0.0.0.2.1.0.0.1+0.0.0.0.2.1.0.0.0.0+0.0.0.0.2.1.0.0.0+0.0.0.0.2.1.0.0 21-22|0.0.0.0.2.1.0 20-21|0.0.0.0.2.1 19-20|0.0.0.0.2.0 17-18|0.1 16-17|0 15-16|0.1.0 14-15|0.1.0.1 13-14|0.1.0.1.0 12-13|0.1.0.0 10-11|0.0.1.0+0.0.1+0.0 8-9|0.0.0.0 7-8|0.0.0.0.2 6-7|0.0.0.0.1 4-5|0.0.0 3-4|0.0.0.1 1-2|0.0.0.0.0.0 0-1|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:46.955
(r / resist-01 
      :ARG0 (c / country 
            :location-of (s3 / study-01 
                  :ARG1 (p2 / pattern-01 
                        :ARG1 (w / we 
                              :ARG0-of (p3 / present)) 
                        :mod (g3 / gene) 
                        :mod (e / express-01 
                              :ARG0 4 
                              :ARG1 (d / differ-02 
                                    :ARG1 (p / phase 
                                          :mod (g / government-organization 
                                                :name (n / name 
                                                      :op1 "CIA") 
                                                :wiki "Central_Intelligence_Agency"))))) 
                  :ARG1-of (e2 / extensive-03)) 
            :name (n2 / name 
                  :op1 "LNs")) 
      :ARG1 (s / strain 
            :op2-of (a / and 
                  :mod (b / both) 
                  :op1 (s2 / susceptible 
                        :mod (g2 / genetics)))))

# ::snt In both strains , differentially regulated genes were highly concentrated at the PI and CA phases , and only a small number of genes were differentially expressed in two or three phases .
# ::tok In both strains , differentially regulated genes were highly concentrated at the PI and CA phases , and only a small number of genes were differentially expressed in two or three phases .
# ::alignments 31-32|0.2 30-31|0.0.0 29-30|0.1.2 28-29|0.0.1.0.0 26-27|0.1 23-24|0.1.1.2 21-22|0.1.1 20-21|0.1.1.0 18-19|0.1.1.1 17-18|0 15-16|0.0.4 14-15|0.0.4.0.1.0.1+0.0.4.0.1.0.0.0+0.0.4.0.1.0.0+0.0.4.0.1.0 13-14|0.0.4.0.1 12-13|0.0.4.0.0.0+0.0.4.0.0+0.0.4.0 9-10|0.0 8-9|0.0.2 6-7|0.0.1 5-6|0.0.1.0 4-5|0.1.0 2-3|0.0.3 1-2|0.0.3.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:47.496
(a / and 
      :op1 (c / concentrate-02 
            :ARG0 3 
            :ARG1 (g2 / gene 
                  :ARG1-of (r / regulate-01 
                        :ARG0 2)) 
            :degree (h / high) 
            :manner (s3 / strain 
                  :mod (b / both)) 
            :time (p2 / phase 
                  :mod (t / thing 
                        :name (n3 / name 
                              :op1 "PI") 
                        :op1-of (a2 / and 
                              :op2 (s2 / state 
                                    :name (n2 / name 
                                          :op1 "CA") 
                                    :wiki "California"))))) 
      :op2 (e / express-01 
            :ARG0 (d / differentially) 
            :ARG1 (n / number 
                  :mod (s / small) 
                  :mod (o2 / only) 
                  :quant-of (g / gene)) 
            :op1-of (o / or)) 
      :op3 (p / phase))

# ::snt This indicates that biological responses in LNs were stronger in the PI and CA phases than in the OA phase , and the responses at different phases were different .
# ::tok This indicates that biological responses in LNs were stronger in the PI and CA phases than in the OA phase , and the responses at different phases were different .
# ::alignments 28-29|0.1.1.1 26-27|0.1.1.0.0 25-26|0.1.1.0 23-24|0.1.1.1.0.0+0.1.1.1.0 21-22|0.1.1 19-20|0.1.1.1.0.0.0 18-19|0.1.1.1.0.0.0.0.0.0+0.1.1.1.0.0.0.0.0+0.1.1.1.0.0.0.0 14-15|0.1.0.1.0 13-14|0.1.0.2.1+0.1.0.2.0.0+0.1.0.2.0+0.1.0.2 12-13|0.1.0 11-12|0.1.0.1.1.0+0.1.0.1.1+0.1.0.1 8-9|0.1 6-7|0.1.0.0.2.0.0+0.1.0.0.2.0+0.1.0.0.2 4-5|0.1.0.0+0.1.0.0.1 3-4|0.1.0.0.0 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:47.970
(i / indicate-01 
      :ARG0 (t4 / this) 
      :ARG1 (s2 / strong-02 
            :ARG1 (a2 / and 
                  :ARG1-of (r2 / respond-01 
                        :ARG0 (b / biology) 
                        :ARG2 (t3 / thing) 
                        :location (c / country 
                              :name (n4 / name 
                                    :op1 "LNs"))) 
                  :op1 (t2 / thing 
                        :mod-of (p3 / phase) 
                        :name (n3 / name 
                              :op1 "PI")) 
                  :op2 (s / state 
                        :name (n2 / name 
                              :op1 "CA") 
                        :wiki "California")) 
            :op1-of (a / and 
                  :op2 (d2 / differ-02 
                        :ARG1 (p / phase)) 
                  :op3 (d / differ-02 
                        :ARG1 (t / thing 
                              :ARG2-of (r / respond-01 
                                    :ARG1 (p2 / phase 
                                          :mod (o / organization 
                                                :name (n / name 
                                                      :op1 "OA")))))))))

# ::snt When comparing the susceptible to the resistant strain , the biggest difference was found in one cluster of genes ( cluster IV , Figure 2 ) .
# ::tok When comparing the susceptible to the resistant strain , the biggest difference was found in one cluster of genes ( cluster IV , Figure 2 ) .
# ::alignments 24-25|0.0 23-24|0.1.0.0 20-22|0.1.0.2.0.0.0.1+0.1.0.2.0.0.0.0+0.1.0.2.0.0.0+0.1.0.2.0.0 18-19|0.1.0.2.0.1 16-17|0.1.0.2.0.1.0 13-14|0.1.0.2 11-12|0.1.0.2.0 10-11|0.1.0.2.0.2.0+0.1.0.2.0.2 7-8|0.1.1+0.1 6-7|0 3-4|0.1.0.1 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:48.231
(r / resist-01 
      :ARG1 2 
      :mod-of (s / strain 
            :ARG2-of (c3 / compare-01 
                  :ARG0 (f / figure) 
                  :ARG1 (s2 / susceptible) 
                  :time-of (f2 / find-01 
                        :ARG1 (d / differ-02 
                              :ARG1 (t / thing 
                                    :name (n / name 
                                          :op1 (c / cluster) 
                                          :op2 (i / IV))) 
                              :location (g / gene 
                                    :consist (c2 / cluster)) 
                              :mod (b / big 
                                    :degree (m / most))))) 
            :wiki "Influenza_A_virus_subtype_H5N1"))

# ::snt These genes had a higher expression in DBA/1 than in FVB/N at the early phases of CIA ( NC , PI and OA ) and the opposite expression pattern in the CA phase .
# ::tok These genes had a higher expression in DBA/1 than in FVB/N at the early phases of CIA ( NC , PI and OA ) and the opposite expression pattern in the CA phase .
# ::alignments 32-33|0.2.2.1 31-32|0.2.2.1.0.1+0.2.2.1.0.0.0+0.2.2.1.0.0+0.2.2.1.0 28-29|0.2.2 27-28|0.2.2.0 26-27|0.2.2.2 24-25|0.2 22-23|0.1.0.0+0.1.0+0.1 21-22|0 20-21|0.0.0.0+0.0.0+0.0 18-19|0.2.0.1.0.1+0.2.0.1.0.0.0+0.2.0.1.0.0+0.2.0.1.0 16-17|0.2.1.0.1+0.2.1.0.0.0+0.2.1.0.0+0.2.1.0 14-15|0.2.1 13-14|0.2.1.1 10-11|0.2.2.2.0.0.0+0.2.2.2.0.0+0.2.2.2.0 5-6|0.2.0 4-5|0.2.0.1 1-2|0.2.0.0 0-1|0.2.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:49.359
(a2 / and 
      :op1 (t / thing 
            :name (n3 / name 
                  :op1 "PI")) 
      :op2 (o2 / organization 
            :name (n2 / name 
                  :op1 "OA")) 
      :op3-of (a / and 
            :op1 (e3 / express-01 
                  :ARG0 (g2 / gene 
                        :mod (t3 / this)) 
                  :ARG1-of (h / high-02 
                        :ARG0 (s2 / state 
                              :name (n4 / name 
                                    :op1 "NC") 
                              :wiki "North_Carolina"))) 
            :op2 (p3 / phase 
                  :mod (g / government-organization 
                        :name (n5 / name 
                              :op1 "CIA") 
                        :wiki "Central_Intelligence_Agency") 
                  :time (e2 / early)) 
            :op4 (p2 / pattern 
                  :ARG1-of (e / express-01) 
                  :location (p / phase 
                        :mod (s / state 
                              :name (n / name 
                                    :op1 "CA") 
                              :wiki "California")) 
                  :mod (o / opposite-01 
                        :ARG2 (t2 / thing 
                              :name (n6 / name 
                                    :op1 "FVB/N"))))))

# ::snt GO term classification revealed that these genes were related to lymphocyte proliferation and activation , suggesting that lymphocytes in the DBA/1 strain are more activated than those in the FVB/N strain .
# ::tok GO term classification revealed that these genes were related to lymphocyte proliferation and activation , suggesting that lymphocytes in the DBA/1 strain are more activated than those in the FVB/N strain .
# ::alignments 30-31|0.0.2.1.0.0.0.0+0.0.2.1.0.0.0 29-30|0.0.2.1.0.0.1.0+0.0.2.1.0.0.1+0.0.2.1.0.0 24-25|0.0.0 23-24|0.0.0.1 21-22|0.0.2.2.0.0+0.0.2.2.0 17-18|0.0.0.0 15-16|0.0.2.1.0 13-14|0.0.2.1.1 12-13|0.0.2.1 11-12|0.0.2.2 10-11|0.0.2.2.1 8-9|0.0.2 6-7|0.0.2.0 5-6|0.0.2.0.0 3-4|0 2-3|0.0 1-2|0.1 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:50.969
(r2 / reveal-01 
      :ARG0 (c / classify-01 
            :ARG0-of (a / activate-01 
                  :ARG1 (l / lymphocyt) 
                  :degree (m / more)) 
            :ARG1-of (g2 / go-01) 
            :ARG2 (r / relate-01 
                  :ARG1 (g / gene 
                        :mod (t2 / this)) 
                  :ARG2 (a3 / and 
                        :ARG1-of (s3 / suggest-01 
                              :ARG0 (t / thing 
                                    :mod-of (s / strain 
                                          :wiki "Influenza_A_virus_subtype_H5N1") 
                                    :name (n / name 
                                          :op1 "FVB/N"))) 
                        :op1 (a2 / activation)) 
                  :ARG4 (p / proliferate-01 
                        :ARG1 (s2 / strain 
                              :wiki "Influenza_A_virus_subtype_H5N1") 
                        :mod (l2 / lymphocyte)))) 
      :ARG1 (t3 / term))

# ::snt However , this difference is not CIA specific because the expression difference between the two strains existed in mice without immunisation .
# ::tok However , this difference is not CIA specific because the expression difference between the two strains existed in mice without immunisation .
# ::alignments 20-21|0.0.0.2 18-19|0.0.0.1 16-17|0.0.0 15-16|0.0.1 14-15|0.0.1.0 11-12|0.0 10-11|0 8-9|0.0.0.0 7-8|0.0.0.0.0 6-7|0.0.0.0.0.1.2+0.0.0.0.0.1.0.0+0.0.0.0.0.1.0+0.0.0.0.0.1 5-6|0.0.0.0.0.1.1 3-4|0.0.0.0.0.0 2-3|0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:51.173
(e2 / express-01 
      :ARG3-of (d / differ-02 
            :ARG0-of (e / exist-01 
                  :ARG0-of (c / cause-01 
                        :ARG1 (s2 / specific-02 
                              :ARG1 (d2 / differ-02 
                                    :mod (t / this)) 
                              :degree (g / government-organization 
                                    :name (n / name 
                                          :op1 "CIA") 
                                    :polarity - 
                                    :wiki "Central_Intelligence_Agency"))) 
                  :location (m / mouse) 
                  :prep-without (i / immunisation)) 
            :ARG1 (s / strain 
                  :quant 2)))

# ::snt Additionally , some genes related to the immune response were upregulated in the DBA/1 strain but not in the FVB/N strain during CIA .
# ::tok Additionally , some genes related to the immune response were upregulated in the DBA/1 strain but not in the FVB/N strain during CIA .
# ::alignments 22-23|0.0.2.0.1+0.0.2.0.0.0+0.0.2.0.0+0.0.2.0 20-21|0.0.2.1.0.0+0.0.2.1.0 19-20|0.0.2.1.1.0+0.0.2.1.1+0.0.2.1 16-17|0.0.0 15-16|0 14-15|0.0.2.2.0.0+0.0.2.2.0 8-9|0.0.2 7-8|0.0.2.2 4-5|0.0 3-4|0.0.1 2-3|0.0.1.0 0-1|0.0.2.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:51.433
(c / contrast-01 
      :ARG2 (r2 / relate-01 
            :ARG0 - 
            :ARG1 (g2 / gene 
                  :quant (s3 / some)) 
            :ARG2 (r / respond-01 
                  :ARG0 (g / government-organization 
                        :name (n / name 
                              :op1 "CIA") 
                        :wiki "Central_Intelligence_Agency") 
                  :ARG1 (t / thing 
                        :mod-of (s / strain 
                              :wiki "Influenza_A_virus_subtype_H5N1") 
                        :name (n2 / name 
                              :op1 "FVB/N")) 
                  :ARG1-of (i / immune-02 
                        :ARG0 (s2 / strain 
                              :wiki "Influenza_A_virus_subtype_H5N1") 
                        :ARG2 (a / additional)))))

# ::snt These differences could explain why a higher antibody response to collagen II occurred in the DBA/1 strain compared to the FVB/N strain , and might partially explain the difference of the susceptibility to CIA between both strains .
# ::tok These differences could explain why a higher antibody response to collagen II occurred in the DBA/1 strain compared to the FVB/N strain , and might partially explain the difference of the susceptibility to CIA between both strains .
# ::alignments 36-37|0.1.0.0.0.0 35-36|0.1.0.0.0 33-34|0.1.1.0.0.1.1+0.1.1.0.0.1.0.0+0.1.1.0.0.1.0+0.1.1.0.0.1 31-32|0.1.1.0.0.0 28-29|0.1.1.0.0 26-27|0.1.1.0 25-26|0.1.1.0.1 24-25|0.1.1 23-24|0.1 21-22|0.0.1.0.1+0.0.1.0 20-21|0.0.1.0.0.0.0+0.0.1.0.0.0+0.0.1.0.0 17-18|0.0.1 16-17|0.1.0.1.0+0.1.0.1 12-13|0.1.0 10-12|0.1.0.0.1.0.1+0.1.0.0.1.0.0+0.1.0.0.1.0+0.1.0.0.1 8-9|0.1.0.0 7-8|0.1.0.0.3 6-7|0.1.0.0.2 3-4|0.0 2-3|0 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:53.115
(p3 / possible-01 
      :ARG1 (e2 / explain-01 
            :ARG1 (d2 / differ-01 
                  :mod (t3 / this)) 
            :ARG1-of (c / compare-01 
                  :ARG2 (s3 / strain 
                        :mod (t / thing 
                              :name (n2 / name 
                                    :op1 "FVB/N")) 
                        :wiki "Influenza_A_virus_subtype_H5N1"))) 
      :op1-of (a / and 
            :op2 (o / occur-01 
                  :ARG0 (r / respond-01 
                        :ARG0 (b / both 
                              :mod-of (s / strain)) 
                        :ARG1 (t2 / thing 
                              :name (n3 / name 
                                    :op1 (c2 / collagen) 
                                    :op2 (i / II))) 
                        :ARG1-of (h / high-02) 
                        :ARG2 (a2 / antibody)) 
                  :ARG1 (s4 / strain 
                        :wiki "Influenza_A_virus_subtype_H5N1")) 
            :op3 (p2 / possible-01 
                  :ARG1 (e / explain-01 
                        :ARG1 (d / differ-02 
                              :ARG1 (s2 / susceptibility) 
                              :ARG2 (g / government-organization 
                                    :name (n / name 
                                          :op1 "CIA") 
                                    :wiki "Central_Intelligence_Agency")) 
                        :manner (p / partial)))))

# ::snt Twenty-one genes were identified as potential candidate genes for six of the eight small-effect QTL according to their gene expression patterns during CIA and their genomic locations .
# ::tok Twenty-one genes were identified as potential candidate genes for six of the eight small-effect QTL according to their gene expression patterns during CIA and their genomic locations .
# ::alignments 26-27|0.0.1.0 23-24|0.0.1 22-23|0.0.1.0.0.1+0.0.1.0.0.0.0+0.0.1.0.0.0+0.0.1.0.0 20-21|0.0 19-20|0.0.3 18-19|0.0.2 15-16|0 12-13|0.0.3.1 9-10|0.0.0 7-8|0.1.1 6-7|0.1.1.0 5-6|0.1.1.0.0 3-4|0.1 1-2|0.1.0 0-1|0.0.3.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:53.358
(s / say-01 
      :ARG0 (p / pattern-01 
            :ARG0 6 
            :ARG1 (a / and 
                  :op1 (l / location 
                        :poss (g / government-organization 
                              :name (n / name 
                                    :op1 "CIA") 
                              :wiki "Central_Intelligence_Agency"))) 
            :mod (g2 / gene) 
            :mod (e / express-01 
                  :ARG0 (t / twenty-one) 
                  :ARG1 8)) 
      :ARG1 (i / identify-01 
            :ARG1 (g4 / gene) 
            :ARG2 (g3 / gene 
                  :mod (c / candidate 
                        :mod (p2 / potential)))))

# ::snt No candidate genes were located in QTL 4 and 7 , suggesting that QTG polymorphisms of the susceptibility genes inside these two QTL might not affect the phenotype by regulating gene expression .
# ::tok No candidate genes were located in QTL 4 and 7 , suggesting that QTG polymorphisms of the susceptibility genes inside these two QTL might not affect the phenotype by regulating gene expression .
# ::alignments 31-32|0 30-31|0.2 29-30|0.1 27-28|0.1.1.1 25-26|0.1.1 24-25|0.1.1.3 23-24|0.1.1.2 21-22|0.1.1.2.0.1 20-21|0.1.1.2.0.0.0.0 19-20|0.1.0.0.0 18-19|0.1.0.0 17-18|0.1.0.0.1 14-15|0.1.0 11-12|0.1.1.2.0 9-10|0.0 8-9|0.1.1.2.0.0.0.2 7-8|0.1.1.0 4-5|0.1.1.2.0.0.0 2-3|0.1.1.2.0.0 1-2|0.1.1.2.0.0.1 0-1|0.1.1.2.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:53.791
(e / express-01 
      :ARG0 7 
      :ARG1-of (r / regulate-01 
            :ARG0 (p3 / polymorphism 
                  :poss (g2 / gene 
                        :location (i / inside) 
                        :part-of (s / susceptibility))) 
            :manner-of (a / affect-01 
                  :ARG0 4 
                  :ARG1 (p / phenotype) 
                  :ARG1-of (p2 / possible-01 
                        :ARG1-of (s2 / suggest-01 
                              :ARG0 (g3 / gene 
                                    :ARG1-of (l / locate-01 
                                          :ARG0 (t / this) 
                                          :polarity - 
                                          :time (a2 / and)) 
                                    :mod (c / candidate)) 
                              :time 2)) 
                  :polarity -)) 
      :mod (g / gene))

# ::snt Two of the 21 candidate genes were reported to be involved in arthritis .
# ::tok Two of the 21 candidate genes were reported to be involved in arthritis .
# ::alignments 12-13|0.0.1 10-11|0.0 7-8|0 5-6|0.0.0 4-5|0.0.0.0 3-4|0.0.0.2 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:53.830
(r / report-01 
      :ARG1 (i / involve-01 
            :ARG1 (g / gene 
                  :part-of (c / candidate) 
                  :quant 2 
                  :quant 21) 
            :ARG2 (a / arthritis)))

# ::snt Mapk14 , a candidate gene for locus 8 and also called p38 mitogen-activated protein kinase ( MAPK ) alpha , regulates the production of arthritis-essential cytokines , such as tumour necrosis factor and interleukin-1 [ 32 ] .
# ::tok Mapk14 , a candidate gene for locus 8 and also called p38 mitogen-activated protein kinase ( MAPK ) alpha , regulates the production of arthritis-essential cytokines , such as tumour necrosis factor and interleukin-1 [ 32 ] .
# ::alignments 35-36|0.0.0.3.0.0.2.1 32-33|0.0.0.3.0 31-32|0.0.0.3.0.1 30-31|0.0.0.3.0.1.0 29-30|0.0.0.3.0.1.0.0 27-28|0.0.0.3.0.0.1 25-26|0.0.0.3.0.0.0 22-23|0.0.0.3.0.0 20-21|0.0.0.3.0.0.2 18-19|0.0.0.1 14-15|0.0 13-14|0 12-13|0.0.1 10-11|0.0.0 9-10|0.0.0.2 8-9|0.0.0.3 7-8|0.0.0.3.0.0.2.0 6-7|0.0.0.0.0 4-5|0.0.0.0 3-4|0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:54.435
(p2 / protein 
      :mod-of (k / kinase 
            :ARG1-of (c2 / call-01 
                  :ARG0 (g / gene 
                        :beneficiary (l / locu) 
                        :mod (c3 / candidate)) 
                  :ARG2 (a2 / alpha) 
                  :manner (a3 / also) 
                  :op1-of (a4 / and 
                        :op1-of (a / and 
                              :example-of (p / produce-01 
                                    :ARG0 (c / cytokin) 
                                    :ARG1 (s / such) 
                                    :ARG1-of (r / regulate-01 
                                          :ARG0 8 
                                          :time 32)) 
                              :op2 (f / factor 
                                    :mod (n / necrosi 
                                          :mod (t / tumour)))))) 
            :mod (m / mitogen-activat)))

# ::snt Moreover , inhibitors of p38 MAPK could attenuate CIA in rats [ 33 ] , and p38 MAPK is becoming a potential therapeutic target in RA [ 32 ] .
# ::tok Moreover , inhibitors of p38 MAPK could attenuate CIA in rats [ 33 ] , and p38 MAPK is becoming a potential therapeutic target in RA [ 32 ] .
# ::alignments 27-28|0.0 25-26|0.1.2.0.0.0+0.1.2.0.0+0.1.2.0 23-24|0.1.3.0.1 22-23|0.1.3.0.1.3 21-22|0.1.3.0.1.2 19-20|0.1.3.0 16-18|0.1.3.0.0.0.1+0.1.3.0.0.0.0+0.1.3.0.0.0+0.1.3.0.0 15-16|0.1.3 12-13|0.1.3.0.1.1 10-11|0.1.2 8-9|0.1.1.1+0.1.1.0.0+0.1.1.0+0.1.1 7-8|0.1 6-7|0 5-6|0.1.0.0 2-3|0.1.0 0-1|0.1.3.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:55.140
(p3 / possible-01 
      :ARG0 32 
      :ARG1 (a2 / attenuate-01 
            :ARG0 (i / inhibitor 
                  :mod (m2 / MAPK)) 
            :ARG1 (g / government-organization 
                  :name (n3 / name 
                        :op1 "CIA") 
                  :wiki "Central_Intelligence_Agency") 
            :manner (r / rat-01 
                  :ARG1 (o / organization 
                        :name (n / name 
                              :op1 "RA"))) 
            :op1-of (a / and 
                  :op2 (b / become-01 
                        :ARG1 (t3 / thing 
                              :name (n2 / name 
                                    :op1 (p2 / p38) 
                                    :op2 (m / MAPK))) 
                        :ARG2 (t / target-01 
                              :ARG0 (m3 / moreover) 
                              :ARG1 33 
                              :mod (p / potential) 
                              :mod (t2 / therapeutic))))))

# ::snt Stat5a , a candidate gene for loci 6 , is an essential molecule for lymphoid development and differentiation [ 34 ] .
# ::tok Stat5a , a candidate gene for loci 6 , is an essential molecule for lymphoid development and differentiation [ 34 ] .
# ::alignments 19-20|0.0.1.2 17-18|0.0.1.1.1 16-17|0.0.1.1 15-16|0.0.1.1.0 14-15|0.0.1.1.0.1 12-13|0.0.1.1.0.2 11-12|0.0.1.1.0.2.0 7-8|0.0.1.1.0.0 6-7|0 4-5|0.0 3-4|0.0.0 0-1|0.0.1.0.0+0.0.1.0+0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:55.249
(l2 / locus 
      :beneficiary-of (g / gene 
            :mod (c / candidate) 
            :mod-of (p / person 
                  :name (n / name 
                        :op1 "Stat5a") 
                  :op1-of (a / and 
                        :op2 (d2 / develop-02 
                              :ARG0 6 
                              :ARG1 (l / lymphoid) 
                              :purpose-of (m / molecule 
                                    :mod (e / essential))) 
                        :op3 (d / differentiation)) 
                  :poss 34)))

# ::snt Stat5a-deficient mice were reported to lose tolerance , resulting in the development of autoimmune diseases .
# ::tok Stat5a-deficient mice were reported to lose tolerance , resulting in the development of autoimmune diseases .
# ::alignments 14-15|0.1.0.1.0.0 13-14|0.1.0.0 11-12|0.1.0.1.0 8-9|0.1.0.1 6-7|0.1.0 5-6|0.1 3-4|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:55.398
(r2 / report-01 
      :ARG1 (m / mouse) 
      :purpose (l / lose-02 
            :ARG1 (t / tolerate-01 
                  :ARG1 (a / autoimmune) 
                  :ARG1-of (r / result-01 
                        :ARG2 (d2 / develop-02 
                              :ARG1 (d / disease))))))

# ::snt Stat5a is suggested to contribute to tolerance through maintenance of the CD4 + CD25 + regulatory T cell population [ 35 ] .
# ::tok Stat5a is suggested to contribute to tolerance through maintenance of the CD4 + CD25 + regulatory T cell population [ 35 ] .
# ::alignments 20-21|0.1.1.0 18-19|0.1.2.0 17-18|0.1.2.0.1 16-17|0.0.1+0.0.0.0+0.0.0+0.0 15-16|0.1.2.0.0 11-12|0.1.1.1 8-9|0.1.2 6-7|0.1.1 4-5|0.1 2-3|0 0-1|0.1.0.0.0+0.1.0.0+0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:55.720
(s / suggest-01 
      :ARG0 (a / aircraft-type 
            :name (n / name 
                  :op1 "T50") 
            :wiki "Sukhoi_PAK_FA") 
      :ARG1 (c3 / contribute-01 
            :ARG0 (p2 / person 
                  :name (n2 / name 
                        :op1 "Stat5a")) 
            :ARG2 (t / tolerate-01 
                  :ARG0 35 
                  :ARG1 (c2 / cd4)) 
            :manner (m / maintain-01 
                  :ARG1 (p / population 
                        :ARG0-of (r / regulate-01) 
                        :mod (c / cell)))))

# ::snt Therefore , we have presented a strategy to identify small-effect QTL and search for potential candidate genes within them .
# ::tok Therefore , we have presented a strategy to identify small-effect QTL and search for potential candidate genes within them .
# ::alignments 16-17|0.0.0.0.0.0 15-16|0.0.0.0.0.0.0 14-15|0.0.0.0.0.0.0.0 12-13|0.0.0.0.0 11-12|0.0.0.0 8-9|0.0.0 6-7|0.1 4-5|0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:55.781
(p2 / present-01 
      :ARG0 (w / we 
            :ARG0-of (i / identify-01 
                  :op1-of (a / and 
                        :op2 (s / search-01 
                              :ARG1 (g / gene 
                                    :mod (c / candidate 
                                          :mod (p / potential))))))) 
      :ARG1 (s2 / strategy))

# ::snt However , it is noteworthy that the low statistical threshold and small number of animals per group could lead to some false positive results .
# ::tok However , it is noteworthy that the low statistical threshold and small number of animals per group could lead to some false positive results .
# ::alignments 23-24|0+0.0 22-23|0.1 21-22|0.0.1 20-21|0.0.2 18-19|0.0.0 17-18|0.0.0.2 16-17|0.0.0.1 14-15|0.0.0.0.1.1 12-13|0.0.0.0.1 11-12|0.0.0.0.1.0 10-11|0.0.0.0 9-10|0.0.0.0.0 8-9|0.0.0.0.0.0 7-8|0.0.0.0.0.0.0 4-5|0.0.0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:56.141
(r / result-01 
      :ARG2 (t / thing 
            :ARG2-of (l / lead-03 
                  :ARG0 (a2 / and 
                        :op1 (t2 / threshold 
                              :mod (s3 / statistic 
                                    :ARG1-of (l2 / low-04))) 
                        :op2 (n / number 
                              :mod (s2 / small) 
                              :quant-of (a / animal))) 
                  :ARG1 (g / group) 
                  :ARG1-of (p2 / possible-01) 
                  :domain-of (n2 / noteworthy)) 
            :mod (f / false) 
            :quant (s / some)) 
      :mod (p / positive))

# ::snt On the genome level , some of the eight small-effect QTL identified using a very low threshold value ( P < 0.05 ) could be false positives .
# ::tok On the genome level , some of the eight small-effect QTL identified using a very low threshold value ( P < 0.05 ) could be false positives .
# ::alignments 26-27|0.1.0 25-26|0.1 23-24|0 19-20|0.0 17-18|0.2.0 16-17|0.2.0.1 15-16|0.2.0.2 14-15|0.2.0.2.1 12-13|0.2 11-12|0.2.1 10-11|0.2.1.0 8-9|0.2.0.2.0 5-6|0.2.1.0.0 3-4|0.2.0.0 2-3|0.2.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:56.586
(p2 / possible-01 
      :ARG0 (p3 / P60) 
      :ARG1 (f / false 
            :mod-of (p / positive)) 
      :condition-of (u / use-01 
            :ARG1 (v / value-01 
                  :ARG0 (l2 / level 
                        :mod (g / genome)) 
                  :ARG1 (t / threshold) 
                  :ARG1-of (l / low-04 
                        :ARG2 8 
                        :degree (v2 / very))) 
            :ARG1-of (i / identify-01 
                  :ARG0 (q / QTL 
                        :quant (s / some)))))

# ::snt For example , locus 4 was identified with a low P value and does not overlap with any previously identified arthritis QTL .
# ::tok For example , locus 4 was identified with a low P value and does not overlap with any previously identified arthritis QTL .
# ::alignments 21-22|0.0.1.0.0 20-21|0.0.1.0 19-20|0.0.1.0.0.0 18-19|0.0.1.0.0.0.1 17-18|0.0.1.0.0.1 15-16|0.1 14-15|0.1.1 12-13|0 11-12|0.0.1 10-11|0.0.1.1 9-10|0.0.1.2 6-7|0.0 4-5|0.0.1.0.0.0.0 3-4|0.1.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:56.788
(a3 / and 
      :op1 (i2 / identify-01 
            :ARG1 (e / example) 
            :ARG2 (v / value-01 
                  :ARG0 (a / arthritis 
                        :mod-of (q / QTL 
                              :ARG1-of (i / identify-01 
                                    :ARG0 4 
                                    :time (p / previous)) 
                              :mod (a2 / any))) 
                  :ARG1 (p2 / P60) 
                  :ARG1-of (l / low-04))) 
      :op2 (o / overlap-01 
            :ARG1 (l2 / locu) 
            :polarity -))

# ::snt On the transcriptome level , the small number of animals per group and the low threshold used to detect gene expression could also result in false positives in the differentially expressed genes .
# ::tok On the transcriptome level , the small number of animals per group and the low threshold used to detect gene expression could also result in false positives in the differentially expressed genes .
# ::alignments 31-32|0.0.0.2.1 30-31|0.0.0.2 29-30|0.0.0.2.0 26-27|0.0.0.1.0.2 25-26|0.0.0.1.0.2.0 23-24|0.0.0.1.0 22-23|0.0.0.1.0.3 21-22|0.0.0.1.0.1 20-21|0 19-20|0.1 18-19|0.0 16-17|0.0.0 15-16|0.0.0.0 14-15|0.0.0.0.0 12-13|0.0.0.1 11-12|0.0.0.1.2 9-10|0.0.0.1.1 7-8|0.0.0.1.1.0 6-7|0.0.0.1.1.0.0 3-4|0.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:57.592
(e2 / express-01 
      :ARG1-of (d2 / detect-01 
            :ARG2-of (u / use-01 
                  :ARG1 (t / threshold 
                        :ARG1-of (l / low-04)) 
                  :op3-of (a2 / and 
                        :ARG0-of (r / result-01 
                              :ARG1 (l2 / level) 
                              :ARG1-of (p2 / possible-01) 
                              :ARG2 (p / positive 
                                    :mod (f / false)) 
                              :mod (a / also)) 
                        :op1 (a3 / animal 
                              :quant (n / number 
                                    :mod (s / small))) 
                        :op2 (g3 / group)) 
                  :purpose (e / express-01 
                        :ARG0 (d / differentially) 
                        :ARG1 (g / gene)))) 
      :mod (g2 / gene))

# ::snt Furthermore , the differential expression of a gene could result not only from allele difference between two strains , but also from other factors .
# ::tok Furthermore , the differential expression of a gene could result not only from allele difference between two strains , but also from other factors .
# ::alignments 23-24|0.0.0.2.0.1 22-23|0.0.0.2.0 20-21|0.1 19-20|0 17-18|0.0.0.2.1 16-17|0.0.0.2.1.0 14-15|0.0.0.2 13-14|0.0.0.2.2 11-12|0.0.0.0 10-11|0.0.0.0.0 9-10|0.0.0 8-9|0.0 7-8|0.0.0.1.1 4-5|0.0.0.1 3-4|0.0.0.1.0 0-1|0.0.0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:57.931
(c / contrast-01 
      :ARG1 (p / possible-01 
            :ARG1 (r / result-01 
                  :ARG0 (o2 / only 
                        :polarity -) 
                  :ARG1 (e / express-01 
                        :ARG0 (d2 / differential) 
                        :ARG1 (g / gene)) 
                  :ARG2 (d / differ-02 
                        :ARG0 (o / other 
                              :mod (f2 / furthermore) 
                              :mod-of (f / factor)) 
                        :ARG1 (s / strain 
                              :quant 2) 
                        :mod (a2 / allele)))) 
      :ARG2 (a / also))

# ::snt Therefore , our findings should be confirmed in future studies .
# ::tok Therefore , our findings should be confirmed in future studies .
# ::alignments 9-10|0.0.1 8-9|0.0.1.0 6-7|0.0 4-5|0 3-4|0.0.0.0+0.0.0 2-3|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:57.958
(r / recommend-01 
      :ARG1 (c / confirm-01 
            :ARG1 (t / thing 
                  :ARG1-of (f2 / find-01 
                        :ARG0 (w / we))) 
            :ARG2 (s / study-01 
                  :time (f / future))))

# ::snt We present a strategy to search candidate genes for small-effect QTL .
# ::tok We present a strategy to search candidate genes for small-effect QTL .
# ::alignments 7-8|0.0 6-7|0 5-6|0.0.0 3-4|0.0.0.1 1-2|0.0.0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:57.985
(c / candidate 
      :mod-of (g / gene 
            :ARG1-of (s / search-01 
                  :ARG0 (w / we 
                        :ARG0-of (p / present)) 
                  :mod-of (s2 / strategy))))

# ::snt With this strategy , we identified 21 candidate genes for 8 small-effect QTL regulating CIA susceptibility .
# ::tok With this strategy , we identified 21 candidate genes for 8 small-effect QTL regulating CIA susceptibility .
# ::alignments 15-16|0.1.0.0 14-15|0.1.0.0.0.1+0.1.0.0.0.0.0+0.1.0.0.0.0+0.1.0.0.0 13-14|0.1.0 10-11|0.2.0.0 8-9|0.1 7-8|0.1.1 6-7|0.1.1.0 5-6|0 4-5|0.0 2-3|0.2 1-2|0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:58.303
(i / identify-01 
      :ARG0 (w / we) 
      :ARG1 (g2 / gene 
            :ARG0-of (r / regulate-01 
                  :ARG1 (s / susceptibility 
                        :mod (g / government-organization 
                              :name (n / name 
                                    :op1 "CIA") 
                              :wiki "Central_Intelligence_Agency"))) 
            :mod (c / candidate 
                  :quant 21)) 
      :time (s2 / strategy 
            :mod (t / this 
                  :mod-of 8)))

# ::snt Our future studies will be carried out using two approaches .
# ::tok Our future studies will be carried out using two approaches .
# ::alignments 9-10|0.1.0 8-9|0.1.0.0 7-8|0.1 5-6|0 2-3|0.0 1-2|0.0.1 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:58.382
(c / carry-out-03 
      :ARG1 (s / study-01 
            :ARG1 (w / we) 
            :time (f / future)) 
      :ARG2 (u / use-01 
            :ARG1 (a / approach-02 
                  :quant 2)))

# ::snt The first is generating congenic animals for promising small-effect QTL that have relatively high P values and overlap with previously-identified arthritis QTL .
# ::tok The first is generating congenic animals for promising small-effect QTL that have relatively high P values and overlap with previously-identified arthritis QTL .
# ::alignments 20-21|0.0.0.1.0.2 19-20|0 17-18|0.0.0.0 16-17|0.0.0.0.0 15-16|0.0.0 14-15|0.0.0.1 13-14|0.0.0.1.0 12-13|0.0.0.1.0.1 7-8|0.0 5-6|0.0.0.1.0.0.0 3-4|0.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:58.523
(p / previously-identifi 
      :ARG0-of (p3 / promise-01 
            :mod-of (v / value 
                  :ARG1-of (o / overlap-01 
                        :op1-of (a2 / and)) 
                  :mod (p2 / P60 
                        :ARG1-of (h / high-02 
                              :ARG2 (g / generate-01 
                                    :ARG1 (a3 / animal)) 
                              :degree (r / relative) 
                              :mod-of (a / arthritis))))))

# ::snt The second approach is investigating candidate genes using both mouse and human studies .
# ::tok The second approach is investigating candidate genes using both mouse and human studies .
# ::alignments 12-13|0.2.0.1 11-12|0.2.0.1.0 10-11|0.2.0 9-10|0.2.1 8-9|0.2.0.0 7-8|0.2 6-7|0.1 5-6|0.1.0 4-5|0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:58.901
(i / investigate-01 
      :ARG0 (a2 / approach-02) 
      :ARG1 (g / gene 
            :mod (c / candidate)) 
      :ARG2 (u / use-01 
            :ARG0 (a / and 
                  :mod (b / both) 
                  :op1 (s / study-01 
                        :ARG1 (h / human))) 
            :ARG1 (m / mouse)))

# ::snt Candidate genes will be selected according to their function and polymorphism between the two strains .
# ::tok Candidate genes will be selected according to their function and polymorphism between the two strains .
# ::alignments 14-15|0.1.0.0.0 13-14|0.1.0.0.0.0 10-11|0.0.0 9-10|0.0 8-9|0.1.0.0 5-6|0 4-5|0.1 1-2|0.1.0 0-1|0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:59.114
(s2 / say-01 
      :ARG0 (a / and 
            :op1 (p / polymorphism)) 
      :ARG1 (s3 / select-01 
            :ARG1 (g / gene 
                  :ARG0-of (f / function-01 
                        :ARG1 (s / strain 
                              :quant 2)) 
                  :mod (c / candidate))))

# ::snt Thereafter , we will generate knock-out mice to investigate the role of the genes in CIA .
# ::tok Thereafter , we will generate knock-out mice to investigate the role of the genes in CIA .
# ::alignments 15-16|0.0.0.0.0.0.1+0.0.0.0.0.0.0.0+0.0.0.0.0.0.0+0.0.0.0.0.0 13-14|0.0.0.0.0 10-11|0.0.0.0 8-9|0.0.0 6-7|0.1 4-5|0 2-3|0.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:59.209
(g3 / generate-01 
      :ARG0 (w / we 
            :ARG0-of (i / investigate-01 
                  :ARG1 (r / role 
                        :poss (g2 / gene 
                              :location (g / government-organization 
                                    :name (n / name 
                                          :op1 "CIA") 
                                    :wiki "Central_Intelligence_Agency"))))) 
      :ARG1 (m / mouse) 
      :time (t / thereaft))

# ::snt For the loci whose counterparts on the human genome are linked to RA , we will investigate the candidate genes using case-control association studies in RA cohorts .
# ::tok For the loci whose counterparts on the human genome are linked to RA , we will investigate the candidate genes using case-control association studies in RA cohorts .
# ::alignments 26-27|0.1.0.0.1 23-24|0.1.0.0 22-23|0.1.0.0.0 20-21|0.1.0 19-20|0.1 18-19|0.1.1 16-17|0 14-15|0.0 12-13|0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 10-11|0.0.0 8-9|0.1.0.0.0.0 7-8|0.1.0.0.0.0.0 4-5|0.0.0.0 2-3|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:46:59.598
(i / investigate-01 
      :ARG0 (w / we 
            :ARG0-of (l / link-01 
                  :ARG1 (c3 / counterpart 
                        :poss (l2 / locus)) 
                  :ARG2 (o / organization 
                        :name (n / name 
                              :op1 "RA")))) 
      :ARG1 (g / gene 
            :ARG0-of (u / use-01 
                  :ARG1 (s / study-01 
                        :ARG1 (a / associate-01 
                              :ARG1 (g2 / genome 
                                    :mod (h / human))) 
                        :ARG2 (c / cohort))) 
            :mod (c2 / candidate)))

# ::snt CA = chronic arthritis ; CIA = collagen-induced arthritis ; CV = coefficiant of variation ; GO = Gene Ontology ; LN = lymph node ; LOD = logarithm of the odds ; MAPK = mitogen-activated protein kinase ; NC = naive control ; OA = onset of arthritis ; PI = post-immunisation ; QTG = quantitative trait gene ; QTL = quantitative trait loci ; RA = rheumatoid arthritis .
# ::tok CA = chronic arthritis ; CIA = collagen-induced arthritis ; CV = coefficiant of variation ; GO = Gene Ontology ; LN = lymph node ; LOD = logarithm of the odds ; MAPK = mitogen-activated protein kinase ; NC = naive control ; OA = onset of arthritis ; PI = post-immunisation ; QTG = quantitative trait gene ; QTL = quantitative trait loci ; RA = rheumatoid arthritis .
# ::alignments 69-70|0.0.0.3.7.0 68-69|0.0.0.3.7.0.0 66-67|0.0.0.3.7 64-65|0.0.0.3.4.0.0.0 63-64|0.0.0.3.4.0.0 62-63|0.0.0.3.4.0.0.0.0 58-59|0.0.0.3.3.0.0.0.0 57-58|0.0.0.3.3.0.0.0.0.0 56-57|0.0.0.3.3.0.0.0 50-51|0.0.0.3.6.0.0+0.0.0.3.6.0+0.0.0.3.6 48-49|0.0.0.3.5.0.0 46-47|0.0.0.3.5.0 44-45|0.0.0.3.5.1.0+0.0.0.3.5.1+0.0.0.3.5 42-43|0.0.0.3.4.0 41-42|0.0.0.3.4.0.1 39-40|0.0.0.3.4.2+0.0.0.3.4.1.0+0.0.0.3.4.1+0.0.0.3.4 37-38|0.0 36-37|0 35-36|0.0.1 31-32|0.0.0.3.3.0.0 28-29|0.0.0.3.3.0 26-27|0.0.0.3.3.1.0+0.0.0.3.3.1+0.0.0.3.3 24-25|0.0.0.3.5.0.0.0.0 23-24|0.0.0.3.5.0.0.0 18-20|0.0.0.1.0.1+0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 16-17|0.0.0 14-15|0.0.0.2 12-13|0.0.0.2.0 10-11|0.0.0.3.2.1+0.0.0.3.2.0.0+0.0.0.3.2.0+0.0.0.3.2 8-9|0.0.0.3.1.0 7-8|0.0.0.3.1.0.0 5-6|0.0.0.3.1.2+0.0.0.3.1.1.0+0.0.0.3.1.1+0.0.0.3.1 4-5|0.0.0.3 3-4|0.0.0.0 2-3|0.0.0.0.0 0-1|0.0.0.3.0.1+0.0.0.3.0.0.0+0.0.0.3.0.0+0.0.0.3.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:01.624
(p / protein 
      :mod-of (k / kinase 
            :ARG0-of (g2 / go-01 
                  :ARG1 (a5 / arthritis 
                        :mod (c5 / chronic)) 
                  :ARG2 (p2 / person 
                        :name (n7 / name 
                              :op1 "Gene" 
                              :op2 "Ontology")) 
                  :mod (v / variation 
                        :mod-of (c3 / coefficiant)) 
                  :op3-of (a4 / and 
                        :domain (s3 / state 
                              :name (n10 / name 
                                    :op1 "CA") 
                              :wiki "California") 
                        :op1 (g3 / government-organization 
                              :domain-of (a3 / arthritis 
                                    :mod (c4 / collagen-induc)) 
                              :name (n9 / name 
                                    :op1 "CIA") 
                              :wiki "Central_Intelligence_Agency") 
                        :op2 (s2 / ship 
                              :name (n8 / name 
                                    :op1 "CV") 
                              :wiki -) 
                        :op4 (c2 / country 
                              :domain-of (l2 / logarithm 
                                    :poss (o4 / odds 
                                          :mod (q2 / quantitative 
                                                :mod-of (g / gene 
                                                      :mod (t2 / trait))))) 
                              :name (n5 / name 
                                    :op1 "LOD")) 
                        :op5 (s / state 
                              :ARG0-of (c / control-01 
                                    :ARG2 (t / trait 
                                          :mod-of (l / locus 
                                                :mod (q / quantitative))) 
                                    :mod (n3 / naive)) 
                              :name (n4 / name 
                                    :op1 "NC") 
                              :wiki "North_Carolina") 
                        :op6 (o3 / organization 
                              :domain-of (o2 / onset 
                                    :mod (a2 / arthritis 
                                          :mod-of (l3 / lymph 
                                                :mod-of (n6 / node)))) 
                              :name (n2 / name 
                                    :op1 "OA")) 
                        :op7 (o / organization 
                              :name (n / name 
                                    :op1 "PI")) 
                        :op8 (r2 / ra 
                              :domain-of (a / arthritis 
                                    :mod (r / rheumatoid))))) 
            :mod (m / mitogen-activat)))

# ::snt The authors declare that they have no competing interests .
# ::tok The authors declare that they have no competing interests .
# ::alignments 8-9|0.0.1 7-8|0.0.1.0 6-7|0.0.0 4-5|0.1 2-3|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:01.665
(d / declare-02 
      :ARG0 (a / author-01 
            :ARG1 - 
            :domain-of (i / interest 
                  :ARG1-of (c / compete-02))) 
      :ARG1 (t / they))

# ::snt XY and KB performed the animal experiments .
# ::tok XY and KB performed the animal experiments .
# ::alignments 6-7|0.0.0 5-6|0.0.0.0 3-4|0.0 2-3|0.2 1-2|0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:01.686
(a2 / and 
      :ARG0-of (p / perform-02 
            :ARG1 (e / experiment-01 
                  :ARG1 (a / animal))) 
      :op1 (x / xy) 
      :op2 (k / kb))

# ::snt DK and HJT performed gene expression profiling experiments .
# ::tok DK and HJT performed gene expression profiling experiments .
# ::alignments 7-8|0.0.0 6-7|0.0.0.0 5-6|0.0.0.0.0 4-5|0.0.0.0.0.0 3-4|0.0 1-2|0 0-1|0.1.0.0+0.1.0+0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:02.004
(a / and 
      :ARG0-of (p2 / perform-02 
            :ARG1 (e / experiment-01 
                  :ARG1 (p / profile-01 
                        :ARG1 (e2 / express-01 
                              :ARG1 (g / gene))))) 
      :op1 (o / organization 
            :name (n / name 
                  :op1 "DK")))

# ::snt XY and DK performed the bioinformatic analysis .
# ::tok XY and DK performed the bioinformatic analysis .
# ::alignments 6-7|0.0.0 3-4|0.0 2-3|0.1.0.0+0.1.0+0.1 1-2|0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:02.026
(a2 / and 
      :ARG0-of (p / perform-02 
            :ARG1 (a / analyze-01 
                  :ARG1 (x / xy))) 
      :op1 (o / organization 
            :name (n / name 
                  :op1 "DK")))

# ::snt SI conceived and designed the experiment .
# ::tok SI conceived and designed the experiment .
# ::alignments 5-6|0.0.1 3-4|0.0 2-3|0 1-2|0.0.1.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:02.042
(a / and 
      :op1 (d / design-01 
            :ARG0 (s / si) 
            :ARG1 (e / experiment-01 
                  :ARG1-of (c / conceive-01))))

# ::snt XY and SI drafted the manuscript .
# ::tok XY and SI drafted the manuscript .
# ::alignments 5-6|0.1 3-4|0 2-3|0.0.1 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:02.058
(d / draft-01 
      :ARG0 (a / and 
            :op1 (x / xy) 
            :op2 (s / si)) 
      :ARG1 (m / manuscript))

# ::snt All authors read and approved the final manuscript .
# ::tok All authors read and approved the final manuscript .
# ::alignments 7-8|0.1.0.0 6-7|0.1.0.0.0 4-5|0.1.0 3-4|0.1 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:02.123
(r / read-01 
      :ARG1 (a3 / author-01 
            :mod (a4 / all)) 
      :op1-of (a2 / and 
            :ARG0-of (a / approve-01 
                  :ARG1 (m / manuscript 
                        :mod (f / final)))))

# ::snt Summary information on the 509 genes differentially expressed between DBA/1 and FVB/N strains .
# ::tok Summary information on the 509 genes differentially expressed between DBA/1 and FVB/N strains .
# ::alignments 12-13|0.1.1 11-12|0.1.0.0.0+0.1.0.0+0.1.0 10-11|0.1 7-8|0 6-7|0.2 5-6|0.0.0 1-2|0.0 0-1|0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:02.167
(e / express-01 
      :ARG0 (i / information 
            :topic (g / gene)) 
      :ARG1 (a / and 
            :op1 (t / thing 
                  :name (n / name 
                        :op1 "FVB/N")) 
            :op2 (s / strain)) 
      :mod (d / differentially) 
      :time (s2 / summary))

# ::snt Comparison was performed between two strains at four stages of CIA , NA , PI , OA and CA .
# ::tok Comparison was performed between two strains at four stages of CIA , NA , PI , OA and CA .
# ::alignments 18-19|0.0.0.5.1+0.0.0.5.0.0+0.0.0.5.0+0.0.0.5 17-18|0.0.0 16-17|0.0.0.4.0.0+0.0.0.4.0+0.0.0.4 14-15|0.0.0.3.0.0+0.0.0.3.0+0.0.0.3 12-13|0.0.0.2.0.0+0.0.0.2.0+0.0.0.2 10-11|0.0.0.1.2+0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 8-9|0.0.0.1.1 7-8|0.0.1 5-6|0.0.0.0 4-5|0.0.0.0.0 2-3|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:02.379
(c / comparison 
      :ARG1-of (p / perform-02 
            :ARG0 (a / and 
                  :mod (s3 / strain 
                        :quant 2) 
                  :op1 (g / government-organization 
                        :name (n5 / name 
                              :op1 "CIA") 
                        :part (s2 / stage) 
                        :wiki "Central_Intelligence_Agency") 
                  :op2 (o3 / organization 
                        :name (n4 / name 
                              :op1 "NA")) 
                  :op3 (o2 / organization 
                        :name (n3 / name 
                              :op1 "PI")) 
                  :op4 (o / organization 
                        :name (n2 / name 
                              :op1 "OA")) 
                  :op5 (s / state 
                        :name (n / name 
                              :op1 "CA") 
                        :wiki "California")) 
            :op1-of 4))

# ::snt Three criteria were applied for selecting the differentially expressed genes : the lower 90 % confidence bound of fold change between the group means exceeded twofold ; the absolute difference between the two groups exceeded 100 ; the P value threshold of the unpaired t-test was 0.05 .
# ::tok Three criteria were applied for selecting the differentially expressed genes : the lower 90 % confidence bound of fold change between the group means exceeded twofold ; the absolute difference between the two groups exceeded 100 ; the P value threshold of the unpaired t-test was 0.05 .
# ::alignments 44-45|0.0.0 43-44|0.0.0.0 40-41|0.0 39-40|0 38-39|0.1 35-36|0.2.0 34-35|0.2.2.0 33-34|0.2.2.1 32-33|0.2.2.1.0 29-30|0.2.2 28-29|0.2.2.2 26-27|0.2.2.0.0 25-26|0.2.2.0.0.0.1.0 24-25|0.2.2.0.0.0.1 23-24|0.2.2.0.0.0 22-23|0.2.2.0.0.0.0.0.0.0 19-20|0.2.2.0.0.0.0.0.0 18-19|0.2.2.0.0.0.0.0.0.1 16-17|0.2.2.0.0.0.0.0 15-16|0.2.2.0.0.0.0 14-15|0.2.1 13-14|0.2.1.0 12-13|0.2 9-10|0.2.2.0.0.0.0.0.0.0.0.0.0.0.1 8-9|0.2.2.0.0.0.0.0.0.0.0.0.0.0 7-8|0.2.2.0.0.0.0.0.0.0.0.0.0.0.0 5-6|0.2.2.0.0.0.0.0.0.0.0.0.0 3-4|0.2.2.0.0.0.0.0.0.0.0 1-2|0.2.2.0.0.0.0.0.0.0.0.0 0-1|0.2.2.0.0.0.0.0.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:03.808
(v / value-01 
      :ARG0 (t2 / threshold 
            :poss (t / t-t 
                  :mod (u / unpair))) 
      :ARG1 (p / P60) 
      :ARG2 (l / low-04 
            :ARG0 100 
            :ARG1 (p2 / percentage-entity 
                  :value 90) 
            :ARG2-of (d / differ-02 
                  :ARG0-of (e / exceed-01 
                        :ARG1 (a2 / and 
                              :ARG2-of (m / mean-01 
                                    :ARG1 (c2 / confidence 
                                          :ARG1-of (b / bind-01 
                                                :ARG2 (c / change-01 
                                                      :ARG1 (g2 / group 
                                                            :ARG0-of (a3 / apply-01 
                                                                  :ARG1 (c3 / criteria 
                                                                        :ARG0-of (s / select-01 
                                                                              :ARG1 (e3 / express-01 
                                                                                    :ARG0 (d2 / differentially) 
                                                                                    :ARG1 (g3 / gene))) 
                                                                        :quant 3))) 
                                                      :mod (f / fold)))) 
                                    :ARG1-of (e2 / exceed-01 
                                          :ARG2 (t3 / twofold))))) 
                  :ARG1 (g / group 
                        :quant 2) 
                  :mod (a / absolute))))

# ::snt Click here for file .
# ::tok Click here for file .
# ::alignments 3-4|0.0 1-2|0.1 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:03.818
(c / click-01 
      :ARG1 (f / file) 
      :location (h / here))

# ::snt Summary information on the 311 genes differentially expressed in joints in the DBA/1 strain during CIA .
# ::tok Summary information on the 311 genes differentially expressed in joints in the DBA/1 strain during CIA .
# ::alignments 15-16|0.0.2+0.0.1.0+0.0.1+0.0 13-14|0.0.0.0+0.0.0 9-10|0.2 7-8|0 6-7|0.3 5-6|0.1 1-2|0.1.0 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:03.916
(e / express-01 
      :ARG0 (g / government-organization 
            :location-of (s / strain 
                  :wiki "Influenza_A_virus_subtype_H5N1") 
            :name (n / name 
                  :op1 "CIA") 
            :wiki "Central_Intelligence_Agency") 
      :ARG1 (g2 / gene 
            :topic-of (i / information 
                  :mod (s2 / summary))) 
      :manner (j / joint) 
      :mod (d / differentially))

# ::snt Pairwise comparisons were performed by comparing PI , OA and CA with NA .
# ::tok Pairwise comparisons were performed by comparing PI , OA and CA with NA .
# ::alignments 12-13|0.1.1.1.1.0.0+0.1.1.1.1.0+0.1.1.1.1 10-11|0.1.1.1.2+0.1.1.1.0.0+0.1.1.1.0+0.1.1.1 9-10|0.1.1 8-9|0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 6-7|0.1.0.0.0+0.1.0.0+0.1.0 5-6|0.1 3-4|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:04.279
(p / perform-02 
      :ARG1 (c2 / compare-01) 
      :ARG2 (c / compare-01 
            :ARG1 (o3 / organization 
                  :name (n4 / name 
                        :op1 "PI")) 
            :ARG2 (a / and 
                  :op1 (o2 / organization 
                        :name (n3 / name 
                              :op1 "OA")) 
                  :op2 (s / state 
                        :name (n2 / name 
                              :op1 "CA") 
                        :prep-with (o / organization 
                              :name (n / name 
                                    :op1 "NA")) 
                        :wiki "California"))))

# ::snt Three criteria were applied for selecting the differentially expressed genes : the lower 90 % confidence bound of fold change between the group means exceeded twofold ; the absolute difference between the two groups exceeded 100 ; the P value threshold of the unpaired t-test was 0.05 .
# ::tok Three criteria were applied for selecting the differentially expressed genes : the lower 90 % confidence bound of fold change between the group means exceeded twofold ; the absolute difference between the two groups exceeded 100 ; the P value threshold of the unpaired t-test was 0.05 .
# ::alignments 44-45|0.0.0 43-44|0.0.0.0 40-41|0.0 39-40|0 38-39|0.1 35-36|0.2.0 34-35|0.2.2.0 33-34|0.2.2.1 32-33|0.2.2.1.0 29-30|0.2.2 28-29|0.2.2.2 26-27|0.2.2.0.0 25-26|0.2.2.0.0.0.1.0 24-25|0.2.2.0.0.0.1 23-24|0.2.2.0.0.0 22-23|0.2.2.0.0.0.0.0.0.0 19-20|0.2.2.0.0.0.0.0.0 18-19|0.2.2.0.0.0.0.0.0.1 16-17|0.2.2.0.0.0.0.0 15-16|0.2.2.0.0.0.0 14-15|0.2.1 13-14|0.2.1.0 12-13|0.2 9-10|0.2.2.0.0.0.0.0.0.0.0.0.0.0.1 8-9|0.2.2.0.0.0.0.0.0.0.0.0.0.0 7-8|0.2.2.0.0.0.0.0.0.0.0.0.0.0.0 5-6|0.2.2.0.0.0.0.0.0.0.0.0.0 3-4|0.2.2.0.0.0.0.0.0.0.0 1-2|0.2.2.0.0.0.0.0.0.0.0.0 0-1|0.2.2.0.0.0.0.0.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:05.755
(v / value-01 
      :ARG0 (t2 / threshold 
            :poss (t / t-t 
                  :mod (u / unpair))) 
      :ARG1 (p / P60) 
      :ARG2 (l / low-04 
            :ARG0 100 
            :ARG1 (p2 / percentage-entity 
                  :value 90) 
            :ARG2-of (d / differ-02 
                  :ARG0-of (e / exceed-01 
                        :ARG1 (a2 / and 
                              :ARG2-of (m / mean-01 
                                    :ARG1 (c2 / confidence 
                                          :ARG1-of (b / bind-01 
                                                :ARG2 (c / change-01 
                                                      :ARG1 (g2 / group 
                                                            :ARG0-of (a3 / apply-01 
                                                                  :ARG1 (c3 / criteria 
                                                                        :ARG0-of (s / select-01 
                                                                              :ARG1 (e3 / express-01 
                                                                                    :ARG0 (d2 / differentially) 
                                                                                    :ARG1 (g3 / gene))) 
                                                                        :quant 3))) 
                                                      :mod (f / fold)))) 
                                    :ARG1-of (e2 / exceed-01 
                                          :ARG2 (t3 / twofold))))) 
                  :ARG1 (g / group 
                        :quant 2) 
                  :mod (a / absolute))))

# ::snt Click here for file .
# ::tok Click here for file .
# ::alignments 3-4|0.0 1-2|0.1 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:05.764
(c / click-01 
      :ARG1 (f / file) 
      :location (h / here))

# ::snt Summary information on the 117 genes that were strain-specific differentially expressed and were dysregulated in the DBA/1 strain during CIA .
# ::tok Summary information on the 117 genes that were strain-specific differentially expressed and were dysregulated in the DBA/1 strain during CIA .
# ::alignments 19-20|0.1.1+0.1.0.0+0.1.0+0.1 17-18|0.2.0+0.2 11-12|0.3 10-11|0 9-10|0.0 5-6|0.3.0.0 4-5|0.3.0.0.0 1-2|0.3.0 0-1|0.4 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:05.886
(e / express-01 
      :ARG0 (d / differentially) 
      :ARG1 (g / government-organization 
            :name (n / name 
                  :op1 "CIA") 
            :wiki "Central_Intelligence_Agency") 
      :ARG2 (s / strain 
            :wiki "Influenza_A_virus_subtype_H5N1") 
      :op2-of (a / and 
            :op1 (i / information 
                  :topic (g2 / gene 
                        :quant 117))) 
      :time (s2 / summary))

# ::snt The physical positions of the genes were retrieved from Ensembl [ 30 ] .
# ::tok The physical positions of the genes were retrieved from Ensembl [ 30 ] .
# ::alignments 11-12|0.0.1.0 9-10|0.1.0.0+0.1.0+0.1 7-8|0 5-6|0.0.1 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:05.964
(r / retrieve-01 
      :ARG1 (p / position 
            :mod (p2 / physical) 
            :poss (g / gene 
                  :op1-of 30)) 
      :ARG2 (c / country 
            :name (n / name 
                  :op1 "Ensembl")))

# ::snt Click here for file .
# ::tok Click here for file .
# ::alignments 3-4|0.0 1-2|0.1 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:05.972
(c / click-01 
      :ARG1 (f / file) 
      :location (h / here))

# ::snt The authors wish to thank Ilona Klamfuss for animal care .
# ::tok The authors wish to thank Ilona Klamfuss for animal care .
# ::alignments 9-10|0.0.2 8-9|0.0.2.0 5-7|0.0.1.0.1+0.0.1.0.0+0.0.1.0+0.0.1 4-5|0.0 2-3|0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:06.043
(w / wish-01 
      :ARG1 (t / thank-01 
            :ARG0 (a2 / author-01) 
            :ARG1 (p / person 
                  :name (n / name 
                        :op1 "Ilona" 
                        :op2 "Klamfuss")) 
            :ARG2 (c / care-03 
                  :ARG1 (a / animal))))

# ::snt This work was supported by a grant from the EU FP6 ( MRTN-CT-2004-005693 , EURO-RA ) .
# ::tok This work was supported by a grant from the EU FP6 ( MRTN-CT-2004-005693 , EURO-RA ) .
# ::alignments 14-15|0.1.0+0.1+0 10-11|0.0.0.0.0 9-10|0.0.0.0.0.0.1+0.0.0.0.0.0.0.0+0.0.0.0.0.0.0+0.0.0.0.0.0 6-7|0.0.0.0 3-4|0.0.0 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:06.184
(t / thing 
      :ARG1-of (w / work-01 
            :ARG1-of (s / support-01 
                  :ARG0 (g / grant-01 
                        :ARG1 (f / FP6 
                              :mod (o / organization 
                                    :name (n2 / name 
                                          :op1 "EU") 
                                    :wiki "European_Union")))) 
            :mod (t2 / this)) 
      :name (n / name 
            :op1 "EURO-RA"))

# ::snt Differentially expressed genes between collagen-induced arthritis ( CIA ) susceptible and resistant strains .
# ::tok Differentially expressed genes between collagen-induced arthritis ( CIA ) susceptible and resistant strains .
# ::alignments 12-13|0.1.0.1 11-12|0.1.0 10-11|0.1.0.1.0 9-10|0.1.0.1.0.0 7-8|0.1.0.0.1+0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 5-6|0.2 4-5|0.2.0 2-3|0.1 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:06.357
(e / express-01 
      :ARG0 (d / differentially) 
      :ARG1 (g2 / gene 
            :ARG0-of (r / resist-01 
                  :ARG1 (g / government-organization 
                        :name (n / name 
                              :op1 "CIA") 
                        :wiki "Central_Intelligence_Agency") 
                  :mod-of (s / strain 
                        :op2-of (a / and 
                              :op1 (s2 / susceptible))))) 
      :time (a2 / arthritis 
            :mod (c / collagen-induc)))

# ::snt Comparison of the gene expression between the DBA/1 and FVB/N strains was performed at four phases of CIA .
# ::tok Comparison of the gene expression between the DBA/1 and FVB/N strains was performed at four phases of CIA .
# ::alignments 17-18|0.0.1.0.1+0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 15-16|0.0.1 14-15|0.1.0 12-13|0.0 10-11|0.3 9-10|0.2.0.0+0.2.0+0.2 8-9|0 4-5|0.1 3-4|0.1.1 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:06.508
(a / and 
      :ARG0-of (p2 / perform-02 
            :ARG1 (c / comparison) 
            :ARG2 (p / phase 
                  :mod (g / government-organization 
                        :name (n / name 
                              :op1 "CIA") 
                        :wiki "Central_Intelligence_Agency"))) 
      :ARG1-of (e / express-01 
            :ARG0 4 
            :mod (g2 / gene)) 
      :op1 (t / thing 
            :name (n2 / name 
                  :op1 "FVB/N")) 
      :op2 (s / strain))

# ::snt Of the 22,000 screened genes , 509 were differentially expressed between both strains at one or more phases of CIA , including 361 genes at the naive control ( NC ) phase , 141 genes at post-immunisation ( PI ) phase , 184 genes at the onset of arthritis ( OA ) phase and 85 genes at the chronic arthritis ( CA ) phase .
# ::tok Of the 22,000 screened genes , 509 were differentially expressed between both strains at one or more phases of CIA , including 361 genes at the naive control ( NC ) phase , 141 genes at post-immunisation ( PI ) phase , 184 genes at the onset of arthritis ( OA ) phase and 85 genes at the chronic arthritis ( CA ) phase .
# ::alignments 63-64|0.4.1.0.0.5.0 61-62|0.4.1.0.0.0.1+0.4.1.0.0.0.0.0+0.4.1.0.0.0.0+0.4.1.0.0.0 59-60|0.4.1.0.0.5 58-59|0.4.1.0.0.3 55-56|0.4.1.5 54-55|0.4.1.5.0 53-54|0.4.1 52-53|0.4.1.4 50-51|0.4.1.0.0.4.0.0+0.4.1.0.0.4.0+0.4.1.0.0.4 48-49|0.4.1.4.0 46-47|0.4.1.3.0 43-44|0.4.1.3 40-41|0.4.1.2 38-39|0.4.1.1.0.0+0.4.1.1.0+0.4.1.1 34-35|0.2 31-32|0.4.1.0 29-30|0.4.1.0.0.2.0.1+0.4.1.0.0.2.0.0.0+0.4.1.0.0.2.0.0+0.4.1.0.0.2.0 27-28|0.4.1.0.0 26-27|0.4.1.0.0.1 23-24|0.4.1.0.0.2.2 19-20|0.4.0.0.0.1+0.4.0.0.0.0.0+0.4.0.0.0.0+0.4.0.0.0 17-18|0.4.0.0 16-17|0.4.0 15-16|0.4 12-13|0.0 11-12|0.0.0 9-10|0 8-9|0.3 6-7|0.1 4-5|0.4.1.0.0.2.1 3-4|0.4.1.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:07.779
(e / express-01 
      :ARG0 (s3 / strain 
            :mod (b / both)) 
      :ARG1 509 
      :ARG2 (g3 / gene) 
      :mod (d / differentially) 
      :op1-of (o4 / or 
            :op2 (m / more 
                  :quant-of (p5 / phase 
                        :mod (g5 / government-organization 
                              :name (n6 / name 
                                    :op1 "CIA") 
                              :wiki "Central_Intelligence_Agency"))) 
            :op3 (a2 / and 
                  :op1 (p4 / phase 
                        :mod (c2 / control-01 
                              :ARG0 (s / state 
                                    :name (n / name 
                                          :op1 "CA") 
                                    :wiki "California") 
                              :ARG1 (n5 / naive) 
                              :ARG2 (s4 / screen-01 
                                    :ARG0 (s2 / state 
                                          :name (n4 / name 
                                                :op1 "NC") 
                                          :wiki "North_Carolina") 
                                    :ARG1 (g6 / gene) 
                                    :op1-of (g4 / gene)) 
                              :op1-of (c / chronic) 
                              :op1-of (o / organization 
                                    :name (n2 / name 
                                          :op1 "OA")) 
                              :op1-of (a / arthritis 
                                    :mod-of (p / phase)))) 
                  :op2 (o3 / organization 
                        :name (n3 / name 
                              :op1 "PI")) 
                  :op3 (p3 / phase) 
                  :op4 (g2 / gene 
                        :location (o2 / onset)) 
                  :op5 (p2 / phase 
                        :mod (a3 / arthritis)) 
                  :op6 (g / gene 
                        :quant 85))))

# ::snt The Venn diagram indicates the number of overlapping genes differentially expressed at different phases of CIA .
# ::tok The Venn diagram indicates the number of overlapping genes differentially expressed at different phases of CIA .
# ::alignments 15-16|0.1.0.0.1.1+0.1.0.0.1.0.0+0.1.0.0.1.0+0.1.0.0.1 13-14|0.1.0.0 12-13|0.1.0.0.0 10-11|0.1.0 9-10|0.1.0.1 8-9|0.1.1 7-8|0.1.1.0 5-6|0.1 3-4|0 2-3|0.0 1-2|0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:07.927
(i / indicate-01 
      :ARG0 (d3 / diagram-01 
            :ARG1 (t / thing 
                  :name (n3 / name 
                        :op1 "Venn"))) 
      :ARG1 (n2 / number 
            :ARG1-of (e / express-01 
                  :ARG2 (p / phase 
                        :ARG1-of (d / differ-02) 
                        :mod (g / government-organization 
                              :name (n / name 
                                    :op1 "CIA") 
                              :wiki "Central_Intelligence_Agency")) 
                  :mod (d2 / differentially)) 
            :quant-of (g2 / gene 
                  :ARG1-of (o / overlap-01))))

# ::snt Differentially expressed genes in the DBA/1 strain during collagen-induced arthritis ( CIA ) .
# ::tok Differentially expressed genes in the DBA/1 strain during collagen-induced arthritis ( CIA ) .
# ::alignments 11-12|0.3.1+0.3.0.0+0.3.0+0.3 9-10|0.2.0 8-9|0.2.0.0 6-7|0.2.1+0.2 2-3|0.1 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:08.046
(e / express-01 
      :ARG0 (d / differentially) 
      :ARG1 (g2 / gene) 
      :ARG2 (s / strain 
            :mod-of (a / arthritis 
                  :mod (c / collagen-induc)) 
            :wiki "Influenza_A_virus_subtype_H5N1") 
      :op1-of (g / government-organization 
            :name (n / name 
                  :op1 "CIA") 
            :wiki "Central_Intelligence_Agency"))

# ::snt Three experimental conditions , post-immunisation ( PI ) , onset of arthritis ( OA ) and chronic arthritis ( CA ) , were compared with nave control ( NC ) to search for differentially expressed genes .
# ::tok Three experimental conditions , post-immunisation ( PI ) , onset of arthritis ( OA ) and chronic arthritis ( CA ) , were compared with nave control ( NC ) to search for differentially expressed genes .
# ::alignments 35-36|0.0.1 34-35|0.0 33-34|0 31-32|0.0.1.0 28-29|0.0.1.0.0.1.0.1+0.0.1.0.0.1.0.0.0+0.0.1.0.0.1.0.0+0.0.1.0.0.1.0 26-27|0.0.1.0.0.0.0 25-26|0.0.1.0.0.0.0.0 23-24|0.0.1.0.0.0 19-20|0.0.1.0.1.1+0.0.1.0.1.0.0+0.0.1.0.1.0+0.0.1.0.1 17-18|0.0.1.0.0.2.1 16-17|0.0.1.0.0.2.1.0 15-16|0.0.1.0.0.2 13-14|0.0.1.0.0.1.1.0.0+0.0.1.0.0.1.1.0+0.0.1.0.0.1.1 11-12|0.0.1.0.0.2.0.0 9-10|0.0.1.0.0.2.0 6-7|0.0.0.0.0+0.0.0.0+0.0.0 2-3|0.0.1.0.0 1-2|0.0.1.0.0.1 0-1|0.0.1.0.0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:08.620
(d / differentially 
      :degree-of (e / express-01 
            :ARG0 (o3 / organization 
                  :name (n5 / name 
                        :op1 "PI")) 
            :ARG1 (g / gene 
                  :ARG2-of (s / search-01 
                        :ARG0 (c4 / condition 
                              :ARG1-of (c2 / compare-01 
                                    :ARG2 (c / control-01 
                                          :ARG1 (n2 / nave))) 
                              :mod (e2 / experiment-01 
                                    :ARG0 (s2 / state 
                                          :name (n / name 
                                                :op1 "NC") 
                                          :wiki "North_Carolina") 
                                    :ARG1 (o / organization 
                                          :name (n4 / name 
                                                :op1 "OA"))) 
                              :op1-of (a2 / and 
                                    :op2 (o2 / onset 
                                          :mod (a3 / arthritis)) 
                                    :op3 (a / arthritis 
                                          :mod (c3 / chronic))) 
                              :quant 3) 
                        :ARG1 (s3 / state 
                              :name (n3 / name 
                                    :op1 "CA") 
                              :wiki "California")))))

# ::snt ( a ) Venn diagram indicating the number of overlapping genes differentially expressed at three phases of CIA .
# ::tok ( a ) Venn diagram indicating the number of overlapping genes differentially expressed at three phases of CIA .
# ::alignments 17-18|0.1.0.1+0.1.0.0.0+0.1.0.0+0.1.0 15-16|0.1 14-15|0.1.1 12-13|0 11-12|0.2 10-11|0.0 9-10|0.0.0 7-8|0.0.1 5-6|0.0.0.0.1 4-5|0.0.0.0 3-4|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:08.811
(e / express-01 
      :ARG0 (g2 / gene 
            :ARG1-of (o / overlap-01 
                  :ARG0 (d2 / diagram-01 
                        :ARG1 (t / thing 
                              :name (n3 / name 
                                    :op1 "Venn")) 
                        :ARG1-of (i / indicate-01))) 
            :quant (n2 / number)) 
      :ARG1 (p / phase 
            :mod (g / government-organization 
                  :name (n / name 
                        :op1 "CIA") 
                  :wiki "Central_Intelligence_Agency") 
            :quant 3) 
      :mod (d / differentially))

# ::snt ( b ) Hierarchical clustering of the 310 differentially expressed genes .
# ::tok ( b ) Hierarchical clustering of the 310 differentially expressed genes .
# ::alignments 10-11|0.1 9-10|0 8-9|0.0.1 4-5|0.0.0 3-4|0.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:08.993
(e / express-01 
      :ARG0 (h / hierarchical 
            :ARG1-of (c / cluster-01 
                  :ARG0 (b / b)) 
            :mod (d / differentially)) 
      :ARG1 (g / gene))

# ::snt The left panel shows the distribution of relative gene expression across the hierarchical tree structure .
# ::tok The left panel shows the distribution of relative gene expression across the hierarchical tree structure .
# ::alignments 14-15|0.1.0.0 13-14|0.1.0.0.1 12-13|0.1.0.0.0 10-11|0.1.1 9-10|0.1.0 8-9|0.1.0.1 7-8|0.1.0.2 5-6|0.1 3-4|0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:09.053
(s2 / show-01 
      :ARG0 (p / panel 
            :mod (l / left)) 
      :ARG1 (d / distribute-01 
            :ARG1 (e / express-01 
                  :ARG1 (s / structure 
                        :mod (h / hierarchical) 
                        :mod (t / tree)) 
                  :mod (g / gene) 
                  :mod (r / relative)) 
            :ARG4 (a / across)))

# ::snt Rows represent individual genes ; columns represent individual value of triplicate samples for each experimental group .
# ::tok Rows represent individual genes ; columns represent individual value of triplicate samples for each experimental group .
# ::alignments 15-16|0.0 14-15|0.0.1 13-14|0.0.0 11-12|0+0.1 10-11|0.1.1 8-9|0.1.0 7-8|0.0.1.1 6-7|0.1.0.0 5-6|0.1.0.0.0 4-5|0.1.0.0.1 3-4|0.1.0.0.1.0.1 2-3|0.0.1.0 1-2|0.1.0.0.1.0 0-1|0.1.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:09.303
(s / sample-01 
      :ARG0 (g / group 
            :mod (e2 / each) 
            :mod (e / experiment-01 
                  :ARG0 (i2 / individual) 
                  :ARG1 (i / individual))) 
      :ARG1 (t / thing 
            :ARG1-of (v / value-01 
                  :ARG1-of (r / represent-01 
                        :ARG0 (c / column) 
                        :op2-of (a / and 
                              :op1 (r2 / represent-01 
                                    :ARG0 (r3 / row-01) 
                                    :ARG1 (g2 / gene))))) 
            :mod (t2 / triplicate)))

# ::snt Each cell in the matrix represents the expression level of a gene , with red and green indicating transcription levels above and below the normal values for that gene , respectively .
# ::tok Each cell in the matrix represents the expression level of a gene , with red and green indicating transcription levels above and below the normal values for that gene , respectively .
# ::alignments 30-31|0.0.3.1.0.1 28-29|0.0.0 27-28|0.0.0.0 25-26|0.0.2.1.0 24-25|0.0.2.1.0.0 22-23|0.0.2.1 21-22|0.0.2 20-21|0.0.2.0 19-20|0.0.1 18-19|0.0.1.0 17-18|0.0 16-17|0.2 15-16|0 14-15|0.1 11-12|0.0.3.1.1 8-9|0.0.3.1 7-8|0.0.3.1.0 5-6|0.0.3 4-5|0.0.3.1.0.0 1-2|0.0.3.0 0-1|0.0.3.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:09.848
(a3 / and 
      :ARG3-of (i / indicate-01 
            :ARG0 (g / gene 
                  :mod (t / that)) 
            :ARG1 (l / level 
                  :mod (t2 / transcription)) 
            :ARG2 (a / and 
                  :op1 (a2 / above) 
                  :op2 (b / below 
                        :op1 (v / value 
                              :ARG1-of (n / normal-02)))) 
            :manner-of (r3 / represent-01 
                  :ARG0 (c / cell 
                        :mod (e2 / each)) 
                  :ARG1 (l2 / level 
                        :mod (e / express-01 
                              :ARG0 (m / matrix) 
                              :ARG1 (r / respective)) 
                        :mod (g3 / gene)))) 
      :op1 (r2 / red) 
      :op2 (g2 / green-02))

# ::snt Four sample groups are indicated above the expression matrix .
# ::tok Four sample groups are indicated above the expression matrix .
# ::alignments 8-9|0.1.0 7-8|0.1.0.0 5-6|0.1 4-5|0 2-3|0.0 1-2|0.0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:09.881
(i / indicate-01 
      :ARG1 (g / group 
            :ARG1-of (s / sample-01) 
            :quant 4) 
      :ARG2 (a / above 
            :op1 (m / matrix 
                  :ARG1-of (e / express-01))))

# ::snt Six basic gene clusters ( clusters I to VI ) were yielded by the analysis according to the gene expression pattern during CIA .
# ::tok Six basic gene clusters ( clusters I to VI ) were yielded by the analysis according to the gene expression pattern during CIA .
# ::alignments 22-23|0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 20-21|0.0 19-20|0.2 18-19|0.2.1 15-16|0 14-15|0.1.0 11-12|0.1 6-7|0.1.0.0 5-6|0.1.1 3-4|0.1.2 2-3|0.1.2.0 1-2|0.1.2.0.0 0-1|0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:10.346
(s / say-01 
      :ARG0 (p / pattern 
            :mod (g / government-organization 
                  :name (n / name 
                        :op1 "CIA") 
                  :wiki "Central_Intelligence_Agency")) 
      :ARG1 (y / yield-01 
            :ARG0 (a / analyze-01 
                  :ARG1 (i / i)) 
            :ARG1 (c / cluster) 
            :ARG2 (c2 / cluster 
                  :mod (g3 / gene 
                        :mod (b / basic)))) 
      :ARG2 (e / express-01 
            :ARG0 6 
            :ARG1 (g2 / gene)))

# ::snt The expression patterns of the gene cluster are graphed and the major biological activities for each cluster that were examined by functional clustering analysis are indicated on the right .
# ::tok The expression patterns of the gene cluster are graphed and the major biological activities for each cluster that were examined by functional clustering analysis are indicated on the right .
# ::alignments 28-29|0.1.2 25-26|0.1 23-24|0.1.1.1.0 22-23|0.1.1.1.0.0 21-22|0.1.1.1.0.1 19-20|0.1.1.1 16-17|0.1.1.1.1 15-16|0.1.1.1.1.0 13-14|0.1.1 12-13|0.1.1.0 11-12|0.1.1.2 9-10|0 8-9|0.0 6-7|0.1.0.0 5-6|0.1.0.0.0 2-3|0.1.0 1-2|0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:10.741
(a3 / and 
      :op1 (g / graph) 
      :op2 (i / indicate-01 
            :ARG0 (p / pattern-01 
                  :ARG1 (c3 / cluster 
                        :mod (g2 / gene)) 
                  :mod (e3 / express-01)) 
            :ARG1 (a2 / activity-06 
                  :ARG0 (b / biology) 
                  :ARG1 (e / examine-01 
                        :ARG0 (a / analyze-01 
                              :ARG1 (c / cluster-01) 
                              :manner (f / functional)) 
                        :ARG1 (c2 / cluster 
                              :mod (e2 / each))) 
                  :ARG1-of (m / major-02)) 
            :ARG2 (r / right-05)))

# ::snt Visualisation of all the chromosomal locations of the small-effect QTL identified in this study ( blue bar ) as well as 120 genes of interest from gene expression profiling ( black letters ) .
# ::tok Visualisation of all the chromosomal locations of the small-effect QTL identified in this study ( blue bar ) as well as 120 genes of interest from gene expression profiling ( black letters ) .
# ::alignments 31-32|0 30-31|0.0 28-29|0.0.0.0.0 27-28|0.0.0.0 26-27|0.0.0.0.0.1 24-25|0.0.0.0.0.0 22-23|0.0.0.0.0.0.1 21-22|0.0.0.0.0.0.1.0 16-17|0.0.0 15-16|0.0.0.1 13-14|0.0.0.0.0.0.0 12-13|0.0.0.0.0.0.0.2 10-11|0.0.0.0.0.0.0.1 9-10|0.0.0.0.0.0.0.1.0.0 5-6|0.0.0.0.0.0.0.1.0 4-5|0.0.0.0.0.0.0.1.0.1 2-3|0.0.0.0.0.0.0.1.0.2 0-1|0.0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:11.029
(l / letter 
      :ARG1-of (b / black-04 
            :ARG1-of (b2 / bar-01 
                  :ARG1-of (e / express-01 
                        :ARG1-of (p / profile-01 
                              :ARG1-of (i / interest-01 
                                    :ARG1-of (s / study-01 
                                          :ARG0 (v / visualisation) 
                                          :ARG1-of (i2 / identify-01 
                                                :ARG0 (l2 / location 
                                                      :location-of (q / QTL) 
                                                      :mod (c / chromosomal) 
                                                      :quant (a / all))) 
                                          :mod (t / this)) 
                                    :ARG2 (g2 / gene 
                                          :quant 120)) 
                              :mod (g / gene))) 
                  :mod (b3 / blue))))

# ::snt The positions of the 120 genes and the peak markers of the QTL were retrieved from Ensembl [ 30 ] .
# ::tok The positions of the 120 genes and the peak markers of the QTL were retrieved from Ensembl [ 30 ] .
# ::alignments 18-19|0.0.2.0.0 16-17|0.0.3.0.0+0.0.3.0+0.0.3 14-15|0 9-10|0.0.2 8-9|0.0.2.0 6-7|0.0 5-6|0.0.1 4-5|0.0.1.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:11.240
(r / retrieve-01 
      :ARG1 (a / and 
            :op1 (p2 / position) 
            :op2 (g / gene 
                  :quant 120) 
            :op3 (m / marker 
                  :ARG1-of (p / peak-01 
                        :ARG0 30)) 
            :op4 (c / country 
                  :name (n / name 
                        :op1 "Ensembl"))))

# ::snt Confidence intervals of all the QTL were set as 40 Mb .
# ::tok Confidence intervals of all the QTL were set as 40 Mb .
# ::alignments 10-11|0.1.0.0.0+0.1.0.0+0.1.0 9-10|0.0.0 5-6|0.1 3-4|0.1.1 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:11.268
(i / interval 
      :mod (c2 / confidence 
            :mod-of 40) 
      :part-of (q / QTL 
            :mod-of (c / country 
                  :name (n / name 
                        :op1 "Mb")) 
            :quant (a / all)))

# ::snt Experimental groups used for gene expression profiling .
# ::tok Experimental groups used for gene expression profiling .
# ::alignments 6-7|0.0 5-6|0 4-5|0.0.1 2-3|0.0.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:11.294
(e / express-01 
      :ARG1-of (p / profile-01 
            :ARG2-of (u / use-01 
                  :ARG1 (g2 / group)) 
            :mod (g / gene)))

# ::snt CA , chronic arthritis ; CFA ; complete Freund 's adjuvant ; CV , coefficient of variation ; LN , lymph node ; NC , naive control ; OA , onset of arthritis ; PI , post-immunisation .
# ::tok CA , chronic arthritis ; CFA ; complete Freund 's adjuvant ; CV , coefficient of variation ; LN , lymph node ; NC , naive control ; OA , onset of arthritis ; PI , post-immunisation .
# ::alignments 34-35|0.6.0.0+0.6.0+0.6 32-33|0.1.0.2 30-31|0.1.0.2.0 28-29|0.5.0.0+0.5.0+0.5 26-27|0.1.0.1 25-26|0.1.0.1.0 23-24|0.4.1+0.4.0.0+0.4.0+0.4 21-22|0.1.0.3.0 20-21|0.1.0.3 16-17|0.3 14-15|0.3.0 12-13|0.2.1+0.2.0.0+0.2.0+0.2 10-11|0.1.0.0.1 8-9|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 7-8|0.1.0 5-6|0.1.2+0.1.1.0+0.1.1+0.1 4-5|0 3-4|0.1.0.2.1.0 2-3|0.1.0.2.1 0-1|0.0.1+0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:11.814
(a3 / and 
      :op1 (s3 / state 
            :name (n9 / name 
                  :op1 "CA") 
            :wiki "California") 
      :op2 (o4 / organization 
            :ARG2-of (c3 / complete-02 
                  :ARG1 (p / person 
                        :name (n7 / name 
                              :op1 "Freund") 
                        :poss-of (a2 / adjuvant)) 
                  :ARG1-of (c / control-01 
                        :mod (n3 / naive)) 
                  :op1-of (a / arthritis 
                        :mod-of (o2 / onset) 
                        :mod-of (c4 / chronic 
                              :mod-of (a4 / arthritis))) 
                  :op1-of (l / lymph 
                        :mod-of (n5 / node))) 
            :name (n8 / name 
                  :op1 "CFA") 
            :wiki "Championnat_de_France_Amateur") 
      :op3 (s2 / ship 
            :name (n6 / name 
                  :op1 "CV") 
            :wiki -) 
      :op4 (v / variation 
            :mod-of (c2 / coefficient)) 
      :op5 (s / state 
            :name (n4 / name 
                  :op1 "NC") 
            :wiki "North_Carolina") 
      :op6 (o3 / organization 
            :name (n2 / name 
                  :op1 "OA")) 
      :op7 (o / organization 
            :name (n / name 
                  :op1 "PI")))

# ::snt Summary of the small-effect QTL identified in this study .
# ::tok Summary of the small-effect QTL identified in this study .
# ::alignments 8-9|0.0.0 7-8|0.0.0.0 5-6|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:11.834
(s2 / summary 
      :ARG1-of (i / identify-01 
            :ARG2 (s / study-01 
                  :mod (t / this))))

# ::snt aIdentified in all F2 290 progeny .
# ::tok aIdentified in all F2 290 progeny .
# ::alignments 5-6|0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:11.842
(p / progeny 
      :quant (a / all))

# ::snt bIdentified in 76 C5 + / + F2 progeny .
# ::tok bIdentified in 76 C5 + / + F2 progeny .
# ::alignments 8-9|0 5-6|0.0 2-3|0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:11.855
(p / progeny 
      :op2-of (s / slash 
            :op1 (p2 / person 
                  :quant 76)))

# ::snt cIdentified in 133 C5 + / - F2 progeny .
# ::tok cIdentified in 133 C5 + / - F2 progeny .
# ::alignments 8-9|0 5-6|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:11.866
(p / progeny 
      :op1-of (s / slash))

# ::snt QTL , quantitative trait loci ; RA , rheumatoid arthritis .
# ::tok QTL , quantitative trait loci ; RA , rheumatoid arthritis .
# ::alignments 9-10|0.0.0 8-9|0.0.0.0 6-7|0.0 5-6|0 4-5|0.0.0.1.0 3-4|0.0.0.1 2-3|0.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:11.893
(a2 / and 
      :op1 (r2 / ra 
            :mod-of (a / arthritis 
                  :mod (r / rheumatoid) 
                  :op1 (t / trait 
                        :mod-of (l / locus 
                              :mod (q / quantitative))))))

# ::snt Summary of the small-effect QTL candidate genes .
# ::tok Summary of the small-effect QTL candidate genes .
# ::alignments 6-7|0.0 5-6|0.0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:11.905
(s / summary 
      :poss (g / gene 
            :mod (c / candidate)))

# ::snt aFold change calculated by comparing DBA/1 with FVB/N .
# ::tok aFold change calculated by comparing DBA/1 with FVB/N .
# ::alignments 7-8|0.1.0.0.0+0.1.0.0+0.1.0 4-5|0.1 2-3|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:11.924
(c2 / calculate-01 
      :ARG0 (c3 / change-01) 
      :ARG1 (c / compare-01 
            :ARG2 (t / thing 
                  :name (n / name 
                        :op1 "FVB/N"))))

# ::snt bFold change calculated by comparing post-immunisation ( PI ) , onset of arthritis ( OA ) and chronic arthritis ( CA ) with naive control ( NC ) , respectively .
# ::tok bFold change calculated by comparing post-immunisation ( PI ) , onset of arthritis ( OA ) and chronic arthritis ( CA ) with naive control ( NC ) , respectively .
# ::alignments 29-30|0.0.0.0.0.1 26-27|0.0.0.0.1.0.1+0.0.0.0.1.0.0.0+0.0.0.0.1.0.0+0.0.0.0.1.0 24-25|0.0.0.0.1 23-24|0.0.0.0.1.2 20-21|0.0.0.0.1.1.1+0.0.0.0.1.1.0.0+0.0.0.0.1.1.0+0.0.0.0.1.1 18-19|0.0.0.1 17-18|0.0.0.1.0 16-17|0.0.0 14-15|0.0.0.0.0.0.0.0.0+0.0.0.0.0.0.0.0+0.0.0.0.0.0.0 12-13|0 10-11|0.0 7-8|0.0.0.0.0.0.1.0.0+0.0.0.0.0.0.1.0+0.0.0.0.0.0.1 4-5|0.0.0.0 2-3|0.0.0.0.0 1-2|0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:12.445
(a3 / arthritis 
      :mod-of (o2 / onset 
            :op1-of (a2 / and 
                  :ARG1-of (c3 / compare-01 
                        :ARG1-of (c4 / calculate-01 
                              :ARG0 (c5 / change-01 
                                    :ARG1 (o / organization 
                                          :name (n4 / name 
                                                :op1 "OA")) 
                                    :op1-of (o3 / organization 
                                          :name (n5 / name 
                                                :op1 "PI"))) 
                              :ARG2 (r / respective)) 
                        :ARG2 (c / control-01 
                              :ARG0 (s / state 
                                    :name (n / name 
                                          :op1 "NC") 
                                    :wiki "North_Carolina") 
                              :ARG1 (s2 / state 
                                    :name (n3 / name 
                                          :op1 "CA") 
                                    :wiki "California") 
                              :mod (n2 / naive))) 
                  :op2 (a / arthritis 
                        :mod (c2 / chronic)))))

# ::snt Chr. , chromosome ; CIA , collagen-induced arthritis .
# ::tok Chr. , chromosome ; CIA , collagen-induced arthritis .
# ::alignments 7-8|0.1.1 6-7|0.1.1.0 4-5|0.1.2+0.1.0.0+0.1.0+0.1 3-4|0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:47:12.479
(a2 / and 
      :op1 (c2 / chromosome) 
      :op2 (g / government-organization 
            :name (n / name 
                  :op1 "CIA") 
            :poss-of (a / arthritis 
                  :mod (c / collagen-induc)) 
            :wiki "Central_Intelligence_Agency"))

